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Introduction 
RESEARCH, BIOBANKS, ETHICS AND ISLAM. AN INTRODUCTION 
An increasing number of medical studies are focusing on the genetics and 
the environment. Understanding inherited diseases is important in order 
to find new treatments. Many research centers around the world have 
started to establish biobanks for the purposes of acquiring tissue samples 
to advance genetic research and surveys.1 However, large population-
based research biobanks are not just enormous repositories of human 
biological materials (blood, saliva, DNA, etc.) they also contain an 
enormous amount of data, such as personal information, clinical data, 
genomic profiles, and medical history of the participants.2,3  
Research biobanks raise many ethical, legal, and social issues regarding 
things such as confidentiality and privacy,4 obtaining approval to 
participate in research,5,6 like one-time consent, the right to withdraw 
consent and the degrees of this withdrawal,6-8 issues related to 
commercial use of information including the possibility of selling it, 
intellectual property issues,9 and benefit to society.10  
Confidentiality is an important principle in clinical and genetic research. 
Confidentiality clauses appear in many international documents, e.g., the 
Declaration of Helsinki, ICH-GCP, CIOMS guidelines, and the Universal 
Declaration on the Human Genome and Human Rights.37 Moreover, the 
protection of patient information is considered a major ethical concern in 
research biobanks.11-14 While it is generally acknowledged that the 
confidentially of all information should be protected, this axiom is often 
ignored and sometimes violated in practice.15 
Even though sample and data information is supposed to be collected on 
an individual basis, in practice, it is not. All family members share similar 
genetic profiles; moreover, in some societies where the tribal system is 
still strong, as in Saudi Arabia, the tribes have, to some degree, cognate 
genes. Stigmatization and harm will not be individual, but familial, and 
maybe tribal.16 In Muslim communities, where marrying relatives is often 
favoured, the family system is built on accurate selection criteria. In most 
cases, marriage decisions are not individual decisions, but familial ones; 
family image and certain stigma can often do play a role. Furthermore, 
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people who may wish not to be involved in research biobanking will still 
be indirectly involved, at least to some extent  through samples collected 
from their close relatives. Respecting medical confidentiality is a basic 
issue in Islam. The disclosure of information may be justified for some 
reasons, especially to avoid larger harms. Even so, this disclosure must not 
cause discrimination and/ or stigma, which must be avoided according 
Islamic law. 
Confidentiality in research is essential because participants disclose 
personal information by the participants to the research team. This 
disclosure must be voluntary for the participants and obtained by using a 
complete informed consent form, preapproved by Institutional Review 
Board. However, obtaining informed consent from the participants is a 
very complicated and controversial topic.7, 17-20 A vast body of literature 
has been published discussing the significance, limitations, and 
inadequacy of informed consent in promoting voluntary participation in 
research.21-23 There are specific issues related to applying informed 
consent in research biobanks, such as sufficient information in consent, 
one-time consent for unlimited research on donated samples, and the 
degrees of withdrawal.   
The principle of informed consent is even mentioned in Islamic law. Some 
issues have social effects (like who has to sign it) and must be investigated. 
Obtaining samples from children for the biorepository is both crucial and 
problematic. Considering children’s vulnerability and their need for 
greater protection, the inability to provide consent raises many ethical 
questions regarding their participation in research as well as sample 
submission for biobanks. These issues prompt many questions; such as 
whether or not children should be participants in biobanks, considering 
very little or no direct benefits, and some inherent risk to be associated 
with it; which should be the proper age for a child to be able to give 
consent; who should give consent for minors; is it sufficient to obtain 
consent from one parent and which parent? Bearing in mind that genes 
are shared with other family members, should these other members have 
rights in taking decisions about participation in research biobanks?16  
Islam shares Western perspectives about offering protection to children. 
For examples, a guardian has to behave with according the best interests 
of the child in mind. However, differences may be found, especially 
concerning who the guardianis. 
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Other ethical issues relating to research biobanks, such as samples and 
information ownership of return of results, will not be disccused in this 
thesis. These issues require an extensive research and can be debated in 
other literature. 
Main challenges in the three studied ethical issuess 
Main challenges in the three studied ethical issuess 
Respect of confidentiality Justified disclosure of information 
Prevent discrimination 
Prevent stigmatization 
Informed consent Obligation of informed consent 
Voluntary 
Ability to decide 
Enough information 
Understandable information 
Withdrawal 
Degrees of withdrawal 
One time consent 
Children particpation Allowing research on children 
At which age child can participate 
Guardian consent 
Child assent 
Best interest of child 
Re-consent at adulthood 
Who is the guardian 
RATIONAL AND IMPLEMENTATION OF DOCTORAL THESIS 
Research biobanks can offer great benefits for science and health care. 
However, they raise many ethical challenges. These challenges may have 
different perspectives in Muslim countries, where some research 
biobanks start to appear. 
The Saudi Biobank (SB) in Riyadh/Saudi Arabia is one of the newly 
established national research biobanks. It includes 200,000 participants, 
half of them having one or more common diseases, such as hypertension, 
asthma, and diabetes; the remaining participants are healthy individuals 
serving as controls for longitudinal studies.  
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The Saudi Biobank is very different from other biobanks, especially those 
in Europe and North America, because of the region’s distinct social issues 
and its ethics system built on Islamic values and fatwas. Islamic opinion 
about any matter, especially recent matters is called a fatwa. Fatwas are 
usually issued by a scholar (called then an individual fatwa) or by a juristic 
council (called a plural fatwa). Plural fatwas are stronger than an 
individual one, and have an increasing interest.24,25 There two main 
groups of Muslims: Sunni 87-90% of total number of Muslims, and Shia 
10-13%. Saudi population is mostly Sunni.26 
The Saudi society is characterized by large family size (eight members on 
average) (Saudi Ministry of Planning, 2007), the presence of genetic 
isolates and semi-isolates, and, above all, by a very young population in 
general. It is important to note that 32.5% of the population is younger 
than 15 years old and only 2% is above the age of 65 years.27,28 There is a 
high rate of consanguinity and genetically inherited diseases in Saudi 
Arabia.29 Considering these social parameters, the Saudi Biobank has been 
built with a focus on family repositories rather than individual ones . 
Although the Saudi Biobank abides by global ethical values, such as 
autonomy, confidentiality, justice, protection, and the non-
commercialization of human tissue, it is not clear whether these values 
are implemented, understood and interpreted to the same way in Saudi 
Arabia because they may be influenced by different social, cultural, and 
religious factors. Consequently, the transfer of these values and concepts 
to research biobanks is ambiguous and complex. 
Obtaining informed consent and maintaining the confidentiality is a well 
discussed topic in medical research.30 The Pub MED search using the 
words (confidentiality + research) results in more than 5,000 articles, 
however, none of these articles focuses on the Islamic society 
perspectives. To our knowledge, there is no empirical research related to 
the ethics of research biobanks, informed consent and participant’s 
confidentiality in Islamic countries. We were also unable to find any 
report regarding the children’s participation in medical research and 
biobanks in the Middle East. Considering the unique social, cultural and 
religious background in the Middle East, special attention should be given 
to maintain the autonomy and confidentiality of the research 
participants. This includes, but is not limited to, both confidentiality 
obligations and infringement justifications. 
17 
 
Participation of children in medical research is a poorly addressed issue in 
the Muslim countries, such as Saudi Arabia. Even if confidentiality and 
autonomy are shared human values among Muslims, applying those 
ethical principles to research biobanking in countries with a majority of 
Muslims, like Saudi, raises many questions. The first question is how the 
tradition and culture of this region is similar compared to the global 
standards and how are they different? The second question is: Can we 
successfully apply the autonomy and confidentiality concepts in research 
biobanking and genetic research in the Saudi Arabia or are they just 
putative concepts? And if we cannot apply them completely, what are the 
justifications for and possible risks of infringement? Will those 
infringements be accepted universally? Does participation of children in 
Saudi Biobanks have different challenges than what is seen in the western 
world? What is the position of Islam regarding pediatric research? In 
male-dominated tribal and Muslim communities such as the Saudi 
community,31 what role should the parents play? Additionally, who should 
be given the priority between the two parents in case of any conflict 
related to the participation of a child in a research study? In this study all 
people 18 years old and younger are called children, while those are 
above 18 are simply called people or persons. 
In this PhD project we aim to investigate the ethical issues related to 
medical/biobanking research in the context of Islamic and Middle East 
countries. Based on this investigation, we will attempt to provide answers 
to the above mentioned questions and recommend guidelines which can 
be used by fellow researchers, policy makers, and ethics committees in 
the Islamic and Middle Eastern countries as well as other countries where 
Muslims are a component of society.  We especially focus on three issues: 
confidentiality, informed consent and children participation in research 
biobanks which are very important and unsearched issues in Islamic and 
Middle East world. 
Our proposed ethical inquiry and subsequent recommendations will be 
achieved by completing the following includes: 
Part I: A state-of-the-art of current research ethics and practices is 
reviewed in the context of Islam and in the Middle East.  
Our reviews are performed in two phases. In phase one, we investigate 
the influence of Islamic values on the confidentiality and participation of 
children in clinical research. We explore the issues related to patient 
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confidentiality and potential conflicts with this practice as a result of 
institutional fatwas* released by international, regional, and national 
Islamic Sunni juristic councils. We discuss how these fatwas affect 
research and publication by Muslim doctors, researchers, and Islamic 
medical organizations. Next we have investigated the guidelines from 
thirteen Arabic countries in the Middle East region considering the ethical 
principles stated in the international guidelines.    
Part II: Empirical inquiries into current ethos of the Islamic community 
regarding confidentiality, informed consent and research on children. 
To review the opinion of medical professionals in the Middle East region, 
we first perform semi-structured interviews with professionals who are 
actively involved in usage of stored tissue samples to perform genetic 
research. This qualitative study is followed by a survey among different 
professionals (medical doctors, students and researchers), lay people and 
participants in the Saudi biobank. We use SPSS 18.0 to perform statistical 
analysis.  
Part III: A theoretical analysis of the existing governance of the Saudi 
biobank.   
Saudi Biobank governance is investigated and checked against the 
concepts and themes derived from the first and the second phase of this 
study. 
We examine the similarities, differences, strengths and weaknesses of the 
current governance of Saudi Biobank (SB) regarding three major ethical 
issues: confidentiality, informed consent and children’s participation in 
research, compared to some selected western national biobanks. We 
evaluate these issues in relation to both international guidelines and 
Islamic law. Then we briefly explore the access policy for the scientific 
community towards SB.    
Part IV: Developing an Islamic opinion on research biobanks in the 
Middle East and Islamic countries. 
Based on the in-depth reflections of the previous parts, we will develop 
an opinion that reflects Islamic methods in reasoning and fatwas. 
                                                             
* A fatwa is a religious opinion concerning Islamic law about a specific matter.   
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Within our methodology, many factors have to be explored in order to get 
a better look at our inquiry about the ethics of research biobanks 
according to Islam. Our methodology includes exploring religious views 
through studying related fatwas, the impact of social factors and Islam on 
people in this area via empirical studies, and regulations placed on 
research and biobanks. All of these can lead to a view that may express 
the real situation about research biobanking perspectives in Muslim 
communities. However, communities in Saudi Arabia and the Arabic 
countries in the Middle East (where the quantitative and qualitative 
research was done) represent just a small proportion of the Islamic world. 
Therefore, we cannot guarantee that it will represent Muslims 
everywhere. We even attempted to study institutional fatwas that 
represent the plural opinions of Muslim scholars, many of whom do not 
share the same point of view.   
Part V: Summary and conclusion 
Next, we present our findings and formulate recommendations not only 
regarding the use of stored tissue samples in research, but also about 
including children and their tissues and about research ethics in general 
in the context of the Middle East. These recommendations can be used 
by researchers, ethics committees and policy makers. 
OUTLINE OF THE DOCTORAL THESIS 
The chapters that form the body of this thesis are composed of papers 
that have been published in or have been submitted to peer-reviewed 
journals. Therefore, they may contain some repetition in the introductory 
paragraphs. 
In Part I, we present the current state of art. In chapter 1 we present the 
Islamic position about medical and research confidentiality and the 
justified breaches of confidentially. In chapter 2 we provide the Islamic 
position regarding research on children. In chapter 3 we provide a review 
of research ethics guidelines in 13 Arabic countries compared with 
international guidelines. 
In Part II, we investigate the current ethos surrounding the topic of ethics 
of research biobanks in Islamic environment. In chapter 4 we present 
findings of in-depth interviews of professionals in the Middle East area. In 
chapter 5 and chapter 6 we describe our findings of a survey about 
20 
 
confidentiality and children participation in research conducted on 
different groups in King Abdulaziz Medical City in Riyadh Saudi Arabia. 
In Part III, in chapter 7, we describe our finding of a comparison of the 
governance of Saudi biobank with four different western biobanks. Then 
we describe access policy in SA biobank. 
In Part IV, we apply our findings from part I, part II and part III to generate 
a normative reflection and develop an opinion about ethics of research 
biobank that we think reflects an Islamic position in the chapter 8.  
In Part V, we present our findings, we provide recommendations for 
researchers and policy makers from professional organizations and give 
some suggestions for future research biobanks in Muslim countries and 
other countries that have Muslim minorities. 
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PART I: Medical Research & Islam 
Chapter 1 
What Do Islamic Institutional Fatwas Say About Medical And 
Research Confidentiality And Breach Of Confidentiality? 
Alahmad, G., & Dierickx, K. 
(2012)..Developing world bioethics, 12(2), 104-112.  
ABSTRACT 
Protecting confidentiality is an essential value in all human relationships, 
no less in medical practice and research.1 Doctor-patient and researcher-
participant relationships are built on trust and on the understanding those 
patients' secrets will not be disclosed.2 However, this confidentiality can 
be breached in some situations where it is necessary to meet a strong 
conflicting duty.3 
Confidentiality, in a general sense, has received much interest in Islamic 
resources including the Qur'an, Sunnah and juristic writings.4-6 However, 
medical and research confidentiality have not been explored deeply. 
There are few fatwas about the issue, despite an increased effort by both 
individuals and Islamic medical organizations to use these institutional 
fatwas in their research.  
Infringements on confidentiality make up a significant portion of 
institutional fatwas, yet they have never been thoroughly investigated. 
Moreover, the efforts of organizations and authors in this regard still 
require further exploration, especially on the issue of research 
confidentiality. 
In this article, we explore medical and research confidentiality and 
potential conflicts with this practice as a result of fatwas released by  
international, regional, and national Islamic Sunni juristic councils. We 
discuss how these fatwas affect research and publication by Muslim 
doctors, researchers, and Islamic medical organizations. 
We argue that more specialized fatwas are needed to clarify Islamic 
juristic views about medical and research confidentiality, especially the 
circumstances in which infringements on this confidentiality are justified.  
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BACKGROUND 
The protection of patients in clinical practice and human participants in 
medical research is of the utmost concern to healthcare providers and 
researchers.7 Both clinical practice and research about individuals and 
groups require collecting information and data. However, exposure of this 
personal information can lead to physical or psychological harm to those 
individuals. Thus, healthcare providers and researchers are obligated to 
protect the confidential information of their clients.1 
Confidentiality is an important and shared human value. It is mentioned 
in international bioethical guidelines, such as the Helsinki declaration, the 
Belmont report, the guidelines of the Council for the International 
Organization of Medical Sciences (CIOMS), and many others.8-10 
It is vital to establish positive, trusting relationships between doctors and 
patients and between researchers and their study participants. 
Confidentiality is not simply an expectation of patients built on trust nor 
just a legal matter.3 It also might raise rates of participation in 
research,11,12 which makes it very important to encourage research 
participants to disclose confidential information.13,14 Moreover, it involves 
an ethical responsibility to ensure that doctors and researchers are aware 
of the parameters of applying medical confidentiality. The issue of 
medical confidentiality becomes more serious when breaching privacy 
and confidentiality leads to discrimination (taking an action against or 
negative attitudes toward a person based on variations in his or her 
genome)15 or stigmatization (socially or economically categorizing people 
according to their attitudes, stereotypes, beliefs, or medical 
conditions)16,17 
Breaching confidentiality can be acceptable or required by medical 
authorities when failure to act could lead to physical harm to either to the 
patient or to people in contact with that patient; such is the case for 
progressive, infectious diseases, where the doctor or researcher has a 
duty to protect the health of those who may be at risk.3 Genetic diseases 
can also cause ethical conflict given that genetic information is not just 
individual, but also familial.3  
Medical confidentiality is a type of confidentiality which is in general an 
important concept in Islam based on the three Islamic principles: first, the 
prohibition against backbiting, as mentioned in Quran: "neither backbite 
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one another" (Qur'an: Dwellings 12); second, the duty to protect secrets; 
and third, the consideration of the protection of confidentiality as a kind 
of loyalty, which has to be saved from harm. This is based on several 
Quranic verses, especially the verse where some characteristics have 
been highly appreciated: "Those who are faithfully true to their Amanât 
(all the duties which Allâh has ordained, honesty, moral responsibility and 
trusts) and to their covenants" (Qur'an: The believers 8).4-6 
Institutional fatwas about medical confidentiality have not been studied 
and remain poorly understood by non-Arabic authors. Indeed, there is 
little to no research on the topic of confidentiality and Islam published in 
English. 
METHODS AND RESOURCES 
A fatwa is an Arabic word used in the Islamic jurisprudence, and means a 
religious opinion concerning Islamic law about a specific new matter 
issued by an Islamic scholar according general Islamic perspectives and 
depending on the primary Islamic resources like Qur'an, Sunnah, 
consensus, and analogy, besides some secondary resources. The mufti 
(the person who issues fatwa) must be well informed about both Islamic 
jurisprudence and about the matter of the fatwa to be issued.18 
In recent decades a new mechanism has grown for the issuance of 
contemporary fatwas: the emergence of collective opinions through 
special institutions has been established for this purpose rather than 
individual opinions that dominated the long history of Islamic 
jurisprudence.19 In those institutes known as "juristic councils", a number 
of jurists and experts from various fields of juristic, cultural, scientific and 
economic knowledge meet together to study new problems of 
contemporary life and to provide integral solutions emanating from 
Islamic heritage and the evolution of Islamic thought.20 
According, the Sunni School individual fatwas are non-binding; 
institutional fatwas have more authority and some scholars even consider 
them as a kind of consensus, and consequently they understand 
institutional fatwas as binding, and can be abrogated only by another 
institutional fatwa.21 This legitimacy of institutional fatwas gives them 
more impact, compared with individual fatwas. On the other hand, we 
can see some overlapping between the individual and institutional fatwas, 
especially when members of these institutions issue their own fatwas 
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individually because the scholar may have a different opinion than the 
opinion taken by the institution, considering that the institutional fatwa 
is the opinion of the majority but not  all of the members.22   
However, because there are neither well defined functions of these 
councils nor a clear system to choose their members, they face some 
difficulties. They only issue religious decisions but have no power to 
impose their fatwas legally for two reasons as understood by some 
authors: first because they are not established on a constitutional basis 
that guarantees their effectiveness, and secondly because they do not 
have well defined tasks. Even in the context of these difficulties, juristic 
councils remain the chief resource of fatwas that formulate Islamic point 
of view regarding many new matters.23  
These juristic councils are national, regional, or international in scope, as 
illustrated in Table 1. 
National councils are established in each country separately, usually by 
the respective governments, and take a variety of names, like: Dar al-Ifta 
al-Massriyyah [Egypt] (http://www.dar-
alifta.org/default.aspx?LangID=1&Home=1), General Presidency of 
Scholarly Research & Ifta [Saudi] (http://www.alifta.net/Default.aspx), 
and Islamic Fiqh Academy (India) (http://ifa-india.org/index.html). 
The second type of juristic councils are those managed regionally, where 
a number of scholars from a few countries in a certain geographical area 
meet, independent of governmental supervision, such as the European 
Council for Fatwa and Research (ECFR) (http://www.e-cfr.org/ar/), the 
Assembly of Muslim Jurists of America (http://www.amjaonline.com/), 
and the Sharia Scholars Association of the Gulf Cooperation Council 
(http://sslgcc.org/index.php). 
Finally, there are international juristic councils, of which there are only 
two: the International Islamic Fiqh Academy 
(http://www.fiqhacademy.org.sa/), which is a part of an inter-
governmental organization called : The Organization of the Islamic 
Conference (OIC), and the Islamic Fiqh Council IFC 
(http://www.themwl.org/bodies/default.aspx?d=1&bid=2&l=AR), which 
is part of a larger, independent organization called the Muslim World 
League. Fatwas stated by both of these two international councils play a 
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significant role in international practice and, in fact, act as referees for 
regional organizations and researchers.3,5,24,25 
TABLE 1: Different Types of Juristic Councils 
Juristic Councils 
International 
(Worldwide) 
International Islamic Fiqh Academy 
Islamic Fiqh Council in the Muslim World League 
International 
(Regional) 
European Council for Fatwa and Research (ECFR) 
Assembly of Muslim Jurists of America 
Sharia Scholars Association of the Gulf Cooperation Council 
Assembly of scholars of countries of al-Sham 
National 
(Examples) 
General Presidency of Scholarly Research and Ifta [Saudi] 
Dar al-Ifta al-Massriyyah [Egypt] 
Islamic Fiqh Academy (India) 
Fatwa Committee of the National Council for Islamic Affairs Malaysia 
Islamic Religious Council of Singapore 
Dar al-Ifta (Palestine) 
The Presidency of Religious Affairs (The Republic of Turkey) 
Jordanian General Ifta Directory 
Collections of fatwas released by these three types of councils can be 
found on their websites and in their publications, such as the Journal of  
the Islamic Fiqh Academy. 
In addition to these formal councils, another form of group effort is 
emerging from a different kind of institute, such as the Islamic 
Organization for Medical Sciences (IOMS) 
(http://www.islamset.com/ioms/code2004/index.html) and the Islamic 
Medical Association of North-America (IMANA) (www.imana.org/). These 
institutes are not juristic councils but medical organizations or 
associations interested mainly in issues related to medicine. Although 
they do not release fatwas, they are interested in studying both juristic 
medical fatwas and the various aspects of Islam and medicine. 
In addition, there are a few remarkable individual efforts to use these 
institutional fatwas. This effort involves both jurists, such as Ibn Baz and 
Al-Jubear, and medical doctors, such as Chamsi Pasha and Albar.26,27 
Because there are many similarities among the different Muslim doctrines 
with regard to new juristic issues, we have limited this study to Sunni 
jurisprudence schools because they represent a clear majority (87 %–90 
%) in Muslim populations.28 
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In this study, we survey institutional fatwas related to confidentiality in 
medical practice and research, and we compare them with the work of 
individual Muslim authors and with international documents. We include 
three types of juristic councils, including the only two universal juristic 
councils: the International Islamic Fiqh Academy and the Islamic Fiqh 
Council IFC;  all regional councils (four councils): European Council for 
Fatwa and Research (ECFR), Assembly of Muslim Jurists of America, Sharia 
Scholars Association of the Gulf Cooperation Council and Assembly of 
scholars of countries of al-Sham, as well as eight national juristic councils: 
Dar al-Ifta al-Massriyyah [Egypt], General Presidency of Scholarly 
Research & Ifta [Saudi], and Islamic Fiqh Academy (India), Fatwa 
Committee of the National Council for Islamic Affairs Malaysia 
(http://www.e-fatwa.gov.my/), Islamic Religious Council of Singapore 
(http://www.muis.gov.sg/cms/index.aspx), Dar al-Ifta [Palestine] 
(http://www.darifta.org/), The Presidency of Religious Affairs [The 
Republic of Turkey] (http://www.diyanet.gov.tr/arabic/default.asp), and 
the Jordanian General Ifta Directory 
(http://www.aliftaa.jo/index.php/ar/decisions/list). We selected these 
eight national councils because they offer online access to their fatwas, 
either in Arabic or in Arabic and English.  
Because of their broad-reaching intent, including answering ad hoc 
medical questions based on fatwas and the anonymity of their medical 
and juristic contributors, we have excluded certain Islamic web sites from 
this study: www.islamonline.net, www.islamweb.net, 
www.islamicity.com, www.islam.tc, www.islamtoday.com, and 
www.understanding-islam.com.29 
RESULTS 
As the technology used in medical treatment and research rapidly 
evolves, many new ethical dilemmas have emerged. As a result, many 
Muslim doctors and researchers are increasingly asking for guidance on 
how to apply the laws of Islam in these cases. Juristic institutes have 
begun to reflect on these issues and to find solutions, issued in the form 
of fatwas. For this study, we have classified our results into two main 
categories: medical confidentiality and research confidentiality. However, 
we make a distinction for the conditions of justified breach of 
confidentiality for both categories, under a separate paragraph. 
Medical confidentiality 
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A thorough review of current fatwas concerning medical confidentiality 
uncovered a special fatwa released by the International Islamic Fiqh 
Academy (A1: Table 2). This lengthy fatwa was included in its decision No. 
79 (10 / 8) 1993, and addresses the obligation of maintaining medical 
confidentiality but states that, in some cases, it is both allowed and, 
indeed, mandatory to disclose confidential information.30 These 
exclusions will be discussed below. 
This fatwa invited ministries of health and health sciences colleges to 
include confidentiality in their programs; they encouraged the colleges to 
add this subject to their courses, to teach doctors about it, and to 
encourage their faculty to pursue research on the issue.30 
With the limited exception of the Fiqh Academy (India), no other fatwa 
related to medical confidentiality has been stated by national councils 
(Table 2). 
Research confidentiality 
In 2005, IOMS not only translated the "International Ethical Guidelines for 
Biomedical Research Involving Human Subjects, 2002" released by CIOMS9 
but also compared all items in this document with relevant aspects of 
Islamic jurisprudence, thus clarifying the Islamic position on the issues 
presented in this document.31 In the section regarding confidentiality, this 
document includes some parts of the fatwa of the International Islamic 
Fiqh Academy about medical confidentiality No. 79 (10/8) 1993 (A1: Table 
2); especially the obligation of confidentiality, and the conditions that 
justifies a breach.31 
The international Islamic Fiqh Academy accepted and included this 
document in its fatwa number No. 161 (11/17) issued in June 2006 that 
discusses the Islamic perspectives on medical and biological research on 
human subjects.32 (B: Table 2). 
The Islamic Fiqh Council (IFC) in the Muslim World League only addressed 
two issues directly, namely, genetic engineering and stem cell 
research.33,34 In fatwa number 1, cycle 15 (October 31, 1998), the council 
stipulated professional obligations in genetic research, such as the 
accurate evaluation of risk, informed consent, confidentiality, and 
maintaining respect for human dignity.33 (C: Table 2) In fatwa number 3, 
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cycle 17 (January 1,2002), about stem cells, the council did not mention 
respect of confidentiality.34 
TABLE 2: Comparison of Councilor Fatwas about Confidentiality 
Results 
 Clinical 
Confidentiality 
Research 
Confidentiality 
Breach of 
Confidentiality 
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(W
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rl
d
w
id
e)
 International Islamic Fiqh 
Academy 
Special fatwa 
about medical 
confidentiality 
No. 79 (10/8) 
1993 (A1) 
Confidentiality is 
included in fatwa No. 
161 (11/17) June 2006 
(B) 
Special fatwa about 
medical 
confidentiality No. 79 
(10/8) 1993 (A2) 
Islamic Fiqh Council in the 
Muslim World League 
No fatwa 
Confidentiality is 
included in fatwa 
number 1, cycle 15 
(October 31, 1998) (C) 
No fatwa 
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n
al
) 
European Council for 
Fatwa and Research 
(ECFR) 
No fatwa No fatwa No fatwa 
Assembly of Muslim 
Jurists of America 
Sharia Scholars 
Association of the Gulf 
Cooperation Council 
Assembly of scholars of 
countries of al-Sham 
N
at
io
n
al
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o
u
n
ci
ls
 
General Presidency of 
Scholarly Research and 
Ifta [Saudi] 
No fatwa No fatwa No fatwa 
Dar al-Ifta al-Massriyyah 
[Egypt] 
Fatwa Committee of the 
National Council for 
Islamic Affairs Malaysia 
Islamic Religious Council 
of Singapore 
Dar al-Ifta (Palestine) 
The Presidency of 
Religious Affairs (Turkey) 
Jordanian General Ifta 
Directory 
Islamic Fiqh Academy 
(India) 
No specific 
fatwa  
No fatwa 
Fatwa (8/1) 33/ 1995 
regards the ethics 
and duties of a 
doctor. (D) 
Fatwa (8/1) 35/ 1995 
regard ADIS and its 
rules. (E) 
 
Not a single one of the national juristic councils have issued any fatwas on 
the issue of medical research or research confidentiality. 
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Justified infringements of confidentiality 
In a fatwa (A2: Table 2) issued by the International Islamic Fiqh Academy, 
jurists affirmed that a breach of confidentiality can be acceptable only if 
the harm of maintaining confidentiality overrides its benefits.30 In fact, 
this fatwa distinguished between two types of exclusions―conditions for 
which breaching confidentiality is required and those in which it is allowed 
but not required. This fatwa did not mention every case; however, it gave 
two forms, or examples, of each type. In cases in which a breach of 
confidentiality is obligatory, the intent of this breach must be to prevent 
harm either to society or individuals. In cases in which a breach of 
confidentiality is allowed but not required, the doctor or researcher must 
see that such a breach would bring benefits to an individual or society or 
be a means to prevent general harm.30 
This particular fatwa calls for national medical guidelines to detail the 
conditions under which a breach of confidentiality is necessary and both 
how and to whom this information should be reported. The fatwa 
recommended that authorities notify medical professionals about these 
conditions and procedures.30 
The Islamic Fiqh Academy (India) has not issued any special fatwa 
concerning medical confidentiality. However, the issue has been 
mentioned in two other fatwas.35,36 In its fatwa regarding the ethics and 
duties of doctors, the Indian Academy required that a patient's personal 
information be shared if it can be used as proof that someone did not 
commit a crime or to notify public safety authorities if a driver is impaired 
by poor vision or drug and alcohol use at the time an accident occurs (D: 
Table 2).35 In another fatwa regarding AIDS, the council insists that it is not 
appropriate to hide a patient's disease (AIDS) if it may cause harm to their 
family or community (E: Table 2).36 
None of the juristic institutes have discussed specific cases in which 
confidentiality can be breached in medical research.  
DISCUSSION 
Medical Confidentiality: 
Institutional interest in medical confidentiality can be seen in two kinds of 
fatwas: fatwas addressing confidentially exclusively, such as the fatwa of 
the International Islamic Fiqh Academy (A1: Table 2),30 and fatwas 
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addressing other medical issues that deal secondarily with confidentiality, 
such as the fatwas of the Islamic Fiqh Academy (India) (D & E: Table 2).35,36 
The first fatwa (A1: Table 2) is the most important fatwa to deal with 
confidentiality, because it is a detailed fatwa, and entirely focused on the 
confidentiality. It was issued in 1993 and clearly states the obligation of 
maintaining medical confidentiality in the medical profession.30 
Moreover; it elucidates some situations in which breaching confidentiality 
is allowed or mandatory.30   
Twelve years earlier, in 1981, the Islamic medical oath was developed by 
the IOMS during the first international conference about Islamic 
medicine; this oath contained a paragraph addressing respecting patients' 
confidential information.37 This was the first institutional organization to 
make a statement about medical confidentiality from an Islamic point of 
view; individual scholars, such as al-Razi (825-925) and Ibn Abi Usaibia 
(1203-1270) had raised the issue long before. 38,39  
Fatwa A1 (A1: Table 2)30 had great influence and has been used as a 
cornerstone by many authors, such as Al-Jubear and Jundi, who are not 
necessarily interested in confidentiality but in sound medical practice.40-
44 Even in this context, these scholars do not explore confidentiality in any 
real depth; instead, they frequently repeat one another’s insistence on 
the obligation of confidentiality without touching on sensitive areas such 
as genetic information. A review of the literature on this subject identified 
only two books that specialize in medical confidentiality, those by Al-
Jubear and Ahmad.4 Both authors and jurists explain confidentiality in 
general terms and try to apply Islamic principles about confidentiality to 
medical confidentiality using fatwa A1. However, we notice other authors, 
such as Arafea and Mubarak, are not aware of fatwa A1 and do not 
mention it in their publications.5,6  
The absence of any direct mention of medical confidentiality in the Qur’an 
and the Sunnah cause doctors and scholars to depend more on fatwa A1. 
For authors who were unaware of this fatwa, the absence of direct 
instruction in the Qur’an and the Sunnah did not cause any problems; they 
simply relied on the general Islamic principle of protecting confidentiality 
in order to construct an appropriate policy in the medical context.  Muslim 
authors often refer to the three basic tenants of Islam that seem to apply: 
the prohibition against backbiting, the prohibition against any 
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unnecessary exposure of secrets, and the consideration of the protection 
of confidentiality as a kind of loyalty.4,5,7  
Fatwa A130 is compatible with nonreligious international guidelines, such 
as the Declaration of Helsinki and the Belmont Report, which state the 
importance and obligation of medical confidentiality.8,10 
Given the importance of fatwa A1,30 it seems special that there are no 
other fatwas about confidentiality issued by other councils. What could 
be the reasons for this? Is it, perhaps, that medical confidentiality is not 
an important principle in Islamic jurisprudence? Or, perhaps fatwa A1 is 
enough to clarify the issue for Muslim doctors worldwide? Given the 
results of this research, it is our opinion that even though fatwa A1 is an 
important fatwa and sets forth an important ethical principle, jurists do 
not appear to be fully aware of the dimensions concerning confidentiality, 
especially in certain sensitive issues related to genetic diseases or sexually 
transmitted infections. Moreover, some of the juristic institutes listed 
here—specifically, the Sharia Scholars Association, the Gulf Cooperation 
Council Countries, and the Assembly of Scholars of Countries of al-Sham—
are all newly established and either may not be interested in the issue of 
medical confidentiality or yet prepared to issue fatwas on such complex 
issues. 
Research Confidentiality: 
Our review of fatwas concerning medical research on both the national 
and international levels shows that there is a general lack of instruction in 
this area. Moreover, the few fatwas that do address these issues are more 
likely brief general statements that lack the specificity required for 
navigating the increasingly complex arena of medical research and 
research confidentiality.      
It is our hypothesis that the reason that so few fatwas on the subject of 
research confidentiality and medical ethics have been issued is a 
reflection of the fact that the field of medical research is still relatively 
new, and despite the rapid progress in other developed countries, it is still 
in its infancy in most Muslim countries. As fatwas are traditionally written 
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in response to actual problems and pressing problems, this latter point 
seems especially germane.* 
In 1998, the Islamic Fiqh Council (IFC) in the Muslim World League issued 
a fatwa (C: Table 2) that addressed the ethical obligations required in 
genetic research.33 This fatwa was very narrow in focus, and the issue of 
confidentiality was given very little attention. As a result, this fatwa is 
insufficient.   
The most important and comprehensive treatment of research ethics and 
Islam came in 2005 when the IOMS translated and analyzed the 
"International Ethical Guidelines for Biomedical Research Involving 
Human Subjects" from an Islamic perspective.31 The outcome was a 
document entitled "International Ethical Guidelines for Biomedical 
Research Involving Human Subjects—Islamic View,"31 which I believe is 
the most important statement concerning Islamic guidelines for medical 
research. In this document, the IOMS agrees with fatwa A1 regarding the 
obligation of confidentiality in medical practice.31  
The IOMS document31 was so influential that after only one year, the 
Islamic Fiqh Academy referred to it and accepted it into their fatwa on the 
issue (B: Table 2).32 This reference only increases the credibility of the 
IOMS document,31 heightening the possibility that it will be used later by 
jurists and institutes when setting guidelines about medical ethics and 
research confidentiality. 
The rare publications by individual Muslim scholars of research ethics and 
confidentiality from an Islamic point of view were influenced and began 
to change in light of both the IOMS document and fatwa (B).31,32 In 2008, 
the first specialized book concerning Islamic medical research ethics was 
published. The authors, Chamsi Pasha and Albar, are both experts at the 
International Islamic Fiqh Academy. In their text, they discuss 
confidentiality, with a special emphasis on genetic research, without 
delving deeply into the investigation of its dimensions or justified 
infringements.26 
To help jurists in councils issue fatwas, more studies on the issue of 
medical ethics and confidentiality are needed. Such research is especially 
important for sensitive cases involving sexually transmitted infections and 
                                                             
* For more information about the fatwa and how it works please go to the web site of Dar al-Ifta al-
Massriyyah [Egypt] http://www.dar-alifta.org/FatawaConcepts.aspx 
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shared genetic information in tribal groups. Because of the emphasis that 
many Muslim communities place on lineage and the importance placed 
on procreation only within official and legal marriages, the issue of genetic 
research is especially important to Muslim communities.45 Any breach of 
confidentiality related to paternity may lead to discrimination and 
stigmatization for the child or parent. Researchers who face these kinds 
of situations may not know what to do, considering the lack of fatwas on 
the subject. 
In much medical research many sensitive data are included. This practice 
may involve significant risk of a breach in confidentiality, especially when 
information related to certain diseases lead to identify research subjects 
or their family, directly or indirectly - it is obvious the need to establish 
clear guidelines for Muslim researchers is very important. 
Justified infringements of confidentiality 
We observed that the attention of the Fiqh councils was focused on two 
main points, the mandatory obligation for maintaining medical 
confidentiality, and the justifications that allow a breach of medical 
confidentiality. In contrast with the first point, where fatwas were limited 
to pointing out the importance of confidentiality without giving details, 
fatwas that addressed the second point with some depth and identified 
many cases where a breach of confidentiality may be justified gives the 
impression that such fatwas give more importance to the protection of 
community, at the expense of maintaining the confidentiality of 
individuals and their interests. Actually, it appears that these particular 
fatwas were built on juristic rules such like the "public interest overrides 
individual interest".46 However, we also note that those councils in turn 
failed to mention the public interest controls that regulate violation of 
medical confidentiality and to what extent breaches are permitted. In 
addition, it is noted that the issue of voluntary consent of the individual 
to allow the dissemination of confidential information had not been 
considered, neither the mechanism to implement that.  
We could find only two institutional fatwas concerning breach of 
confidentiality: the fatwas A2 by Islamic Fiqh Academy and E by Islamic 
Fiqh Academy in India.30,35,36 
In fatwa A2, the Islamic Fiqh Academy differentiated between an obliged 
breach of confidentiality and one in which the doctor or researcher is 
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allowed to infringe on this agreement.30 This fatwa, which was written in 
very general language, did not mention any specific cases and left room 
for more detailed studies in the future. Specifically, this fatwa did not 
identify the difference between what it called: “the harm to society” that 
is considered serious enough to require the breach of confidentiality, and 
“the general harm” that only allows the doctor or researcher to infringe 
on their patient’s confidentiality; resulting in the perception that 
clarification of both terms are needed. 
In addition to fatwa A230 and the IOMS document31, some authors have 
begun to discuss exceptions to the obligation of confidentiality. These 
justified situations have been adapted and quoted from the IOMS 
document;31 most commonly, these authors refer to cases in which the 
patients request that their information be shared, cases in which sharing 
the information is in the best interest of the patients or their community, 
cases in which the law or judicial authorities request the information (to 
prevent or solve crimes or provide evidence in court), cases in which the 
health of a wife or husband is at risk, or cases in which public health is in 
jeopardy (that is, to prevent outbreak of an infectious disease).31 
Muslim jurists have used the five basic concerns of Islamic jurisprudence 
to deduce these exceptions: religion, life, mind, money, and progeny.27,40 
This has been stated in fatwa A2.30 Muslim jurists have built their opinions 
on various juristic rules,4 such as " choosing the lesser evil or greater good 
is always the priority"(Ibn Taymia) and the idea that the "public interest 
overrides individual interest".46 However, these jurists do not discuss how 
to evaluate harm—that is, the difference between major or minor harm 
and what to consider when evaluating whether a breach in confidentiality 
is right or wrong.30 These ideas are used as a basis for evaluation by 
scholars in the West. Beauchamp and Childress, for example, consider 
two factors in particular: the probability of harm and the magnitude of 
potential harm.3 No doubt, these are important points that will need to 
be studied in depth. 
Though some Muslim authors in addition to the Islamic Fiqh Academy in 
India have discussed justified infringements of confidentiality (Fatwa 
E),30,31 these issues have not been investigated sufficiently. For instance, 
we did not find any studies equivalent to those conducted in Western 
countries, for example on the issue of AIDS. Studies such as "AIDS and 
Confidentiality" by Gillett, "AIDS and a Duty to Protect" by the Hastings 
Center, and "To tell or not to tell: breaching confidentiality with clients 
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with HIV and AIDS " by Hook & Cleveland have created a nuanced view of 
the problem outside of the Islamic context.47-49 
Moreover, Islamic fatwas have not explored concerns about the 
disclosure of genetic information to third parties, an issue that is very 
important in modern medicine and has been extensively investigated by 
Western authors, such as Beauchamp & Childress, Andrews, and Parker & 
Lucassen.3,50 
Moreover, none of the institutes or the jurists provided specific cases of 
justified confidentiality infringement in the field of medical research. We 
assume, however, that these cases must occur in clinical research, 
especially in the context of research concerning sexually transmitted 
diseases or genetic research. Confidentiality infringements in relation to 
the publication of medical research are also a new area in which fatwas 
and additional research will be required in the future. 
Despite the importance of both - keeping confidentiality, and justified 
breach as stated in these fatwas - none of the fatwas discuss the possible 
drawbacks for breaching confidentiality: for example, the case of 
undermining the trust of the patient in the doctor or the health care 
system. This obviously is an area that needs deep exploration, considering 
that is a right of patients or research participants. 
CONCLUSION 
There is no doubt that the maintenance of personal confidentiality is a 
shared value throughout the world. Islam, especially, places a high value 
on the principle of confidentiality in the broadest sense.   
Confidentiality is an essential part of the modern profession of medicine. 
Confidentiality is built on trust, duty, and responsibility to the well-being 
of the patient. Preventing harm is also crucial in medical research. 
Considering fatwas that have already been issued, medical confidentiality 
seems to be a very important issue; however, these fatwas do not go far 
beyond general studies and do not fully investigate the issue of patient 
confidentiality. Additionally, there is a lack of accurate and detailed 
research about medical confidentiality, especially in sensitive areas and in 
determining which cases may require an infringement of confidentiality. 
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Confidentiality in medical research is still not well explored from an 
Islamic point of view. More specialized fatwas and comprehensive studies 
are vital to properly elucidate the position that Muslim practitioners 
should take when ethical conflicts arise. 
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ABSTRACT 
Background: Children’s participation is crucial in research on childhood 
diseases and cases associated with childhood health. Despite the 
existence of many publications that address ethical issues related to the 
participation of children in clinical research around the world, very little 
has been written about these ethical issues from an Islamic perspective.  
Methods: In this study, we analyzed medical research on children from 
three Islamic resources: plural fatwas by juristic institutions, the opinions 
of Islamic medical organizations and individual writings. Results: Seven 
plural fatwas from three juristic councils could be found. Only four of 
them raise ethical concerns about research on children. Two documents 
from medical organizations were identified. Conclusion: Three different 
positions could be concluded from these fatwas: a total prohibition, 
prohibition unless and permission. Prevention any harm is a major 
concern in all fatwas. Guardian's consent is necessary, but more details 
are needed. The guidelines of Islamic Organization of Medical Sciences 
IOMS reflect the best available Islamic perspective about research on 
children.  
INTRODUCTION 
Scientific progress in the fields of biology, medicine, and health relies on 
research in these areas. Clinical research and medical experiments are 
important for obtaining better treatments for diseases with the least 
harmful effects. 1 
Many researchers and pharmaceutical companies in the West opt to 
conduct research in third world countries for economic reasons or 
because most of these countries do not have strict ethical laws like those 
in the West.2 Moreover, many researchers from developing countries 
conduct research activities in their own countries, including Muslim 
countries.3  At the same time, Western scholars have very little knowledge 
regarding Islamic ethical views on medical issues, including regulations 
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related to medical research, especially on children. Many hear about the 
Islamic Law, the Sharía, but very few know whether Islamic law on medical 
issues is compatible with or contradictory to international perspectives on 
medical research.  
Children's participation is crucial in research on childhood diseases and 
cases associated with childhood health, such as vaccine-related issues, or 
cases related to drugs designed for children.4 In the past, many new 
medications were tested only on adults despite the fact that these 
medications were applicable to diseases that occur in childhood. This is 
also true for research on stored tissue material from children, which raises 
distinct ethical challenges with regard to the involvement of adults. 5 
However, children are not simply small adults, and we cannot always 
apply the results of research conducted on adults to children and young 
people. This is especially true for the safety of tested medications. 
Therefore, many research institutions and researchers feel that it is 
important to conduct research on children.6 
Medical research in Arab countries is increasing rapidly. The high 
percentage of children in Arab and Islamic societies (compared to 
Western societies), as statistics show, makes conducting research on 
children a crucial issue. For example, according to statistics from 2007, 
32.5% of the people in Saudi Arabia are 15 years old or younger.(Saudi 
Export Developing Center, 2007) Medical research on children has made 
room for ethical debates that reflect the publication of numerous 
recommendations, ethical laws and guidelines to achieve a balance 
between the need for children’s participation in medical research and the 
duty to offer them protection and to avoid doing them harm, as expressed 
in the Declaration of Helsinki (adopted 1964; latest amendment, 2008)7 
and the International Ethical Guidelines for Biomedical Research Involving 
Human Subjects (1982; revised, 2002) by Council for International 
Organizations of Medical Sciences.8  
Key ethical issues addressed by bioethicists regarding clinical research on 
children include the following: first, researchers can conduct clinical 
research on children only when it aims to address a pediatric problem or 
to obtain knowledge related to the health needs of children and cannot 
be feasibly conducted to the same degree with adults; second, 
researchers should seek the consent of the parents or legal guardians of 
children participating in the research; third, researchers should obtain the 
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child's assent according to his ability; and fourth, the researchers should 
respect the child's desire to withdraw from participation in the research. 9 
Religious principles (including Islamic law) form a basis for many practical 
applications of medical regulations and ethical guidelines.10 The 
relationship between Islam and medical research on children has not yet 
been explored in depth. Despite the remarkable increase in the number 
of researchers, conducting medical research on children and the existence 
of many publications that address ethical issues related to the 
participation of children in clinical research around the world, very little 
has been written about these ethical issues from an Islamic perspective. 
This paper will provide a first step in filling this gap. The objective of this 
essay is to present Islamic opinions regarding medical research on 
children through an analysis of key Islamic resources on the Islamic 
attitude toward research on children. 
METHODS 
In this study, we analyze medical research on children from three Islamic 
resources: plural fatwas by juristic institutions, the opinions of Islamic 
medical organizations and individual writings.  
A fatwa is a legal opinion concerning Islamic law. It is called a plural fatwa 
if it is issued by a group in a juristic council and an individual fatwa if it is 
issued by a single scholar.11 Plural fatwas play an increasingly important 
role in representing Islamic views of some issues, especially new 
matters.12 We included in our study all Arabic or English, Sunni, plural 
fatwas that could be accessed online.13 Our study focused on the Sunni 
school (87-90% of Muslims are Sunni Muslims and 10-13% are Shia).14 We 
excluded individual fatwas from our resources because there is a problem 
of selection of scholars. Moreover, after a random pilot survey of 
approximately 20 websites of scholars from various countries, we could 
not find any individual fatwas about research on children. Even more 
survey of medical fatwas mentioned in certain Islamic web used in 
previous research of fatwas about organ donation no fatwa related to 
medical research of children could be found: www.islamonline.net, 
www.islamweb.net, www.islamicity.com, www.islam.tc, 
www.islamtoday.com, and www.understanding-islam.com.15 
In a recent review we showed that 14 juristic councils offer online access 
to their fatwas: two international councils, the International Islamic Fiqh 
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Academy (IIFA) and the Islamic Fiqh Council (IFC) in the Muslim World 
League (IFC); four regional councils covering Europe, America, the Gulf 
and Al-Sham (Syria, Jordan, Lebanon and Palestine); and eight national 
councils in Saudi, Egypt, India, Malaysia, Singapore, Palestine, Turkey, and 
Jordan.13 We surveyed all institutional juristic fatwas released by these 
institutions. 
For the opinions of Islamic medical organizations, we concentrated on the 
two leading organizations that could be accessed online in either English 
or Arabic as found in a previous study: the Islamic Organization for 
Medical Sciences (IOMS) 
(http://www.islamset.com/ioms/code2004/index.html) and the Islamic 
Medical Association of North America (IMANA) (www.imana.org/). 13 
Although these are not juristic councils, they are medical organizations 
that adhere to Islamic law.  
We excluded fatwas and opinions about embryonic stem cell research, 
anonymous fatwas and opinions on websites that do not represent official 
parties. 
We continued by exploring related articles on the Islamic perspective on 
medical research on children. These articles were retrieved using search 
engines in both Arabic and English and by employing the search terms 
research+Islam+children. PubMed was used for English articles, and The 
Comprehensive Encyclopedia (ةلماشلا ةعوسوملا)   www.islamport.com/ and 
The Comprehensive Library (ةلماشلا ةبتكملا) http://shamela.ws/ were used to 
access Arabic resources. We also accessed the King Abdulaziz Public 
Library in Riyadh-Saudi and the Jarir and Obeikan bookshops. 
We attempt to establish a generalized standpoint on research on children 
from an Islamic perspective. We analyzed the compatibility of this 
research with international views as stated in official documents, such as 
the Declaration of Helsinki, Good Clinical Practice GCP and the CIOMS 
guidelines.7,16,8  
RESULTS 
Data collection 
We retrieved nine different documents covering Islamic perspectives on 
one or more issues about clinical research (table 1). 
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We found seven different fatwas from three juristic councils between 
1992 and 2008 and two opinions from medical organizations. Six of them 
have an international scope, and the  
Table 1: Institutional fatwas about research on children 
Size of document 
Scope 
Background of 
author 
Author Subject Title 
Type of 
resource 
Year The part 
about 
children 
Total 
document 
1 line 73 lines International 
Juristic 
Council 
International 
Islamic Fiqh 
Academy 
IIFA 
Informed consent 
No harm 
Lacking capacity or 
incompetent 
Decision 67 about medical 
treatment 
Institutional 
fatwa 19
92
 
- 105 lines International 
Juristic 
Council 
International 
Islamic Fiqh 
Academy 
IIFA 
Encourage research 
Cloning 
Genetic engineering 
Decision 94 about cloning 
Institutional 
fatwa 19
97
 
- 48 lines International 
Juristic 
Council 
Islamic Fiqh 
Council 
IFC 
Genetic research 
Informed consent 
Decision 1/15 about genetic 
engineering 
Institutional 
fatwa 19
98
 
1 line 24 lines International 
Juristic 
Council 
Islamic Fiqh 
Council 
IFC 
Stem cells research 
Informed consent 
Research on children 
Decision 3/17 about stem cells 
Institutional 
fatwa 20
02
 
  International 
Juristic 
Council 
IIFA Encourage research 
Decision 142 about doctor 
responsibility 
Institutional 
fatwa 20
04
 
2 pages 190 pages International 
Medical 
Organization 
Islamic 
Organization for 
Medical Sciences 
IOMS  
All research ethics 
issues presented in 
CIOMS, including 
research on children 
International Ethical 
Guidelines for Biomedical 
Research Involving Human 
Subjects - An Islamic 
Perspective 
Opinion 
20
05
 
4 lines 60 lines International 
Juristic 
Council 
International 
Islamic Fiqh 
Academy 
IIFA 
Research integrity 
Approving of Islamic 
perspectives of CIOMS 
by IOMS 
Informed consent 
Protection (even from 
guardian) of those 
lacking capacity or 
incompetent 
Decision 161 Islamic controls 
of biomedical research on 
humans 
Institutional 
fatwa 20
06
 
1 line 25 lines 
National 
(Egypt) 
Juristic 
Council 
Dar-Alifta Al-
Misrriyah 
Stem cells research 
Informed consent 
Research on children 
Using of stem cells in research 
(598) 
Institutional 
fatwa 20
08
 
2 lines 16 pages 
Regional 
(North 
American) 
Medical 
Organization 
Islamic Medical 
Association of 
North America 
IMANA 
Genetic research & 
engineering 
Stem cells research 
Conceive to abort the 
fetus to obtain stem cells 
Stem Cell Research: the 
IMANA perspectives 
Opinion 
N
o 
da
te
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seventh, by Dar-Alifta Al-Misrriyah (Egypt's Fatwa House),17 has a national 
scope. Only four of them raise ethical concerns about research on children 
and three address the subject generally. 
Two documents from medical organizations were identified. One of them, 
by IOMS, has an international scope and includes a separate chapter for 
research on children.18 The second, by IMANA, has a North American 
scope and is not specific to children.19 
The Dar-Alifta Al-Misrriyah' fatwa and the IMANA' document addressed 
stem cells in general.16,18 They were included because they were not 
limited to embryos; they also contained a section on research on adults 
or children. 
Besides these fatwas from councils and opinions of organizations, few 
individual writings could be found, and none of them could be included in 
our results because they either presented a Shia point of view,20 merely 
repeated fatwas and IOMS opinions without farther discussion;21 Fadel 
just copied the IOMS opinion in his article about the Islamic perspective 
of medical research,22 Abu Matar in her master thesis about the ethics of 
clinical trials talked about the guardians roles and used fatwa 67 of IIFA 
about preventing research on children especially in case of harm.23 
Research on children  
Two questions arise from our results: Is it allowed to conduct research on 
children? And if the answer is yes, what are the allowing requirements? 
We discussed these two questions in two major themes: the position(s) 
toward conducting research on children and the requirements of research 
on children: ethics committee approval, best interest of child, no harm, 
informed consent of guardians and the assent of the child. 
There are three different positions expressed by the studied documents. 
1) Research on children is not allowed, as clearly stated by fatwa IIFA 67: 
"It is not allowed to conduct medical research on people who lack capacity 
or incompetents, even after guardian approval".24 2) Research on children 
is not allowed unless there are certain situations, as mentioned by IOMS: 
first situation, there is an exclusive or preponderant interest or an urgent 
need of the child in the research, even if the child refuses; second 
situation, it is absolutely necessary to conduct research on childhood 
diseases and vaccines and drugs related to children.18 Fatwa (IIFA 161) 
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accepts IOMS perspectives with regard to children in research.18,25 3) 
Research on children is allowed; this position is taken by fatwa by Islamic 
Fiqh Council regarding stem cells and by Dar-Alifta Al-Misrriyah about 
using stem cells in scientific experiments (Table 2).17,26  
Table 2: Ethical concerns in research on children in Islamic resources 
Document IIFA 67 IFC 3/17 IOMS IIFA 161 
Dar-Alifta 
Al-
Misrriyah 
(598) 
Date 1992 2002 2005 2006 2008 
Permission for research on children No Yes 
No 
unless 
No 
unless 
Yes 
Elements 
for 
conducting 
research 
on 
children 
Best interest of child 
Not 
applicable 
Not 
available 
Yes Yes 
Not 
available 
Obligation of guardian 
consent 
No Yes Yes Yes Yes 
No harm Yes Yes Yes Yes Yes 
Child assent 
Not 
applicable 
Not 
available 
Yes 
Not 
available 
Not 
available 
Ethics committee 
Not 
available 
Not 
available 
Yes 
Not 
available 
Not 
available 
Five elements for conducting research on children can be identified in the 
documents that allow research on children: 1) ethics committee approval 
was not mentioned in any of the studied fatwas, but it is mentioned in 
IOMS guidelines.18 2) the best interest of the child himself or the group of 
children 7,8,25 3) "no harm" is a prerequisite in all documents, even if the 
harm is only potential harm, as stated in fatwa 161 by International 
Islamic Fiqh Academy;25 4) guardian consent is necessary, but none of the 
documents provide details on who can be a guardian; 5) child assent is 
not clearly mentioned in any of the documents; however, IOMS states 
that the assent of the child cannot replace guardian consent.18 
DISCUSSION 
Research on children 
Only few documents about research on children could be found in Islam. 
This is compatible with our results of a previous study about medical 
research in general in 13 Muslim countries in the Middle East, that 
showed that only three countries mentioned research on children in their 
guidelines.27-30 (See table 3)  
Table 3: Children’s research ethics in the guidelines of some Arab Middle Eastern countries  
 Egypt Saudi Qatar 
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Profession Ethics 
Regulations 
The law of ethics of 
research on living 
creatures 
Guidelines, Regulations and 
Policies for Research Involving 
Human Subjects 
Guardian 
consent 
Yes Yes Yes 
Child assent - Yes Yes 
Best interest of 
child 
Yes Yes Yes 
No more than 
minimal risks 
- Yes Yes 
Ethics 
committee 
- Yes Yes 
In the fatwas, we notice three different positions regarding clinical 
research on children: it is not allowed, it is not allowed unless in special 
situations and it is allowed. At the international levels, the Declaration of 
Helsinki and the CIOMS guidelines permit research on children under 
certain conditions.7,8  
The oldest fatwa (IIFA 67, 1992) issued more than 20 years ago, disallows 
research on children.24 This prohibition can be explained by a limited 
awareness about the importance of research on children among the 
jurists of IIFA, and the lack of a complete and clear understanding of 
research on children. Moreover, jurists tend to take the safe side that 
offers better protection of children. This fatwa also reflects the poor 
participation of medical doctors and specialists in the formulation process 
of this fatwa,23 since medical doctors are not full members in juristic 
council but they are just consultants.   
Since that fatwa IIFA 67, other fatwas have been issued (IFC 3/17, 2002; 
IIFA 161, 2006; Dar-Alifta Al-Misrriyah 598, 2008) that allow research on 
children under certain conditions. That will be discussed below.17,25,26 
Islamic Organization Medical Sciences faced a challenge in dealing fatwa 
(IIFA 67), which disallowed research on children.24 IOMS agrees to this 
prohibition, but then it provides two exceptions to allow research on 
children.18 These exceptions are: first, the research must be beneficial or 
address an urgent need for the child; second, there must be a general 
need for research on childhood diseases, provided that the potential risks 
are minimal.  
The different positions between the IOMS opinion and IIFA's fatwa 67 can 
be attributed to the difference in the composition of the teams that 
formulated the documents. In contrast with the IIFA, the IOMS, which was 
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originally an Islamic-oriented medical institution, has a drafting 
committee composed of scholars in law and medical doctors and experts 
in medical research, and one of them is not even a Muslim.18  
Conditions for research on children 
Looking at the conditions at which the research on children is possible, 
the following five conditions are mentioned in the international guidelines 
such as CIOMS guidelines8:  1) Ethics committee approval of any research 
on children must be collected, 2) any research must be in the best interest 
of child, 3) risk of any research must be not more than minimum risk (do 
no harm), 4) consent must be collected from the child guardian and 5) if 
possible the assent of the child should be sought for. In the following, we 
discuss these five conditions in an Islamic perspective comparing them 
with international guidelines.  
Ethics committee:  
None of the fatwas refers to ethics committees. Only IOMS talks about 
the obligation of approval by research ethics committees prior to research 
on children.18 The obligation of an ethics committee approval has been 
mentioned in many international guidelines, such as the Declaration of 
Helsinki and the CIOMS,7,8 and now is considered one of the most 
important mechanisms to offer protection to research subjects especially 
when children are involved. 
Best interest of child: 
Fatwa IIFA 161 and IOMS mention the best interest as one of the 
conditions for allowing research on children.18,24 For IOMS the best 
interest of the child is either the beneficence of the individual child, or the 
beneficence of childhood community.18 This implies that therapeutic 
research, in contrast with IIFA 67 can be interpreted in a broader way: not 
primary beneficial of the individual child but beneficial to children in the 
same age.24      
In Islam, even if guardians can decide for the children’s affairs, their 
decisions must always be in the best interest of the child. It is the parents’ 
responsibility to provide care and protection for their children. Similarly, 
many Muslim and Western scholars agree that any decision of the parents 
must be considered within this framework.31,32 Taking into account the 
best interest of the child is the most obvious of respecting the child as a 
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human being.31,33 The best interest of child is a major concern in research 
on children and is mentioned in the Declaration of Helsinki and the IOMS 
opinion.7,18  
Do no harm: 
The principle "do no harm" is stated by all documents including IOMS 
guidelines.22 
In Islam and internationally it is accepted that children are a vulnerable 
group; their protection is the responsibility of their guardians and the 
community at large.5,34 The government has the responsibility of 
controlling this protection through its regulations. This is clearly 
mentioned in fatwa (IIFA 161), which withdraws parental approval if the 
research causes harm to the child.25 This fatwa is consistent with Muslim 
scholars’ statements that the relationship between parents and children 
is not just a relationship of mercy and compassion but is also a 
relationship based on responsibility of parents toward their children, in 
raising them and offering them better care.35 
Although the documents in this study agree that any medical research to 
be performed on a child should not cause harm to that child, they do not 
define or specifically note the harm or its degree or state before it is 
possible to conduct research with minor risks. Only IOMS specifies that 
the potential risk should be minimal when conducting research on 
children.18 "Minimal risk," as stated by many authors in the west, is one 
of the criteria for allowing research on children.36 
Guardian consent: 
Medical research can be conducted only after obtaining informed consent 
from the subject, if he is an adult, or from the guardian, if the subject is a 
child or is unable to give consent. Three fatwas IFC 3/17, IIFA 161 and Dar-
Alifta Al-Misrriyah (598) and IOMS require getting guardian informed 
consent prior any research conducted on children.17,18,25,26 This 
prerequisite is also required in the international research ethics 
guidelines, such as the Declaration of Helsinki and CIOMS guidelines. It is 
also explicitly mentioned in the writing about ethics of research on 
children in both documents and individual writings.7,8,37 
Fatwas use word the "guardian", but they do not provide details about 
who is considered a guardian. The Helsinki Declaration in the context of 
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incompetent subject uses "authorized representative" while the CIOMS 
speaks about "guardian or parents".7,8 The Islamic position regarding who 
is a guardian, can be deduced from other fatwas or juridical sources such 
as Al-Mausoha Al-Feqhia (Juridical Encyclopedia) by the Ministry of Awqāf 
and Islamic Affairs.38 For Islamic resources generally define the guardian 
in issues like the child's inheritance, but not for medical research or 
medical issues. Some authors, such as Shankeeti favor applying the 
general definition of guardians for medical issues.39 Consequently, the 
priority of the guardians of a child according to Islamic resources can be 
classified as follows: fathers, then grandfathers, and then adult brothers, 
respectively.  
Child assent: 
Except for the IOMS opinion, child assent in research ethics is not 
mentioned in any of the documents.22 None of documents describes from 
which age on a child can give assent or when it becomes an adult and gives 
consent. Although not explicitly given a certain age for medical majority, 
the CIOMS and the Helsinki Declaration mention to the importance of 
considering child opinion.7,8 CIOMS stated that from 12-13 year on, the 
child opinion should be taken into account.7,8 
Table 4: Levels of ages according to Al-Mausoha Al-Feqhia. 
Child’s Actions Technique Stage 
Invalid <7 years Before the age of distinction 
Harmful Neutral Beneficial 
>7 years Age of distinction (financial 
issues) Invalid Related to other 
party Valid 
Valid 
Majority age 
(defined by 
government) 
Adult age (financial or criminal 
issues) 
The age under which children can take decisions related to their health 
varies from country to country regulations.5 The ability to take decisions 
depends on the degree of capacity, which differs from one child to 
another and is affected by many factors, such as personal abilities and 
social context.36,40,41 A study by Stultiens et al. shows three different types 
of the relation between medical majority and legal majority: 1) they are 
the same, 2) they are different and 3) medical majority must be studied 
case by case depending on age and maturity.42 For Islam we can return to 
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the Al-Mausoha Al-Feqhia (Juridical Encyclopedia), which identifies the 
age of majority in financial and criminal issues, but not in medical issues.38 
It divides ages to three levels. At the first level, a child's decisions cannot 
be accepted when he/she is under the age of seven because he/she 
cannot understand the nature of the issue. At the second level, from 
seven years old to majority, we can only accept those decisions that are 
both correct and do not cause harm to the child. Decisions by children 
that are not to be considered correct, and/or cause harm to the child can 
be rejected by the guardian. The third level is majority. (Table 4) Al-
Mausoha Al-Feqhia did not define a specific age for a child to be 
considered an adult; it referred to the laws of each country.38 For 
example, the official documents of some Muslim countries stipulate 
different ages of majority: 18 years for Jordan,43 19 for Algeria,44 20 for 
Tunisia 45 and 21 for Egypt. 46 
CONCLUSION  
Despite the importance of the ethics of medical research on children, 
there are few Islamic documents on the subject, and they do not reflect 
the importance of this subject. The fatwas are brief and do not cover all 
aspects of the ethics of research on children. In ideas like assent and 
consent, fatwas do not develop a specific theory, but refer to other 
resources. Three different positions could be distinguished from these 
fatwas: a total prohibition by the oldest fatwa (IIFA 67), prohibition unless 
and permission by the fatwas later. Most of the conditions of research on 
children presented in the international guidelines like the Declaration of 
Helsinki and the CIOMS can be found in the fatwas, although a single 
fatwa does not mention all international conditions. However, the 
international requirement of approval by ethics committee cannot be 
found in the fatwas.   
The detailed IOMS document is important and represents the most 
balanced available document that provides an Islamic perspective on 
clinical research ethics in general, including research on children. The view 
provided by IOMS is mostly compatible with international guidelines.  
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Chapter 3 
Review of National Research Ethics Regulations and 
Guidelines in Middle Eastern Arab Countries 
Alahmad, G., Al-Jumah, M., & Dierickx, K.  
(2012). BMC medical ethics, 13(1), 34.  
ABSTRACT 
Background: Research ethics guidelines are essential for conducting 
medical research. Recently, numerous attempts have been made to 
establish national clinical research documents in the countries of the 
Middle East. This article analyzes these documents. Methods: Thirteen 
Arab countries in the Middle East were explored for available laws, 
national codes, regulations, and guidelines concerning research ethics, 
and 10 documents from eight countries were found. We studied these 
documents, considering the ethical principles stated in the Declaration of 
Helsinki, the Council for International Organizations of Medical Sciences 
(CIOMS) guidelines, and the International Conference of Harmonization - 
Guidelines for Good Clinical Practice (ICH-GCP). Our paper comprises a 
complete list of protections, such as confidentiality, informed consent, 
ethics committees, and others. Results: This study found different levels 
and kinds of research ethics regulations and guidelines in the countries 
examined. Two groups can be distinguished: the countries in the first 
group have one or more research ethics regulations or guidelines, while 
the countries in the second group have not yet established any. Most of 
the documents showed various degrees of deficiencies in regard to ethical 
protection. The majority of the documents that were examined refer to 
one or more international documents on biomedical research ethics. 
Conclusions: Recently, a lot of efforts have been made in many countries 
in the Middle East. However, compared with international documents, 
most of the research ethics documents in use in this region demonstrate 
numerous deficiencies. As it relates to these documents, extensive 
differences could be observed in regard to development, structure, 
content, and reference to international guidelines.  
BACKGROUND 
In recent decades, there has been increased awareness of ethical issues 
because of the extensive expansion of clinical research and trials.1,2 There 
has also been growing debate over the ethical challenges faced by 
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different societies.3,4 Accordingly, scholars have begun to consider how to 
offer protection to the research community, resulting in the creation of 
research ethics guidelines in many countries1. Interest  
Ethical guidelines did not truly appear until after World War II. Prior to 
this point, efforts to regulate human experimentation—such as the codes 
of Thomas Percival in England (1794)—were few and exceptional1. The 
code of William Beaumont, issued in 1833, is the oldest American 
document dealing with the ethics of human experimentation 2. In 1847, 
the American Medical Association (AMA) issued its code of ethics2. 
However, the well-known Nuremberg Code, issued in 1947, was the 
actual beginning of established national ethical codes governing medical 
research.5 Many countries later issued their own memorandums about 
research ethics. Nuremberg was followed by the Declaration of Helsinki 
(adopted, 1964), established by the World Medical Association (WMA), 
which created international regulations governing many countries.6 Many 
other international guidelines were subsequently proposed by different 
organizations, including the International Ethical Guidelines for 
Biomedical Research Involving Human Subjects (1982; revised, 2002), 
prepared by the Council for International Organizations of Medical 
Sciences (CIOMS) and the World Health Organization WHO,7 and the 
Guidelines for Good Clinical Practice (GCP, 1995; revised, 2004), prepared 
by the ICH.8 However, there is a question about the appropriateness of 
the application of such international guidelines to regions across the 
globe, particularly including the Middle East. Because of differences in 
social and economic elements and the development of institutes in less 
developed countries, it is crucial to remember that these international 
guidelines were decided upon by professionals from developed countries. 
Statistics between 2006 and 2010 show a 4 percent rise in the global 
number of drug trials conducted in the Middle East, which was the largest 
increase in any region of the world.9 Conversely, the number of drug trials 
in North America decreased by 11 percent in the same period.9 Many 
factors make the Middle East attractive for clinical research, including its 
patient diversity, good medical facilities, cost advantages, and favorable 
infrastructure, especially in the Gulf countries.9 In addition, recent 
medical advances and economic growth in many Arab countries have 
made educational improvement the focus of many governments; thus, 
many new universities and research centers have appeared, such as the 
King Saud bin Abdulaziz University for Health Sciences and the King 
Abdullah International Medical Research Center, which was established 
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in Saudi Arabia in 2005. Moreover, with countries in the Middle East 
operating under considerably fewer strict ethical guidelines than their 
European and North American counterparts,9 drug companies are 
increasingly moving trials of new and untested drugs to Arab countries.  
As a result of this increase in clinical research in the Middle East, many 
ethical issues involving the use of human subjects in these countries have 
been brought to the attention of ethicists in the region.10-12,, In a study 
conducted among members of research ethics committees in Egypt, 92% 
of interviewees ranked the development of appropriate national 
guidelines as a major challenge.10 Moreover, there is a sense that 
governments and research communities are keen on developing good 
guidelines for clinical research.  
In this paper, we reviewed the relevant guidelines, regulations, and 
ethical codes of the Arab countries in the Middle East; investigated 
whether each country had national regulations or guidelines on research 
ethics; determined whether ethical principles are stated in these 
guidelines and, if so, which ones; and then compared them with each 
other and with the major international guidelines. 
METHODS 
Data sources and study selection 
Using direct access to the websites of various governmental agencies in 
each country, we conducted a review of the available online direct data 
sources for guidelines on research ethics and clinical research laws and 
the indirect data sources included in the codes of ethics. The websites of 
ministries of health, ministries of higher education, medical councils, the 
food and drug administrations, research centers, medical unions, and 
national committees of bioethics in the 13 member nations of the League 
of Arab States in the Middle East were searched.13 The countries studied 
were Kuwait, Qatar, Bahrain, Saudi Arabia, the UAE, Oman, Egypt, Syria, 
Lebanon, Palestine, Jordan, Iraq, and Yemen.  
Our study selection included all national codes or guidelines (after 
confirmation by professional research ethics experts from each country) 
available online that addressed research ethics either exclusively or 
partially. We critically examined all these national codes and guidelines, 
considering the protections mentioned in the Declaration of Helsinki, the 
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CIOMS guidelines,7 and the ICH-GCP. Owing to their wide acceptance 
around the world, we selected the Declaration of Helsinki and the ICH-
GCP for comparison. We selected the CIOMS guidelines for the same 
reason, but also because they were crafted specifically with the aim of 
applying the Declaration of Helsinki to developing countries in a way that 
reflects the conditions and needs of biomedical research in those 
countries, and due to the implications for the multinational or 
transnational research in which they may be partners.7 A list of the 19 
ethical protections could be found in these international documents and 
considered a standard to be used in our comparison. (See table 2). 
All relevant documents, written in either English or Arabic, were eligible 
for inclusion. 
Data extraction and synthesis 
Our study approach included both qualitative descriptions and 
comparisons of selected guidelines.14 First, guidelines from each country 
were examined for an explicit description of the type of regulations that 
existed and the entities that released them. We then noted the purpose 
of the guidelines and sought to ascertain whether the research ethics 
protections were determined exclusively by the guidelines.  
RESULTS 
We retrieved the 10 available guidelines from eight different countries. 
Three of the guidelines came from Saudi Arabia. No national guidelines 
could be found in the remaining five countries: Syria, Iraq, Palestine, 
Yemen, and Oman. (See table 2) 
Historical overview 
After the establishment of the first international and Western clinical 
research guidelines, it required a few decades for decision makers in the 
Arab countries in the Middle East to begin making about their own 
guidelines. The first attempts at crafting clinical research regulations 
appear as summarized chapters in the general medical ethics guidelines: 
in Lebanon, the “Law of Medical Ethics” (1994),15 in Saudi Arabia, the 
“Ethics of the Medical Profession” (1998; renewed, 2007) 16 and in Egypt, 
the “Profession Ethics Regulations” (2003).17   
Table 1:  Research ethics guidelines and laws found in the 13 countries in the Middle East  
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  Country Entity Year Guidelines 
1s
t   
G
ro
u
p
 
A 
UAE 
Ministry of 
Health 
2006 
Guidance for conducting Clinical Trials 
Based on Drugs/Medical Products & 
Good Clinical Practice 
Qatar 
Ministry of 
Health 
2009 
Guidelines, Regulations and Policies 
for Research Involving Human 
Subjects 
Bahrain 
Ministry of 
Health 
2009 Ethical Guidelines for Health Research 
Kuwait 
Kuwait 
Institute for 
Medical 
Specialization 
(KIMS) 
2009 
Ethical Guidelines for Biomedical 
Research 
Saudi 
Arabia 
Saudi Food 
and Drug 
Authority 
(SFDA) 
2005/2008 I Clinical Trial Requirement Guidelines  
Saudi Council 
for Health 
Specialties 
1998/2007 II Ethics of the Medical Professions 
Council of 
Ministries 
2010 
III Law of ethics of research on living 
creatures (and its bylaw 2011) 
Jordan 
Prime 
Minister’s 
Council 
2001 
Law of Clinical Studies. Provisional 
Law No. (67) for the Year 2001. 
B 
Egypt 
Ministry of 
Health & 
Population 
2003 
Profession Ethics Regulations No. 
(238) for the Year 2003. 
Lebanon 
Perlman 
Council 
1994 
Law of Medical Ethics No. (288) for the 
Year 1994. 
2n
d
 G
ro
up
 
C 
Syria 
Ministry of 
Health 
- 
Refers to Helsinki Declaration, 
International Ethical Guidelines for 
Biomedical Research Involving Human 
Subjects (CIOMS) 
Iraq Ministry of 
Health 
- 
Refers to unknown Guidelines 
D 
Oman - - No document 
Palestine - - No document 
Yemen - - No document 
The Jordanian “Law of Clinical Studies” (2001)18 was the first effort to 
regulate, as national law, how clinical research was conducted, and is the 
first document in the Arab countries to reference international guidelines 
and regulations such as the Declaration of Helsinki and the ICH-GCP. 
Ten years after establishing universal ICH-GCP guidelines (1995), the first 
local GCPs began to appear in the region through the Saudi Food and Drug 
Authority’s (SFDA) “Clinical Trial Requirement Guidelines” (2005; 
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renewed, 2008)19 and the UAE’s “Guidance for Conducting Clinical Trials 
Based on Drugs/Medical Products & Good Clinical Practice” (2006).20  
Kuwait’s “Ethical Guidelines for Biomedical Research” (2009)21 and 
Qatar’s “Guidelines, Regulations and Policies for Research Involving 
Human Subjects” (2009)22 are the first clinical research guidelines in these 
countries. The Saudi law, “Law of Ethics of Research on Living Creatures” 
(2010)23 and its bylaw (2011)24 is the most recent document listed and 
assumes that many regulations, guidelines, and laws are expected to 
appear in future years. 
Description of the guidelines reviewed 
Many differences exist in terms of whether countries in the Middle East 
have research ethics guidelines. We classified the countries into two main 
groups. The countries in the first major group already have guidelines and 
can be divided into two subgroups according to whether they have special 
national research ethics guidelines (A)—as is the case for Saudi Arabia, 
Qatar, Bahrain, Kuwait, the UAE, and Jordan—or whether they have 
general documents that contain some paragraphs about research ethics 
(B), as in Egypt and Lebanon. 
The second major group contains countries that have no special 
guidelines but either refer to international guidelines, as in Syria25,26 and 
Iraq27 (C), or no documents are found (D), as in Oman, Palestine, and 
Yemen. 
Even though the guidelines used in Group A countries have similar names, 
their structures are not the same. All of them use the words ‘guidelines’ 
and ‘research’ or ‘trials’ in their titles. Additionally, the UAE’s guideline 
adds ‘good clinical practice’ to its title (“Guidance for Conducting Clinical 
Trials Based on Drugs/Medical Products & Good Clinical Practice,” 2006), 
which seems reasonable because the UAE’s guideline uses the ICH-GCP 
structure and contains similar chapters, such as a glossary, principles, 
requirements for the approval of clinical trials, goals, medical institutes, 
protection of subjects participating in the clinical trial, and responsibilities 
of the investigator.  
This GCP structure is also used by the SFDA guidelines (I in Table 1), which 
are called the “Clinical Trial Requirement Guidelines” (2005), without 
mentioning GCP in its title. The Kuwaiti guidelines, “the Ethical Guidelines 
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for Biomedical Research” (2001), contain only a small section that has 
been adapted from the ICH-GCP, specifically concerning the elements of 
informed consent.  
The Bahraini (draft 2009)28 and Qatari (2009) guidelines, in addition to the 
Jordanian “Law of Clinical Studies” (2001), do not use the ICH-GCP 
structure and diverge widely from each other. While the Bahraini 
guidelines and Jordanian law are summarized and abstracted, the Qatari 
document is detailed and has a comprehensive structure (Table 1). 
Egypt and Lebanon do not have special guidelines; however, both 
countries have medical documents containing an abstracted chapter 
concerning clinical research.  
Saudi Arabia is the only country that has three different documents 
referring to the regulation of research ethics. The first document (I) is a 
general guide and contains a chapter concerning biomedical research on 
both humans and animals, referring specifically to the main principles of 
clinical research. The second document (II) is issued by SFDA, while the 
third document (III) is an official legal document, stated by the council of 
ministers. The third document (Law of Research on Human Creatures) is 
followed by bylaw, which give explanations and details. 
Of the 10 documents related to biomedical research ethics that were 
found, five are guidelines, three are national laws, and two are medical 
codes. Two of the three laws (Saudi Arabia and Jordan) focus on medical 
research, while the third (Lebanon) is a general medical law. 
What ethical protections are mentioned? 
Each guideline contains at least two or more protections. The Qatari 
guideline and Saudi law & bylaw contain the most protections at 19, 
followed by the Saudi “Clinical Trial Requirement Guidelines” with 15 
protections. The Jordanian and Lebanese guidelines come at the end of 
the list, with only five; three, and two protections, respectively (see Table 
2).  
The obligation to obtain informed consent is the most frequent protection 
in the list of protections and represents the only item mentioned in all of 
the guidelines. Nine of the 10 guidelines examined mention an obligation 
of scientific validity and review by an ethics committee, while seven of 10 
mention benefits, risks ratios, and confidentiality. Only five guidelines 
66 
 
discuss inducements to participate. Items related to incapacitation come 
next; thus five of 10 guidelines require limiting risks when dealing with 
incapable people, while only four discuss gaining their consent. 
Table 2: Ethical protections stated in the research ethics document for the 13 countries in the 
Middle East 
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Informed consent 10 + + + + + + + + + + 
E. C. 9 + + + + + + + + - + 
Scientific validity 9 + + + + + + + + - + 
Confidentiality 7 + - + - + + + + + - 
Benefits and risks of 
participation  
7 + + + + + + + + - - 
Limitations of risk of 
research on 
incapables  
5 + - + - + + - + - - 
Inducement to 
participate 
5 + + + + + - - - - - 
Consent of incapables 4 + - + - + - - + - - 
Research involving 
children 
4 + - + - + - - + - - 
Ethical review of 
externally sponsored 
research  
4 + - + - + - + - - - 
Information in the I. 
C.  
4 + - + + + - - - - - 
Who is responsible 
for collecting I. C. 
4 + - + + + - - - - - 
Research with l imited 
resources 
2 - - + - + - - - - - 
Research involving 
vulnerable persons 
2 - - + - + - - + - - 
Compensation 3 + - + - + - - - - - 
Strengthening ethical 
and scientific capacity  
3 + - + - + - - - - - 
Obligation to provide 
health-care 
3 + - + - + - - - - - 
Women  as research 
subjects  
2 - - + - + - - - - - 
Equitable distribution 
of burdens and 
benefits 
2 - - + - + - - - - - 
Total number of 
protections 
 
15 5 19 7 19 6 6 9 2 3 
I. C. = Informed consent, E. C. = Ethics committee 
Four guidelines specifically mention special protections for research 
conducted on children. Four or fewer guidelines mention other specific 
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protections. Women and pregnant women are mentioned in only two of 
the guidelines. 
What external resources are used as reference? 
Eight of the guidelines and laws reviewed in our study refer to external 
resources. Five refer to international guidelines, while the other three 
claim to respect Islamic law. The Bahraini and Lebanese documents do not 
refer to any external references. The Declaration of Helsinki is used by five 
of the guidelines; the ICH-GCP by four, the Nuremberg Code and Belmont 
report by two, and the CIOMS is used only once. Even though Syria and 
Iraq do not have national guidelines, the Syrian Ministry of Health refers 
to the CIOMS guidelines and the ICH-GCP26, while, on its website, the Iraqi 
Ministry of Health refers to guidelines extracted from an unknown 
reference, but mentions that no objection with the Islamic law can be 
accepted27 (See Table 3). 
Table 3: External references mentioned in the research ethics document for the 13 countries 
in the Middle East 
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Nuremberg code - - - + + - - - - - - - - - - 
Belmont report - - - + + - - - - - - - - - - 
Declaration of 
Helsinki  
+ - - + + + - - - + - - - - - 
CIOMS 
Guidelines 
- - - - + - - - - - + - - - - 
ICH-GCP + - - - + + - - - + + - - - - 
Others - - - - + - - - - - - + - - - 
Islam - + + - - - - + - - - + - - - 
DISCUSSION 
Economic power leads advances 
Efforts have been made to regulate research ethics in some countries in 
the Middle East. These efforts can be seen in the new regulations that 
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contain all or most of the protections mentioned in the international 
guidelines related to research ethics, such as the ICH-GCP, the CIOMS 
guidelines,7 and the Declaration of Helsinki. Specifically, these efforts can 
be seen in the Qatari guidelines, Saudi law and the Saudi “Clinical Trial 
Requirement Guidelines” crafted by the SFDA, which contain the 
maximum number of protections. However, the Arab Middle Eastern 
countries were at different levels with regard to the development of 
research ethics guidelines; most of the GCC (The Cooperation Council for 
the Arab States of The Gulf which includes Bahrain, Kuwait, Oman, Qatar, 
Saudi Arabia, and the United Arab Emirates) made advanced steps in this 
regard compared with non-GCC countries (Figure 1). 
Figure 1: Development of research ethics documents in GCC and non-GCC countries. 
 
 
The dissimilarities between the countries could be interpreted as 
resulting from the distinct differences in the levels of financial support 
awarded to health care and research in GCC and non-GCC countries in the 
Middle East. Increasing economic power impacts the quality of life in GCC 
regions, especially in terms of medical services and therapeutic 
manufacturing and, consequently, also affects medical research and 
research ethics development (See figure 1). This is clear when we 
compare health care expenditure per capita. According to statistics from 
2006, expenditure was $538 in Bahrain, $379 in Saudi Arabia, $628 in 
Kuwait, $716 in the UAE, and $2,151 in Qatar, yet only $103 in Jordan and 
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$38 in Egypt.9 Expenditure on health in GCC countries enhances the 
Middle Eastern market for pharmaceuticals. BioPlan Associates (A leading 
company of source for scientific information through industry-leading 
surveys, reports and publications) expect the health market in the GCC to 
be worth approximately $15 billion by 2014.9  
Wide variation and major deficiencies  
Compared to international guidelines, such as the ICH-GCP and CIOMS,7,8 
all of the national guidelines described here have many deficiencies in 
their stated protections, which differ in type and number from one 
country to another. This variation could be interpreted as a sign of the 
degree of development of these guidelines, or as a sign of the level of 
importance associated with each protection on the other.  
These deficiencies will have an effect on clinical research—especially 
experimental trials—in the region. Fewer protections mean less strict 
guidelines, which, in addition to good medical facilities and a suitable 
research environment, will prove attractive to many pharmaceutical 
companies who may wish to transfer their research activities to such a 
region.9 The many deficiencies observed in these guidelines will leave a 
question mark as to their adequacy in offering the necessary protections 
to research subjects in the region.         
Scientific validity and obligations for informed consent and review by an 
ethics committee were mentioned in 10, and nine of the 10 reviewed 
guidelines, respectively. This indicated the importance of these 
protections as well as the awareness of the principle of autonomy and 
freedom in making decisions to participate in clinical research and taking 
care to carefully review research proposals and concrete ethical 
guidelines. Confidentiality and the balance of benefits and risks are also 
important, as they are mentioned seven times. Additionally, even though 
there is consensus on the guidelines regarding the obligation to have 
informed consent, only three guidelines described who is responsible for 
obtaining consent or explained the elements required, which is 
considered a great deficiency because simply having consent without its 
elements will invalidate this consent. In the region, there have been few 
studies about the adequacy of informed consent in medical research; 
however, this has not yet been reflected in the national document.29,30 
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Another clear deficiency in the majority of these guidelines is the failure 
to reflect on the special societal requirements that result from ignoring 
vulnerable groups. Only two of the guidelines discussed vulnerable 
groups, two spoke of individuals with limited resources, four about 
children, one about women, and one about pregnant women. In fact, it is 
not only strange, but also a significant deficiency that children were 
mentioned in only four of the 10 guidelines because the nations in the 
Middle East are young and children represent a significant portion of their 
populations. For example, according to statistics from 2007, 32.5% of 
people in Saudi Arabia are 15 years old or younger.31 Thus, regulating the 
participation of children in clinical research and offering them sufficient 
protections are vital requirements for conducting research in the Middle 
East. 
Despite their importance, providing compensation to research subjects 
and the equitable distribution of burdens and benefits are rarely among 
the listed protections. This reflects insensitivity toward these concerns 
and demonstrates a weakness in the experience and awareness of the 
results of clinical research. On the other hand, it is, to some extent, 
understandable that research on populations and communities with 
limited resources were mentioned in only two guidelines, as the current 
guidelines that appear in the GCC countries do not really lack resources. 
Are international research ethics guidelines a proper measure for the 
assessment of research ethics documents in Middle Eastern Arab 
countries? 
The majority of the published and discussed documents refer to one or 
more international documents on biomedical research ethics, such as the 
Declaration of Helsinki, ICH-GCP, and others. This also applies to Syria and 
Iraq, where, until now, no such national documents have been available; 
however, both countries have referred to one or more of the research 
ethics international documents on their Ministry of Health websites. 
Different social, religious and cultural factors raise the question of the 
appropriateness of using international documents as a standard-bearer 
for national documents on biomedical research ethics in Middle Eastern 
countries. 
The principles stated in these international documents are undoubtedly 
universal and reflect shared values. However, in many regions worldwide 
values derived from religion and culture share in formulating bioethics, 
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including research ethics. It is, consequently, important for national 
documents to reflect international values as well as the values of their 
societies. The CIOMS guidelines have significant importance in this regard 
because they were formulated to be applicable to developing countries. 7 
The Islamic reading of this document, as seen by some Muslim scholars 
assigned by the Islamic Organization of Medical Sciences IOMS, is that the 
ethical principles of the CIOMS guidelines were fully compatible with 
Islamic law.32 Consequently, the CIOMS guidelines can be considered valid 
for use in the Middle Eastern countries where the majority of the 
population is Muslim.  
Surprisingly, only three documents of the ten studied—two from Saudi 
Arabia and one from Egypt—discuss respect for Islamic perspectives. 
Additionally, these references are merely general statements about 
respecting Islamic values. None of the guidelines refers to the documents 
and regulations released by Islamic medical entities such as the IOMS.32 
This can be interpreted in two ways: either the authors of research ethics 
documents in the Middle Eastern countries see no contradiction between 
biomedical research ethics and Islam or, alternatively, there is no relation 
at all between the two and, therefore, no need to refer to Islam in any 
national document about biomedical research ethics. Moreover, none of 
the documents mentions any related fatwa, which indicates that fatwas 
are not well known or are not seen as important by national guideline 
makers.33   
However, theoretical agreement between ethical principles and 
cultural/religious values is insufficient. The interpretation and application 
of ethical principles may differ from one society to another. This is not 
limited to the situation in the Middle East, but also to other areas in the 
developing world, such as Africa.34 Issues such as research on women, 
informed consent, and breaches of confidentiality require more attention 
in the guidelines and applications of research in the Middle East.29,33 
LIMITATIONS 
While the information in this study is based on the most recent data 
available, three restrictions on the data should be noted. First, analysis of 
and comparison between the contents of the guidelines among national 
documents and international documents—such as defining minors, 
incompetent persons, benefits, risks, and so forth—cannot be performed 
in a scientific manner because these guidelines are designed to provide 
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concise and general ethical protections. Thus, there is no ability to 
estimate or analyze the meanings and dimensions behind the stated 
protections. Meaning is expected to be detailed in the manuals of the 
policies and procedures for research ethics guidelines, similar to the 
newly published “Saudi Bylaw of ethics of research on the living 
creatures” (2011), which is the only manual related to research ethics 
available in the region.24  
Second, we do not include the ongoing efforts to establish guidelines in 
many countries, such as in Egypt, Jordan and Saudi Arabia, where it is 
expected that new guidelines will appear in the coming years.  
Third, our paper does not report information on the process of ethical 
review at the national level or on what mechanisms are used to encourage 
adherence to regulations or guidelines. 
CONCLUSIONS 
Recently, notable efforts to establish national research ethics guidelines 
have been made in many countries in the Middle East. However, 
compared with international documents, most of the research ethics 
documents in use in this region demonstrate numerous deficiencies. 
Many differences among the documents can be observed in the 
development, structure, content, and reference to international 
guidelines. Guidelines from GCC countries are more developed compared 
with guidelines from other countries in the Middle East. Greater efforts 
are required to develop better regulations and guidelines in most 
countries in the Middle East. 
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PART II: Empirical Research 
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ABSTRACT 
The ethical issues regarding research biobanks continue to be a topic of 
intense debate, especially with respect to issues of confidentiality, 
informed consent, and child participation. Although considerable 
empirical literature concerning research biobank ethics exists, very little 
information is available regarding the opinions of professionals from the 
Middle East on this subject. To close this gap, we conducted 12 interviews 
with professionals from the Middle East to document their opinions. We 
found few differences between those interviewed; their primary concerns 
were mainly similar to what is stated internationally; they generally 
believed that confidentiality protection is socially very important and that 
informed consent must be obtained from both adult and child 
participants. In addition, because most populations have a high 
percentage of children, and because children are not just small adults, but 
they show important differences, the interviewed professionals strongly 
believed that it is imperative to include children in biobank research. 
Keywords:  confidentiality; children; informed consent; developing 
countries; ethics; genetics; Middle East 
INTRODUCTION 
An increasing number of medical studies are focusing on the genetics and 
the environment. Understanding inherited diseases is important in order 
to find new treatments. The Framingham Heart Study, 
http://www.framinghamheartstudy.org/, Monitoring of Cardiovascular 
Diseases (MONICA) http://www.ktl.fi/monica /, and Prospective 
Cardiovascular Münster Study (PROCAM), http://ear001.uni-
muenster.de/index.html, represent several examples of longitudinal 
studies that have used collected stored materials and have considerably 
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influenced our understanding of the pathogenesis of several diseases, 
including infarction and angina.  
Considerable discussion currently exists regarding biobanks and the use 
of stored tissue samples in genetic research. In particular, these 
discussions focus on the ethical, legal, and social aspects, such as issues 
of the ownership of the samples, data, return of research results back to 
participants,  privacy and confidentiality; and the procedural aspects 
related to issues of storage, information, and research projects.1 The 
biobank debates range from issues relating to research approvals, 
storage, and archiving of samples to those concerning the problems of 
sharing data with other biobanks including private biobanks, the 
responsibilities of the biobanks, and conflicts of interest among 
institutions.2 Considerable discussion is centered around issues such as 
confidentiality and privacy,3 the best scientific basis for genetic research, 
commercial use of the information including the possibility of sale, 
intellectual property issues,4 and benefit to society.5 Moreover, the issue 
of obtaining approval to participate in research has received significant 
attention,6,7 especially discussions regarding one-time consent as well as 
the right of the patient to withdraw consent and the degrees of this 
withdrawal.7-9 
The participation of children in biobank studies poses unique ethical 
challenges in contrast to the participation of adults.10,11 In particular, 
debates focus on the necessity of child participation, minimizing risk, the 
right of either parent or a single parent to sign on behalf of the child, the 
extent of this consent, the right of the child to provide participation 
consent, and so forth. 
Recently, some discussions and scientific events concerning ethical issues 
relating to sample storage and biobanks have occurred in Saudi Arabia 
one of the Middle Eastern countries, because of the implementation of 
the first national biobank in that region. For example, workshops on gene 
ownership (King Abdul Aziz City of Science and Technology KACST 2003), 
ethics of biobanks (King Abdullah International Medical Research Center 
KAIMRC 2010), and tissue banks leadership (College of Medicine at the 
King Saud University 2011) were conducted in Saudi Arabia. 
Researchers in the Middle East are influenced by many social and cultural 
factors in contrast to the environment in the west where a lot of 
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professionals educated there. This mixture of many factors pushes us to 
study their thoughts about some ethical concerns in clinical research.  
Despite numerous debates and publishing on biobanks in Western 
countries, we could not find any published empirical work regarding the 
opinions of clinicians and researchers working with stored tissue samples 
in the Middle East. Examples of such studies in other countries include, 
Ruiz et al. who compared researchers from Spain and the USA 12 and Ries 
et al., who interviewed investigators of six studies to determine how these 
studies handled different ethical, legal, and social issues.13 Meulenkamp 
interviewed researchers about the communication of the results of 
biobank research.14 Several researchers have focused on examining the 
ethics of stored samples collected from children.11,15-17 
Very few empirical studies in the Middle East concern research ethics in 
research on stored samples could be found. Abou-Zeid A, et al. obtained 
the viewpoints of patients regarding stored samples for future research. 
This study showed that many participants do not favour sample donation 
for future research, and prefer restricting the future research to the illness 
being. Moreover, many participants were hesitant to have their blood 
samples donated for genetic research or exported out of the country.18 
Another study was general and not focused on the ethics of stored 
samples in particular conducted by El-Dessouky et al, who performed a 
pilot study to assess the knowledge, awareness, and attitude of research 
ethics among dental faculty. This article showed that there is a knowledge 
gaps in research ethics and there is broad-based acceptance of IRBs and 
training in research ethics.19 
The concepts that professionals in the Middle East consider ethically 
concrete and the common practices in stored sample research in this area 
remain largely unexplored. What is the position of professionals in the 
Middle East regarding the ethical challenges in research biobanking? How 
they think? What are their concerns? We considered it important to 
interview such professionals with the aim of understanding their thoughts 
and opinions on the main ethical issues involved in the storage and usage 
of tissue samples in research. Our study presents the main findings of 
these interviews. 
METHODOLOGY  
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Because there is a paucity of information regarding the opinions of 
professionals from the Middle East on clinical research in general and on 
genetic research in particular, we conducted in-depth interviews with 
professionals from the Middle East involved in medical and genetic 
research (including research biobanks). In this qualitative method of 
analysis, we identified and focused on themes of importance, after 
conducting three interviews with three professional from different 
backgrounds. None of these three interviews were included in our study. 
This is a preliminary study of the ethical issues in biobank research, and 
we believe our results could provide a starting point for additional 
quantitative studies in the form of surveys. We used the snowballing 
technique to select our interviewees, resulting in 11 interviews from 
experts in the Middle East plus 1 interview with a biobank expert from 
Sudan, which can be included in the Middle East in a wider definition. 
Even there are many definitions of the Middle East region; we were 
interested only in professionals from Arab countries in this region, 
because they represent much similarity among each other especially 
regarding language, history, culture, and religions.  
Table 1 Interviewee Characteristics 
Profession of Interviewees 
Epidemiologist 5 
Internist 2 
Pediatrician 1 
Surgeon 1 
Pathologist 1 
Forensic 1 
Microbiologist 1 
Gender of interviewees 
Male 8 
Female 4 
Location of interviewees 
Saudi Arabia 4 
Jordan 2 
Syria 2 
Egypt 2 
Sudan 1 
Lebanon 1 
Places of interviewees’ medical / 
scientific training 
Middle East only 1 
Middle East and Europe or US 11 
Type of collection 
 
Collected for research purpose (only) 3 
Collected for diagnostic purpose, but can be used in 
research later 
6 
Collected primarily for both for diagnostic and 
research purposes 
3 
Type of interview Live 12 
We considered the geography and specialty diversity to the extent 
possible and obtained a final pool of interviewees from six countries and 
seven specialties, which are indicated in Table 1. Although the 
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interviewees’ profiles and specialties varied (Table 1), all of them are or 
were working with stored samples.  
We initially contacted all 12 interviewees via email, and subsequently, we 
scheduled face-to-face interviews. All interviewees have been selected on 
basis of having experience and work on research on stored human 
samples, in different Arabic countries in the Middle East. We conducted 
these interviews during April and July 2012. The duration of each 
interview ranged between 40 and 75 minutes. We conducted the 
interviews in English or Arabic. 
Our interviews focused on the three themes of confidentiality, informed 
consent, and child participation. We used a semi-structured approach for 
our interviews rather than a structured one to enable us to include 
important remarks and findings throughout the interviews.20 GA was the 
interviewer for all 12 interviews. Interview guide were prepared together 
by GA and KD. 
After we recorded our interviews, we transcribed the audio records 
without performing any language corrections to retain the oral nature of 
the speech of our interviews.21 We manually coded the texts of the 12 
interviews, and classified the responses into an introductory theme and 
the three main themes that were focused on in the interviews. 
Subsequently, we made sub-themes of the four themes. Illustrative 
quotes were selected to reflect the meanings of the themes and sub-
themes. We have indicated the professions of the interviewees with their 
quotes, and translated them into English, wherever necessary. To protect 
confidentiality the word "interviewee" is used to refer to any of our 
interviewees.  
RESULTS 
Research ethics guidelines 
Regarding clinical research ethics guidelines in general, many 
interviewees felt the need for more national or institutional guidelines, 
such as that in developed countries, like US and Europe. Two interviewees 
felt that there was no requirement for more guidelines, citing the fact that 
most countries rely on international guidelines, such as the Declaration of 
Helsinki, Council for International Organizations of Medical Sciences 
(CIOMS) guidelines,33 or Guidelines for Good Clinical Practice (ICH-GCP), 
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or have derived their own guidelines from international guidelines. 
However, all interviewees agreed that research ethics training is 
necessary. One of the interviewees said,  
"The issue is not related to guidelines, but it is a matter of education. We 
already adapt and use Western and international guidelines." 
(Epidemiologist 1) 
This professional clearly alluded to the main points that were quoted by 
other interviewees. All the interviewees felt that research professionals 
in the Middle East need training to increase their awareness of clinical 
research and to eliminate any potential misunderstandings. 
The lack of guidelines and training is not unique to clinical research and 
this issue was also brought up during the discussion on genetic research 
or research on stored samples and biobanks. It is necessary to provide 
more training to researchers, particularly because of the increased 
importance of confidentiality. All the interviewees conceded that there is 
a major lack of regulations and guidelines in both national and 
institutional standards.  
Table 2 Overview of the themes and findings 
Themes Findings 
Research ethics regulations & 
ethical challenges 
Better national & institutional guidelines concerning research 
on stored tissue samples are required 
No different ethical changes in the Middle East or in Muslim 
countries 
Social values must be respected 
Islamic rules can form a basis to control ethical challenges 
related to clinical research and research on stored samples  
Confidentiality 
Confidentiality is a major concern 
The nature of genetic information is familial 
Breaching confidentiality may have serious consequences 
Stigma is a real fear 
Sending samples abroad must be minimized 
Informed consent 
Informed consent is mandatory 
Both women and men have the right to sign the consent form  
The process of obtaining informed consent is inadequate 
Broad consent is preferred 
Participants have a right to withdrawal of consent at any time 
Degrees of withdrawal 
Child participation 
Clinical research is important, particularly in the Middle East 
Children need more protection 
Exposure to not more than minimum risk 
Fathers are given priority to give consent for their children 
Child assent is important 
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When comparing international and institutional guidelines, the majority 
of interviewees stated that national guidelines and regulations are more 
important and they should be applied in all medical research institutes in 
the country, because this would facilitate collaborative research among 
many centers, and the enable better control over them.   
According to the interviewees, confidentiality, informed consent, and 
avoiding harm to research participants are among the most important 
ethical research concerns on stored samples. The interviewees did not 
observe any differences specific to the Middle East, where the majority of 
people are Muslims. In other words, Islam does not create specific ethical 
challenges for clinical or genetic research. This is well illustrated by the 
following quote from a professional who has worked in both Western and 
Middle Eastern countries: 
"There might be religious and cultural impacts on genetic research and 
biobanks of which I am not aware, and one must be careful. Islam 
eventually does not negatively affect clinical research. It is not an issue of 
Islam; this impact comes from misunderstanding. This is not limited to 
Muslims, but is a phenomenon that I observed among Christians as well. 
It is an issue of social habits and customs." (Internist 1) 
One interviewee stated that rules derived from Islamic principles can 
manage all ethical challenges that clinical research, genetic research, or 
research biobanking might face.   
"Islam has its ethical principles but also its flexibility. Nonetheless, we do 
not follow these ethical principles." (Pediatrician) 
Notably, one interviewee recalled a certain fatwa* about research, 
whereas three other interviewees reported that they had heard of such a 
fatwa, but were unsure of its existence. The remaining eight interviewees 
were unaware of any related fatwa, but they thought that having such a 
special fatwa would be effective for supporting the existing guidelines and 
encouraging people to participate in genetic research or research 
biobanks. 
Confidentiality 
                                                             
* In Islam, a fatwa is a juristic ruling concerning Islamic law issued by an Islamic scholar. 
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All the interviewees indicated that respecting privacy and confidentiality 
are extremely important ethical principles of clinical research. An 
interviewee said: 
"All doctors must consider and deal with medical information as secret 
between doctors and their patient. This is important as well between 
researchers and research subjects." (Internist 1) 
Privacy and confidentiality are even more important in genetic research 
because the information collected from patients pertains not only to 
those individuals but also to their families and, according to four of 
interviewees from Saudi Arabia and Jordan, to their tribes. 
According to a majority of the interviewees, confidentiality is a major 
concern of research participants. They believed that the fear of breaches 
of confidentiality might prevent people from participating in clinical 
research and genetic research. One interviewee said,  
"I think assuring people that no breaches of confidentiality exist in a 
certain research area will encourage them to participate much more." 
(Epidemiologist 2) 
However, another interviewee believed that the fear of breaches of 
confidentiality does not deter people from participating in clinical 
research, as expressed in following quote, 
"People are accustomed to having extensive and deep social 
relationships. The difficulty comes only from not having the habit of 
participating or donating. In general, they are not fully aware of the 
importance of confidentiality itself." (Internist 2) 
Stigma and discrimination are genuine fears that negatively impact 
societies in the Middle East and can extend from the research participant 
to other family members. Such discrimination will not only have effects 
on employment opportunities or obtaining insurance, but might assume 
different forms. One interviewee stated, 
"Stigma and discrimination are very strong in our society. If one was 
known to be HIV-positive or to have failed a paternity test, his sisters and 
possibly his brothers would face difficulties getting married." 
(Epidemiologist 1)   
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In general, most interviewees believed that additional procedures and 
regulations are required for protecting genetic information. However, in 
some cases, breaches of clinical information could be as serious as those 
of genetic information. This was clearly stated by one interviewee,  
"Information in clinical research and information in genetic research are 
the same; they can be routine or sensitive information." (Epidemiologist 
2) 
According to all the interviewees, transferring any genetic information 
from any research participant to a third party, should be strictly 
prohibited. This prohibition against transfer of genetic information is also 
applicable to research institutes or genetic centers. Without a court order, 
even police officers have no right to obtain genetic information. All 
interviewees expressed caution with respect to sending samples or data 
to other countries, even for a better diagnosis. One interviewee said, 
"Sending samples outside the country must be minimized to very 
necessary cases, unlike what was done a few years ago." (Epidemiologist 
3) 
Another interviewee expressed concern that despite legal restrictions, 
some doctors and researchers intend to send samples to other countries 
illegally, whereas other researchers do so out of ignorance for such legal 
restrictions. 
Therefore, the challenges related to sending samples abroad include 
unethical or illegal use of samples and confidentiality issues.    
Informed consent 
All interviewees clearly stated that obtaining a signed voluntary informed 
consent from research participants is mandatory for conducting any 
clinical research. Written consent must be obtained, especially for 
research on stored tissue materials. These conditions apply to both men 
and women. None of interviewees accept any difference between men 
and women regarding giving informed consent for research on stored 
samples. An interviewee commented,  
"Adult women must also sign the informed consent. It is neither 
acceptable, nor ethical to only obtain the signature of her father or 
husband. Otherwise, we would violate the woman’s dignity." (Internist 1) 
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This comment reflects the unanimous opinion of all interviewees. 
However, one interviewee added, 
"Ethically, when a pregnant woman wants to participate in research, 
informed consent must be collected from both the woman and her 
husband." (Epidemiologist 4) 
All the interviewees confirmed that obtaining an informed consent from 
all research participants is a part of the usual practice in genetic research 
in all research centers. The interviewees also agreed that each of the 
following elements must be included in the consent form: research 
descriptions, risks, benefits, alternatives, confidentiality, compensation, 
contacts of the researcher, and voluntary participation. The interviewees 
consider these elements essential, and none of these elements must be 
eliminated. 
However, the main challenge regarding informed consent arises from the 
manner in which it is obtained. According to the interviewees, the process 
followed for collecting informed consent does not always guarantee that 
research subjects are provided with all information they will need to know 
before giving their informed consents. This is elucidated in a quote from 
one of the interviewees, who described the process that her institute 
follows for obtaining informed consent: 
"Usually, a nurse will bring many pages of informed consent and ask a 
potential participant whether he/she agrees to participate in research 
that will be performed by a doctor. If yes, the nurse will ask him/her to 
sign at the bottom on the informed consent without reading a single 
sentence in the informed consent. This process takes just a few seconds. 
This is not true informed consent." (Internist 1) 
The interviewees in this study think that one-time consent (collecting only 
one informed consent for unlimited number of research) is better when 
dealing with stored samples research and biobanks. However, they insist 
that all the participants have a right to withdraw their consent in both 
biobanks and all other types of research. Nonetheless, in some research 
studies, complete withdrawal cannot be permitted, as explained by one 
of the interviewees, 
"Many studies cost a lot, and sometimes, we need to buy special 
equipment, and if we allow complete withdrawal, we might lose a lot on 
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money. This is also the case when the research is studying rare diseases. 
We might allow only partial withdrawal and continue using stored 
samples by making the data fully anonymized." (Epidemiologist 4) 
Many interviewees agree with the concept of partial withdrawal; 
however, they insist that if complete withdrawal is permitted, participants 
must be informed and their consent must be obtained. 
This is illustrated by the following quote, 
"Many biobanks around the world, like the UK biobank, allow different 
degrees of withdrawal. We have to do the same." (Epidemiologist 2) 
Another interviewee stated, 
"Biobanks are expensive and require significant effort and personnel, and 
we expect great benefits from the research on biobanks, so we have to 
find a solution. This can happen by allowing different degrees of 
withdrawal. We can stop collecting new data or samples, but we continue 
use parts of samples and data after doing full anonymisation so 
confidentiality is guaranteed." (Epidemiologist 4) 
Child participation 
All our interviewees believed that conducting research on children is 
essential. They agreed that using adult medications on children by only 
adjusting doses is neither scientific nor appropriate, as the physiology of 
children is different from that of adults. One interviewee said,  
"Doing research on children is very important; even more so, not doing 
research on children is bad and harmful." (Pediatrician) 
Some interviewees referred to the differences between the proportion of 
children to the total population of Middle Eastern countries and Western 
countries. The interviewees assumed that a higher percentage of children 
in Middle Eastern countries emphasized the need to conduct research on 
children in these countries. 
Although necessary, interviewees indicated that it is difficult to attract 
children to participate in genetic research, and mentioned the need for 
effective educational programs to encourage people to permit their 
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healthy children to participate in research. Therefore, some efforts need 
to be made to convince parents to enroll their children in research. 
Most interviewees perceived no differences in the risks associated with 
the research information collected for adults and children. Nevertheless, 
they believed that children due to children vulnerability need more 
protection and the information obtained from them should be addressed 
with greater care. One interviewee said, 
"Children are vulnerable; we have to offer more protection to them. They 
cannot decide by themselves; we must help them and protect them. A 
needle prick is a major harm for children, so they need more protection" 
(Epidemiologist 3). 
All the interviewees preferred that both parents jointly decide whether to 
enroll their children in clinical research and research biobanks or not; 
however, they indicated that the father is the final decision maker in case 
the parents’ decisions differ. When we introduce a question about the 
mother-only consent for a child’s participation in research the majority of 
the interviewees said that a mother cannot take a decision independently 
if the father is unavailable, unless the father’s designee also agrees with 
the mother’s decision. One interviewee dissented with this opinion and 
said that the mother can take an independent decision when the father is 
absent. This interviewee said, 
"A mother knows her children very well and makes decisions in their best 
interest of them. Thus, there is no reason not to allow her to decide 
alone." (Epidemiologist 3) 
All interviewees agreed that it was important to obtain assent from the 
participating children, wherever this was possible. Moreover, they 
considered obtaining the consent of the parents necessary and not 
wasteful. On asking the interviewees from what age onwards should 
assent be obtained from children, we received different answers: some 
said 10 years and above, some said 12 years and above, and others said 7 
years and above. Moreover, some interviewees said that consent is not 
related to age, but to the ability to understand that the consent is for 
research purposes and to understand the informed consent. Using easy 
language and obtaining parent’s help plays a vital role in the success of 
encouraging children to accept participation in research. 
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DISCUSSION 
Need for establishing guidelines and providing training 
We interviewed 12 professionals from the Middle East, who were working 
in the field of stored tissue samples, on the topic of principles of research 
ethics.  
Most of the interviewees indicated that there is a need for more 
guidelines concerning research ethics in their countries. This is 
understandable because many guidelines in several countries are 
deficient and thus far, many Middle Eastern Arabic countries do not even 
have guidelines concerning research ethics.19,22 Despite the recently 
published guideline 23, which contains most ethical principles for research, 
interviewees from Saudi Arabia also agreed to the need for more 
guidelines regarding research ethics. This can be explained by the lack of 
awareness of these guidelines, moreover it is supported by other studies 
in other countries where there are no national guidelines till now.22 Two 
other interviewees agreed on the need for new guidelines, which is 
understandable given that many of the interviewees explained that their 
countries rely on international documents such as the Declaration of 
Helsinki, ICH-GCP, COMS guidelines, so forth.22  
The consensus of our interviewees regarding the lack of guidelines 
concerning genetic research in the Middle East is in line with our previous 
finding that thus far, no published guidelines on genetic research ethics 
are available in the region.22 
All our interviewees emphasized the importance of training in the 
understanding and application of ethics principles in their research. The 
lack of training in research has been addressed in several studies 
performed in the Middle East,19,24,25 and in some developing countries 
from other regions.26,27 
An Islamic opinion about any matter, especially recent matters is called a 
fatwa. Fatwas are usually issued by a scholar (called then an individual 
fatwa) or by a juristic council (called a plural fatwa). Plural fatwas are 
stronger than an individual one, and have an increasing interest.28,29 There 
two main groups of Muslims: Sunni 87-90% of total number of Muslims, 
and Shia 10-13%.30  Fatwas, especially in the Sunni school, are usually not 
binding and do not have power to influence laws of Muslim States.31 Some 
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fatwas regarding clinical or genetic research have been issued by Islamic 
institutions, such as fatwas by International Islamic Fiqh Academy, a part 
of the Organization of Islamic Cooperation, like fatwa No. 161 regarding 
the Islamic perspectives on medical and biological research on human 
subjects,32 fatwa No. 67 concerning medical treatment,33 fatwa No. 79 
concerning confidentiality in the medical professions,34 and fatwas 1/15 
and 3/17 on genetic and stem cell research respectively by the Islamic 
Fiqh Council in the Muslim World League.35,36 Only one interviewee could 
define a certain fatwa. Three possible explanations for this are as follows: 
(1) the number of these fatwas is very limited, (2) the factual effect of 
these fatwas is very limited, and (3) they fail to reach doctors and 
researchers, especially because of the insufficient power that these 
institutions have in implementing these fatwas in Islamic countries.22  
Nonetheless, the interviewees believed that Islam and Islamic rules could 
form the basis for good ethical practice in clinical research. This can be 
understood in the context of the emphasis on trust in general Islamic 
ethics, such as honesty, respecting secrets, avoiding causing harm 
intentionally, respecting people, so forth. However, there is another issue 
that cannot be disregarded, which is related to the fatwas themselves for 
clinical or genetic research, because of the limited number of fatwas and 
their non binding power.  
Confidentiality, more concerns, and more fears 
Our interviewees seemed to implicitly acknowledge that confidentiality is 
an important principle in clinical research and genetic research. The 
interviewees’ opinions matched perfectly with the ethical principles 
expressed in international documents, such as the Declaration of Helsinki, 
ICH-GCP, COMS guidelines, and Universal Declaration on the Human 
Genome and Human Rights.37 Moreover, our interviewees emphasized 
the concept of confidentiality as an important principle in biobanks, and 
this is in line with many other studies 38-40.    
Interfamilial marriages result in genetic information shared by numerous 
people. Our interviewees indicated that family members, including 
extended family members, share similar genetic profiles. Similar studies 
mentioned to such opinion by interviewees as the study by Hens et. al 11. 
Moreover, in some countries in the Middle-East such as Saudi Arabia, the 
tribal system is a powerful social network with pragmatic impact on 
people’s lives, including their matrimonial decisions. Marrying relatives is 
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often favoured and the tribes have thus, to some degree, cognate genes. 
Breaches of individual confidentially might lead not only to individual 
stigma but also to familial and tribal stigmas.41 The family system in 
Muslim communities is built on specific selection criteria, such as degree 
of religiosity, beauty, wealth and family name. Marriage decisions in these 
groups most often are not individual decisions, but familial ones; thus, the 
family image and such stigmas can play a role in marriage decisions. 
Consanguinity and its social stakes, rationale and impact have been 
noticed as well in non-Middle Eastern Muslim communities such as 
Pakistani immigrant in the UK.42,43 The interviewees’ concern regarding 
extended stigmas is supported by other studies, especially with regard to 
the high rate of consanguinity and genetically inherited diseases in Middle 
East countries such as Saudi Arabia.44 
Our interviewees show some concern regarding sending human tissues 
and data to developed countries for diagnostic and research purposes, 
because a study of these tissues can reveal very sensitive information. The 
practice of sending tissues overseas was common in different countries in 
the Middle East. The concern of researchers and our interviewees with 
sending samples outside the country stem from the fear that these 
samples will be misused. This concern of researchers has led many 
countries to establish laws for regulating the transfer of such research 
samples and materials outside the country, thereby limiting such transfer 
to very essential cases, such as Saudi Arabia (National Committee of Bio-
Medical Ethics).23 
Informed consent 
Although our interviewees agreed that informed consent in clinical and 
genetic research is mandatory, they expressed significant dissatisfaction 
with the process used for obtaining informed consent. This is in line with 
results of studies conducted in different areas. 7,45,46 
Our interviewees were concerned with the following two points: the 
minimal experiences of staff who obtain informed consent and the limited 
time given to participants to sign their consent. Deschenes et al. (2011) 
analyzed informed consent document utilization in a minimal-risk genetic 
study and concluded that few research participants thoroughly read the 
consent document before agreeing to participate in the genetic study.47 
The interviewees preferred obtaining one-time consent from research 
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participants for practical reasons; this opinion corresponded with the 
findings of many authors of ethics studies of biobanks.11,48 
According to interviewees, both women and men have the right to sign 
alone consent for participating in clinical research. However, there are 
some limitations. Some interviewees argued that social values have to be 
considered, and it is preferable to approach both the husband and the 
wife together. Group consent processes were mentioned in a survey study 
by Kneipp et al.49 Our interviewees expressed that both women and men 
have the right to sign informed consents. None of the interviewees 
considered the question about who (the husband or the wife) can sign 
informed consents to be unusual question in Middle East communities. 
The interviewees thought that some people might believe that men can 
sign on behalf of their female relatives (wives, sisters, so forth.), which 
might reflect a cultural difference between the Middle East and the 
Western countries, where such question might be considered illogical. We 
were unable to find any study on research biobanks in the West that asked 
a similar question. 
Interviewees reported that withdrawal is a fundamental right of 
participants and agreed that participants must be aware of this right. This 
is supported by ethical guidelines and by many studies.50,51 Instead, our 
interviewees acknowledged that besides participants’ right of withdrawal, 
other factors, such as employment of expensive equipment, considerable 
effort expended by researchers, anonymization, and technical difficulties, 
needs to be considered in biobank research. This creates a contradiction 
between rights and welfare of participants vs. scientific interest. It will be 
unethical to revoke the participants’ rights to withdraw their consent for 
economic gain, as human rights are always given priority. A solution to 
this contradiction is to permit partial degrees of withdrawal; this solution 
is preferred by our interviewees and has been applied in many biobanks, 
including the UK biobank, where no new samples and/or data to be 
collected; however, already collected samples and data can be used by 
applying anonymization techniques.52 Eriksson and Helgesson  introduced 
the idea of “sufficient reason” in this regard and argued that those wishing 
to withdraw their samples from being included in the research must 
present sufficient reasons for doing so.48 
Children 
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Our interviewees agreed that it is imperative to conduct research on 
children. This importance arises from the scientific necessity of 
conducting clinical research on children and on samples from children, 
given that children are not simply young adults.53 Moreover, the 
proportion of children and young people to the total population in Third 
World societies, including Middle East societies, is generally higher than 
that in Western societies, thereby increasing the significance of research 
on children. For example, statistics in Saudi Arabia indicate that children 
aged under 15 years account for approximately 32.5% of the total 
population according to Saudi Export Developing Center. 54 
The interviewees’ belief that children are vulnerable and need more 
protection is in line with those of other authors.11 A majority of our 
interviewees indicated that research on children and on the tissues from 
children should be conducted only if the research risk is not more than 
minimum risk. It is now acknowledged that “minimum risk,” as stated by 
many authors, is one of the criteria for permitting research on children. 
55-58. Research biobanks show no major physical risks; minor risks are 
related to some issues such as needle prick and allocating time. Other 
risks can be eliminated by following regulations and guidelines. Besides, 
consent from the parents, our interviewees emphasized the importance 
of the practice of obtaining children’s assent. According to the 
interviewees, the researchers should use easy language so that children 
are able to understand the consent process. The results confirm the 
importance of obtaining children’s consent.11 Both these studies and 
surveys by Avard et al. and Jackson et al. indicate that effective 
communication with families regarding the benefits of clinical and genetic 
research results in a higher percentage of child participation in such 
research. Nevertheless, the opinions of the interviewees differed with 
respect to the age at which children should ideally be able to give consent. 
The opinions of our interviewees varied with respect to the ideal ages of 
assent, and their suggestions included 7, 10, 12, and 18 years. Other 
studies suggested that ideal age at which children should be able to give 
their consent was 12 years old. Besides age, all our interviewees and other 
researchers were interested in the ability of the children to understand 
the research and give their assent.59,60  
Besides emphasizing the importance of providing all the necessary 
information to the families for obtaining informed consent, most of our 
interviewees think that fathers always have priority over mothers in 
signing informed consent for their children and in case the fathers are not 
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available, the fathers’ designees have priority over the mothers. However, 
all interviewees preferred that both parents sign consents for research 
conducted on children. This opinion is also expressed by Diekema for 
cases in which procedures are not medically required and preferred not 
to perform these procedures in cases of parental disagreement.61 
However, this study did not discuss which parent has priority. Moreover, 
we were unable to find any study discussing the priority of the parents in 
signing consent for inclusion of their child in research. That maybe is 
related to the manifold social and cultural meanings of adulthood, the 
self, citizenship and parental authority in diverse societies. We believe 
that our interviewees’ preference to give priority to fathers over mothers 
stems from religious and social perspectives.62 
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Interview Guide 
Confidentiality, Informed consent and children participation in the stored 
tissue samples: Interviews with professionals from Middle East 
This questionnaire includes 4 parts:  
1. Introduction 
2. Confidentiality 
3. Informed consent 
4. Children 
First: Profile of the institution and the collection and the interviewed biobank 
staff OR IRB member 
1. Can you give a short description of your position, and background? 
2. Are you involved in biobanks, IRB or both? If so, why? 
3. Tell me more about your experience with and work in the biobanks, IRB or 
both? 
4. Have you previously been involved in another biobank, IRB or both in another 
institute? For how long? Do you see any differences between both institutes? 
5. How did you become involved in bioethics? 
a. by courses: 
1) in medical research ethics 
2) in biobanking ethics 
3) both 
b. by experience and research: 
c. by both courses and experience and research 
d. other 
6. Can you give a short description of the biobank, and its aims? Is the biobanks 
disease-related or population -related? What diseases are studied?  
7. How long have you been working at your biobank or IRB? 
8. Is your biobank part of a university, research center, hospital or others? 
Explain. 
9. How many staff members are engaged in the collecting, storing,  and 
maintaining of bodily materials from patients and donors?  
10. Whose material is included in your biological sample collection (select all that 
apply) 
a. Healthy volunteers (for control studies or other studies?) 
b. Patients 
c. Participants of clinical and research studies 
d. Citizens, looking for genetic advice 
Please explain 
11. Do you document and store links between individual members of families? 
12. How long do you intend to store biological samples 
a. For future genetic research? 
b. For clinical/diagnosis purposes? 
c. For control studies? 
13. Which associated data do you keep? (medical data, lifestyle data, 
environmental data, etc.…). Please give some examples. 
a. For future genetic research? 
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b. For future medical research? 
c. For clinical/diagnosis purposes? 
d. For control studies? 
14. Have you documented your legal and ethical procedures of storage of 
biological samples for: 
a. For future medical research? 
b. For future genetic research? 
Can we have a copy of these procedures? Is this documentation accessible to 
the general public? 
15. What is the size of the biobank (in number of samples)? How many raw tissue 
samples do you have? How many extracted DNA samples do you have? 
16. Do you think being biobanks in Islamic countries will have different challenges 
than in other countries? 
a. Yes 
b. No 
c. Maybe  
Why? 
a. Do you think Islamic law affects biobanks differently? 
b. Do you think Muslims have different perspectives or habits that 
may affect the biobanks? 
What are these challenges? 
17. Do you think the biobanks in the Middle East will have different challenges 
than other biobanks? Why? What are these challenges? Are these challenges 
related to religion (Islam)? 
18. Considering your position, what are the most pressing challenges in research 
biobank (select all that apply)*: 
a. Confidentiality 
b. Informed consent 
c. No harm 
d. Others: please specify . 
19. Do you think Islamic rules are able to control all challenges in research 
biobanks? 
20. Are you aware about Islamic fatwas regarding : 
a. Medical research 
b. Genetic research 
c. Research Biobanks 
If yes: 
1) Which ones? Please explain. 
2) Do you think we need more fatwas? 
21. Do you think we need more regulation in regarding to : 
a. Medical research? 
1) National 
2) Institutional 
b. Biobanking? 
                                                             
* We start here to talk about research biobank rather than biobank in general. 
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1) National 
2) Institutional 
If not, please explain . 
 
Second: Confidentiality 
1. What according to you, is the major challenge with regard to confidentiality 
protection and the use of: 
a. Stored tissue samples?  
b. Data and information?   
Please explain 
2. What is the ideal protection in your opinion to confidentiality in biobanking? 
3. Do you think confidentiality is well protected through the procedures and 
guidelines in your institute? 
4. How is material for non-therapeutic research stored? Anonymous, coded, 
directly identifiable? 
5. Do you think genetic information is: 
a. Individual only 
b. Familial only 
c. Both individual and familial 
6. Can confidentiality breaching be risky? If yes what are its risks? 
7. Do you agree with sending genetic material outside the country for both 
clinical diagnosis and research?  Why? Please explain. 
 
Third: Informed consent 
1. What do you think are the major challenges with regard to informed consent 
in biobanks? 
2. Is informed consent mandatory or optional? And who has to sign the consent 
in the case of male participants and also female participants. Please explain. 
3. Which kind of informed consent do you prefer: general informed consent or 
consent for each study? Why? 
4. Do you think most research participants in your biobank/ research are capable 
of understanding the information presented in informed consent documents? 
5. Do you think that the process of getting the informed consent is good enough 
to empower the potential participant to make an informed choice to 
participate or not to participate in the study? Please explain. 
6. In biobanks, which is better: one-time consent for all research conducted in 
the donated samples and data, or offering consent for each study conducted 
on the same samples? Why?  
7. Do you allow withdrawal of participants? If yes, do you think that withdrawal 
must be a one degree or multiple degrees, and why? 
8. Which choices of degree of withdrawal have to be available? 
 
Fourth: Children 
1. What do you think are the major challenges with regard to the use of human 
tissue samples from minors? 
2. Do you think that minors have to participate in biobanks? Why? 
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3. Do you think there are differences between involving the children in clinical 
trials and in biobanks? 
4. For which ages do you think we should have to ask for : 
a. Only consent from the parent(s) 
b. Consent from the parents, plus assent from the child 
c. Assent from the child only 
5. Do we have to ask consent of : 
a. Father only 
b. Mother only 
c. Both parents 
d. None  
Do we need to offer more protection for information and data from children, 
or the same amount as we do for that from adults? 
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Chapter 5 
Attitudes toward medical and genetic confidentiality in the Saudi 
research biobank: an exploratory survey 
Alahmad, G., & Dierickx, K. (2014).  
ABSTRACT 
Achieving a balance between giving access to information and respecting 
donors’ confidentiality is a crucial issue for any biobank, with its large 
number of samples and associated information. Despite the existence of 
much empirical literature on confidentiality, there are too few surveys in 
the Middle East about the topic, particularly in the Saudi context.  A 
survey was conducted of 200 respondents at King Abdulaziz Medical City 
in Riyadh, Saudi Arabia, among five groups of equal size, which included 
researchers, physicians, medical students, donors and laypersons. The 
majority of participants agreed that confidentiality is an important issue 
and that it is well protected in the Saudi biobank. All five groups showed 
different attitudes toward disclosing information to various third parties. 
They were in favor of allowing treating physicians, and to a certain extent 
family members, to have access to medical and genetic results from 
research. No significant difference was found between views on medical 
and genetic confidentiality. The majority of the respondents agreed that 
confidentiality may be breached in case of justified reasons. Even 
considering differences in religion, culture, and other factors, the study’s 
results were consistent with results presented in the literature and 
research conducted in other countries. 
Key words: Confidentiality; Survey; Ethics; Biobank; Genetic research 
INTRODUCTION 
Medical research on stored samples is very important for discovering the 
mechanisms and pathology of diseases and for developing appropriate 
treatments.1 Establishing research biobanks with huge numbers of 
samples and personal and genetic data will contribute to wide advances 
in medical research, especially through computerizing information and 
medical records to enable easy and safe access to medical information 
needed for empirical research.1,2 Having access to medical information is 
necessary for conducting medical research; however, unintended leakage 
of information may cause very dangerous results.3 So, research biobanks 
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usually use various mechanisms to keep medical confidentiality intact, 
such as coding and security systems. Medical confidentiality is crucial in 
all human relationships and medical matters including medical research, 
and safeguarding the confidentiality of medical information is an ethical 
duty of all medical workers and researchers.4 Medical confidentiality is 
essential for trust, which is considered necessary to conduct research; it 
enables the conditions where are research participants will give correct 
and accurate information.3,5 Genetic information holds a special 
importance because it is related to sensitive issues that may be attached 
not only to the person himself but also to his relatives. It is very essential 
to have a balance between the necessities of giving access to information 
for research purposes on one side and the obligation of respecting 
medical confidentiality on the other side. Any disclosure of medical 
information in clinical research or practice must be according to informed 
consent by participants to allow researchers to access or disclose any 
information related to participants.6,7 However, in some situations 
disclosing medical information without consent by research participants 
may be justified in order to avoid greater harm, or in cases of clear 
individual or societal benefits, like notification of infectious diseases, such 
as AIDS.8 Confidentiality is not limited to information provided by 
research participants, or taken from their samples or data but also 
extends to the research results.9,10 
Because of the importance of medical and genetic confidentiality, and the 
lack of surveys in the Middle East about it, particularly in the Saudi 
context, research in the field is necessary.  
METHODS 
This study was an investigation of the views of a random sample of 
employees and visitors in the King Abdulaziz Medical City, Riyadh, Saudi 
Arabia on the topic of confidentiality in medical and genetic research, 
especially in the research biobank in Saudi Arabia, which was established 
recently. This study comprised five different groups, each consisting of 40 
participants. These five groups included physicians, researchers, medical 
students, donors, and laypersons. The researchers are working in the King 
Abdul International Medical Research Center (KAIMRC), the physicians 
are working in the King Fahad Hospital, National Guard, and the medical 
students are at the University of King Saud bin Abdulaziz University for 
Health Sciences. The members of donors group comprised individuals 
who previously agreed and donated samples for the purposes of research, 
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and finally the laypersons group included persons who visited hospital or 
were companions of patients. The questionnaires were collected 
personally by two trained research coordinators and one medical student 
during an eight-month period until reaching our target number 200 
respondents. 
Several specialists from different medical specialties, such as research, 
quality management and a general practitioner reviewed the questions in 
order to ascertain the suitability, effectiveness, reliability, and content 
validity.  
Survey questions were written in English and then translated into Arabic, 
and the content of Arabic copy has been validated. The English version 
was used to elicit the views of groups of physicians, researchers, and 
medical students while the Arabic version was used to elicit the views of 
donors and the public. 
The questions included several sections. The first questions inquired 
about participants’ personal information. Questions in 2nd section 
measured their attitude towards the importance of confidentiality in 
medical research as well as the actual respect of confidentiality in the 
research center. The 3rd section assessed participants’ views on the 
accessibility of medical and genetic information by different people. The 
4th section assessed participants' views about providing research results 
to others. Finally, in the 5th section we explored participants' views about 
the justified reasons to disclose confidential medical information to third 
parties. 
The Institutional Ethics Committee at the King Abdullah International 
Medical Research Center granted an approval to conduct this research. 
We collected approval from all participants and informed them about the 
research and its goals before gathering any information from them. We 
assured them about the issue of respect for privacy and confidentiality at 
all stages of the search. We also gave participants the right to withdraw 
at any time without any negative consequences. 
The data were collected and analyzed using the program SPSS, 19 edition. 
All items were measured on a 5-point Likert scale, which we then 
converted to a 3-point Likert scale to conduct statistical analysis and 
estimate the standard deviation. 
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The study used Chi Square test and ANOVA test to test between group 
differences and considered the p-value of less than 0.05. 
RESULTS 
Personal Characteristics 
This study comprises 200 respondents from five different groups, who 
differ significantly in age, sex and education (P<0.001). More women are 
involved and the majority of respondents were between 26-40 years. 
Almost all physicians had a post graduate degree, while laypersons and 
donors have lower educations. (Table 1)   
Table 1: Socio-demographic characteristics of the study groups: 
 Researchers Physicians Students Donors Laypersons Totals 
18-25 years 7.5% 5% 77.5% 37.5% 17.5% 29% 
26-40 years 85% 75% 22.5% 57.5% 57.5% 59.5% 
14-55 years 7.5% 17.5% 0% 2.5% 20% 9.5% 
>55 years 0% 0% 0% 2.5% 2.5% 1% 
X2 = 80.865, P < 0.001 
Male 27.5% 62.5% 75% 15% 40% 44% 
Female 72.5% 37.5% 25% 85% 60% 56% 
X2 = 39.489, P < 0.001 
None/ Primary 0% 0% 0% 10% 17.5% 2.8% 
Secondary School / 
Diploma 
20% 0% 45% 30% 30% 25.1% 
Bachelor 25% 2.6% 37.5% 50% 35% 35.2% 
Postgraduate 30% 97.4% 17.5% 10% 17.5% 34.2% 
X2 = 107.533, P < 0.001 
Confidentiality in Theory and Practice 
When investigating two issues (firstly if medical information is considered 
secret information and secondly if data confidentiality is well protected in 
Saudi biobank), the majority of respondents agree that medical 
information is secret and that confidentiality is protected. However, one 
significant difference is found: while more than 90% agree on the 1st issue, 
only about two thirds agree on the 2nd issue. 
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Donors indicated the lowest degree of agreement regarding the necessity 
of keeping medical information confidential (P < 0.001), and both donors 
and laypersons agree less than others that data confidentiality is well 
protected in the Saudi biobank. 
When comparing the two opinions of the same group about both issues, 
we find that respondents intend to agree less on the second issue. (Table 
2) 
Table 2 Attitudes toward confidentiality in theory and practice 
 Researchers Physicians Students Donors Laypersons Total 
Agree that medical 
information in clinical 
research must be dealt as 
secret information 
97.5% 95.0% 97.5% 70.0% 94.9% 91.0% 
Agree that data 
confidentiality is well 
protected in this research 
center or biobank 
75.0% 72.5% 62.5% 47.5% 45.0% 60.5% 
Medical and Genetic Confidentiality
  
For giving access to clinical and genetic information in research to 
different groups or individuals or institutions, respondents show high 
levels of agreement (>80%) with giving access to donors and the treating 
physician and a moderate level of agreement with providing access to 
researchers in Saudi Arabia. However there is a low level of agreement 
with giving access to government, insurance companies, and to 
researchers outside Saudi Arabia.  
There is no significant difference among the study groups in giving 
medical and genetic information to others, except in three cases. 
Researchers are least likely to agree to give medical information to 
donors, compared with other groups. The donors are most likely to agree 
to provide medical information to insurance companies. However, the 
students were least likely to agree with providing genetic information to 
the treating physician.  
When comparing agree of giving access of medical information to 
individuals or institutions versus genetic information there is no 
significant difference.  
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Table 3 Attitudes toward access to medical and genetic Information among study 
groups 
 Researchers Physicians Students Donors Laypersons Total 
P 
value 
The biobank may 
provide any 
medical 
information to 
donor 
75% 90% 87.5% 97.5% 95% 89% 
< 
0.001 
The biobank may 
provide any 
genetic 
information to 
donor 
82.5% 95% 85% 92.5% 92.5% 89.5% 0.14 
The biobank may 
provide any 
medical 
information to 
insurance 
companies 
32.5% 25% 42.5% 62.5% 27.5% 36% 0.04 
The biobank may 
provide any 
genetic 
information to 
insurance 
companies 
27.5% 37.5% 27.5% 50% 30% 34.5% 0.24 
The biobank may 
provide any 
medical 
information to 
researchers inside 
Saudi 
60% 55% 65% 60% 50% 58% 0.35 
The biobank may 
provide any 
genetic 
information to 
researchers inside 
Saudi 
57.5% 55% 65% 47.5% 55% 56% 0.60 
The biobank may 
provide any 
medical 
information to 
researchers 
outside Saudi 
37.5% 50% 47.5% 37.5% 42.5% 43% 0.24 
The biobank may 
provide any 
genetic 
information to 
researchers 
outside Saudi 
35% 50% 40% 35% 42.5% 40.5% 0.22 
The biobank may 
provide any 
medical 
information to 
treating physician 
75% 77.5% 82.5% 90% 87.5% 82.5% 0.05 
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The biobank may 
provide any 
genetic 
information to 
treating physician 
77.5% 82.5% 67.5% 92.5% 85% 81% 
< 
0.001 
The biobank may 
provide any 
medical 
information to 
government 
35% 37.5% 60% 40% 50% 44.5% 0.50 
The biobank may 
provide any 
genetic 
information to 
government 
41% 37.5% 55% 37.5% 42.5% 42.7% 0.54 
 
Genetic Confidentiality among Family Members 
When investigating giving genetic information to different family 
members, respondents showed moderate agreement.  Respondents were 
most likely to agree with providing genetic information to both parents, 
followed by sons and daughters. However, less than half of them agree to 
give access to brothers and sisters.  
Study groups differ significantly in providing genetic information to each 
of the family members. Donors and laypersons have the highest 
agreement towards providing access to each family member, while 
medical physicians agree the least. Researchers and medical students 
score in the middle (Table 4) 
Table 4: Attitude toward access to genetic Information among family members in relation to profession 
 Researchers Physicians Students Donors Laypersons Total 
P 
value 
The biobank may 
provide any 
genetic 
information to 
mother 
55% 37.5% 57.5% 82.5% 77.5% 62% <0.001 
The biobank may 
provide any 
genetic 
information to 
father 
55% 40% 57.5% 85% 77.5% 63% <0.001 
The biobank may 
provide any 
genetic 
information to 
brother 
40% 17.5% 40% 80% 60% 47.5% <0.001 
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The biobank may 
provide any 
genetic 
information to 
sister 
37.5% 20% 35.5% 80% 57.5% 46% <0.001 
The biobank may 
provide any 
genetic 
information to 
son 
47.5% 30% 47.5% 82.5% 67.5% 55% <0.001 
The biobank may 
provide any 
genetic 
information to 
daughter 
45% 22.5% 50% 82.5% 65% 53% <0.001 
Justified Breach of Confidentiality 
Three possible reasons are used to investigate justified breaching of 
confidentiality among the study groups (Table 5). While the majority of 
respondents agree that infectious and genetic diseases are justified 
reasons to breach confidentiality, a lower percentage of respondents 
agree that confidentiality can be breached according to a court order. 
However, a much lower percentage agrees to breach confidentiality for 
other undefined reasons. The study groups do not differ significantly in 
terms of justified reasons to breach confidential information. 
Table 5: Attitudes towards justified reasons for breaching confidentiality among the study groups 
 Researchers Physicians Students Donors Laypersons Total 
P 
value 
The biobank may 
give confidential 
medical 
information in 
infectious diseases 
70% 75% 72.5% 80% 80% 75.5% 0.76 
The biobank may 
give confidential 
medical 
information in 
shared genetic 
diseases 
70% 55% 75% 82.5% 80% 72.5% 0.05 
The biobank may 
give confidential 
medical 
information in 
court order 
55% 42.5% 65% 67.5% 62.5% 58.5% 0.23 
The biobank may 
give confidential 
medical 
information for 
other reasons 
22.5% 17.5% 15% 30% 32.5% 23.5% 0.48 
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DISCUSSION 
The majority of participants agree on the confidentiality of 
medical/genetic information and a smaller majority agrees that 
confidentiality is well protected in the Saudi biobank. Donors agree less 
on both points, and laypersons agree less only on the second point. 
Confidentiality in genetic research in stored tissue samples is a vital issue 
because information may be related to sensitive points, and because 
genetic information is not only individual but also familial 
information.3,11,12 Breaching confidentiality might lead to negative 
impacts on a donor and his relatives, in the present and future.13 A high 
percentage of agreement among respondents (above 90%) for 
considering medical information as confidential can possibly be explained 
by the fear of stigma both for donors and for their families, especially in a 
society such as Saudi Arabia where there are high rates of consanguinity 
and inherited diseases.14 
Having good methods to protect information is essential in any 
biobank.15,16 So, it is not a surprise to see that those who have the most 
experience and knowledge about the Saudi biobank procedure and 
protections, such as physicians and researchers, give the highest positive 
response rate about confidentiality protection in Saudi biobank, with 
researchers being the highest at 75%. This is interesting because having a 
greater understanding of the limits and expectations of people and 
increasing their awareness about the biobank's values and protection 
procedures including respecting confidentiality might build trust and 
consequently raise participation rates.17,18  
Access to Genetic/Medical Information 
More respondents agree with giving access to donors and treating 
physician than to researchers in Saudi Arabia, and much less to 
government, insurance companies, and researchers outside Saudi Arabia. 
Researchers agree at a lower rate with giving access to donors, and 
medical students are the least likely to agree with providing genetic 
information to a treating physician. There is no any significant difference 
between views on medical and genetic confidentiality. 
Disclosure of individual information to the research participant has 
received a lot of discussion and debate since the 1990s.19 Our research 
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question here concentrates on confidentiality and giving access to family 
members without reference to an inherited disease, which is totally 
different from disclosure of information to the relative who may have the 
same disease, for the sake of better management of the disease in the 
future—which is extensively researched in medical literature.   
The majority of people felt that the donors themselves should have access 
to medical information, and all groups agree on that regarding genetic 
information. This result is in line with some other surveys and 
interviews.19-22  Many researchers agree on the importance of disclosing 
significant individual information to research participants because they 
consider it is a participant’s right to know related information of his/her 
samples and data,19,23 and because of its possible diagnostic or 
therapeutic benefits,24-26 and also because having such information will 
help the participant make decisions autonomously either to continue or 
to withdraw from research.19,27 Moreover, some authors agree on 
disclosing information even when it is non-significant information.23,28  On 
the other hand some other researchers object to disclosing information 
to research participants because they believe this information is stressful 
and may be as harmful as it is beneficial.19,29 Because a significant amount 
of stress can come from disclosing information,30 counseling and advice 
are needed, which increases the cost of research.19,22 
Participants’ information in research biobanks may help treating 
physicians to offer better care and reduce diagnostic procedures if they 
get access to this medical and genetic information. However physicians 
have to treat the information with strict confidentiality.3,31,32 This positive 
attitude toward giving access to information to medical doctors is seen as 
well in other studies.33 Donors in particular think it is necessary that 
physicians have access to this information (90% of respondents in this 
group), which suggests that there is a high degree of trust in treating 
physicians, because trust is very important to encourage research 
subjects to disclose confidential information.5,34 However, it may also 
reflect a kind of therapeutic misconception, in which participants in 
research biobanks may think that the purpose of the study is therapeutic 
and has medical benefits rather than just being focused on research.19,35-
37  
Sharing information is important in biobank work, especially in 
multicenter research, which may put confidentiality at risk and cause 
damage to individuals and families in case of sensitive information.5 
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Studies have shown that participants generally agreed that information 
sharing with others would be acceptable, as would sharing with nonprofit, 
public-interest research organizations.33 Interestingly, there seems to be 
a discrepancy between who gets access to the information in the research 
biobank. Researchers inside Saudi Arabia (where the study was 
conducted) were seen as more favorable candidates for receiving medical 
and genetic information across the groups—all values are around or 
above 50%. Those in favor of giving access to researchers abroad may feel 
that it is necessary for diagnostic purposes especially in rare and 
complicated diseases.38 Also maybe they feel that confidential 
information is more secure when it is used outside, since it is inaccessible 
to people inside. It is interesting that people were slightly less likely to 
believe that access to their medical and genetic information should be 
allowed to researchers outside Saudi Arabia compared with researchers 
inside Saudi. However, for people who prefer to limit access to Saudi 
researchers, the possible reason for this could be that people want their 
information to stay local and to be used in research that will help those 
living in their home country. Saudi law forbids sending genetic samples 
except in strict conditions and only through the National Committee of 
Bio Ethics.39 
All five groups were least likely to have positive attitudes (36%) towards 
giving access to medical and genetic information in research biobanks to 
insurance companies. The remaining percentage may have concerns in 
this regard that are much higher when compared with the findings of an 
interview conducted in the US by Ormond et al., where only 25% of 
respondents mentioned insurance discrimination as one of their 
concerns.36 The relationship between confidentiality and information 
disclosure and discrimination toward individuals and vulnerable groups 
has been mentioned by other researchers.5 This suggests that people are 
aware of how medical and genetic information from research biobanks 
may affect their coverage by health insurance. Even though the Saudi 
government offers free health services to all Saudi nationals, without a 
need to be insured, non-Saudi people working in Saudi may be affected 
by the leaking of information to insurance companies, since non-Saudis 
are not covered by insurance unless they are working for governmental 
authorities.40 Fear of any consequences of having access to medical and 
genetic information by insurance companies reflects on how fast genetic 
research moves and the ways it may affect individuals in the future. Von 
Ferber et al. suggest that this may be a result of “confused thinking” since 
research results are unlikely to get into the hands of insurance companies 
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anyway.41 They note that it is illegal to use information from research to 
make any decisions regarding insurance premiums. This also is illegal in 
Saudi Arabia.40  
Many research biobanks mention preventing discrimination, including the 
Icelandic, Estonian, and Saudi biobanks.42-44 Also, international 
documents, such as the International Declaration on Human Genetic Data 
by UNESCO, the Statement on human genomic databases by the Human 
Genome Organisation's Ethics Committee HUGO, and the Genetic 
Databases by WHO have provisions against discrimination.45-47 Despite 
this, it is evidently a significant concern for respondents to this 
questionnaire. 
Disclosing Genetic Information to Family Members 
Respondents mostly agree with providing genetic information to both 
parents, followed by sons and daughters, and least to brothers and sisters. 
Donors and laypersons agree more than others, followed by researchers 
and students; however, medical doctors were the least to agree with 
sharing genetic information with family members. 
Genetic information is not just individual information but also familial, in 
that family members share a significant part of their genes.13,48,49 
Therefore it may have consequences for the health of family members 
and relatives.50,51 Any disclosing of genetic information may have a direct 
impact on other family members.34,52,53  
Our research question in this study is a general question on confidentiality 
of information and disclosing an individual's information to family 
members without reference to a possible familial inherited disease. We 
only investigated the research participants' positions regarding disclosing 
their medical and genetic information to the very closely related people. 
However, disclosure of information to at risk relatives who may have the 
same inherited disease in the future, for better management, showed a 
conflict between respecting confidentiality and reducing the possible 
harm to relatives, besides the moral duty to inform at risk relatives, which 
is extensively researched in medical literature. 54-57 
Donors showed more positive attitudes to disclose information to other 
family members compared with others, probably because they may be 
less likely to understand genetic information, or they may feel more 
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family solidarity. Individuals need support and education about the 
implications of genetic information.51 The physicians were the least likely 
to allow disclosure of genetic information to other family members. This 
can be explained by the physicians being more aware of the consequences 
of information disclosure, or because they are more sensitive regarding 
legal results in case of any risk that may occur because of disclosing. Some 
other authors suggest developing a family-based numerical coding 
procedure that would allow the use of conﬁdential data and the 
determination of familial relationships without risk of disclosure.58  
Justified Breach of Confidentiality 
The majority of the respondents agree that infections, genetic diseases, 
and court orders may be justified reasons to breach confidentiality, 
without any significant difference among the groups. 
It is important to have balance between better health for the community 
and respect for the right of confidentiality and privacy of individuals 
participating in research.59 However, in some cases an absolute respect 
for confidentiality leads to greater harm.60,61 Many authors, such as 
Beauchamp and Childress, consider two factors of harm, which are the 
probability and the magnitude of potential harm.8  
In the current study, we asked our respondents about some possible 
reasons that may justify the breaching of confidentiality. The two main 
reasons the respondents felt the breaching of confidentiality could be 
beneficial were cases that involve either infectious diseases or shared 
genetic diseases. Even though there is no significant difference among 
groups, donors and laypersons were more supportive of giving 
confidential information for these two reasons. A lot of literature 
supported the claim of safeguarding public health, and added an 
addendum to cover the justification of using genetic information to 
override individual confidentiality,62,63 especially when the information 
may help relatives who are at risk.54-57 The majority of national and 
international research regulations gives research participants the 
absolute right to keep the information confidential and not to have 
genetic information of stored research samples disclosed to a third 
person. However, this is questioned when encrypted information is used, 
especially when the research subject is part of a family and societal 
structure and he/she is responsible of their well-being. Some resources 
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such as HUGO give immediate relatives the right of access to stored DNA 
for the purpose of learning about their status in the case of high risk.48 
Disclosing genetic information to at risk relatives is particularly important 
in close-knit communities with extended families and high percentages of 
interfamily marriages, like the case in Saudi Arabia where we can find 
isolated and semi-isolated genes among many people who live there.64 
Governance of the Saudi biobank allows giving confidential information 
by a higher authority for safeguarding important public interests, or to 
avoid threats to the welfare of the community. According to Islamic fatwa 
No. 79 (10/8) 1993, issued by the International Islamic Fiqh Academy, a 
breach of confidentiality can be acceptable only if the harm of maintaining 
confidentiality overrides its benefits.65 This Islamic opinion is assured by 
the position of the Islamic Organization for Medical sciences and the 
writings of many authors.66,67  
Interestingly, the groups were very split on court orders and court cases 
being reasonable justification for breach of confidentiality—only around 
60% of respondents felt that this was legitimate. This study is supported 
by results of other research that allow having access to information 
without consent, even with the presence of a "Confidentiality 
Certificate".68,69  Saudi biobank’s governance agrees to disclose 
confidential information, as permitted by authority order, for 
investigating criminal acts. Islamic opinion shows a similar position and 
agrees with disclosing of confidential information according to legal 
demands.66,67 
The least popular reason for breaching confidentiality is the vague “other 
reasons.” Of our respondents, 23.5% do not mind where the research 
center gives their results, but the majority would probably prefer some 
type of explanation about the breach of confidentiality. Some authors 
mention cases where there is a need to use identified information in order 
to validate research results, or for publication reasons. Using anonymized 
information gives a good solution. Some biobanks require decoding and 
disclosing donors' information for quality assurance, as is the case in the 
Saudi biobank.44  
CONCLUSIONS 
There are many interesting conclusions that can be drawn from this 
research. Firstly, confidentiality is an important issue according the 
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majority of participants, without a significant difference between the 
disclosure of genetic information and general medical information. 
Secondly, overall, all five groups showed different attitudes toward 
disclosing information to the various third parties. They were in favor of 
treating physicians, and to a certain extent family members, having access 
to medical and genetic results from research. People were much more 
likely to want their results to be shared with other researchers within 
Saudi Arabia than outside, probably because they want their results to 
help the local community. Even with the positive attitude to respect 
medical/genetic confidentiality, the majority of respondents agree to 
disclose information where is a justified reason, such as sharing genetic 
information with at risk relatives or in response to a court order. 
Generally, even considering differences in religion, culture, and other 
factors, all our results are consistent with results presented in the 
literature and research conducted in other countries. Future research 
could focus on the importance of keeping research genetic results local 
and not transferring them out of the country, as well as investigating how 
people feel about their genetic profiles being made public.  
Limitations 
Our study has many limitations; first, the participants in the 
“Researchers,” and “Physicians” groups could represent a substantial 
proportion of medical specialists in Saudi Arabia, especially in that they 
may represent particular persons who work at the tertiary medical 
centres. “Researchers” and “Physicians” groups may have more positive 
attitudes because their work at the same centre where the study is 
conducted. Second, because the results came from a specific geographical 
area, they may not be generalizable to other geographical areas. Thus, it 
would be important to increase the sample size and have samples from 
different regions in future research. Third, “Donors” and “Laypersons” 
groups were helped by research coordinators and may be affected by 
their explanation, while for other groups a self-administration style was 
used.  
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Chapter 6 
The Ethics of Children Participation in Saudi Biobank: An Exploratory 
Survey 
Alahmad, G., & Dierickx, K.  
ABSTRACT 
The ethical issues regarding children’s participation in research biobanks 
has considerable interest today. Despite the existence of  empirical 
literature on the ethics of pediatric research biobanking in different areas  
worldwide, no studies have yet explored the opinions on this issue in 
Saudi Arabia and the Middle East overall. A survey of 160 respondents 
from four equal different groups was conducted on this issue with 
researchers, physicians, medical students, and laypersons at King 
Abdulaziz Medical City in Riyadh, Saudi Arabia. The results show a clear 
and positive attitude toward pediatric clinical and genetic research inside 
and outside of Saudi Arabia. Parental consent is viewed as essential with 
60% saying parental consent is sufficient for children up to 12 and 40% for 
children 12-18 years. More than 90% of the respondents preferred to gain 
approval from any child with decision-making capacity; 58.2% and 38.6% 
believe that children between 12 and 18 and people above 18 years, 
respectively, can understand and thus give their approval for genetic 
research. Clear majorities in the study agreed with re-consenting children 
when they become adults, allowing the child to withdraw at any time.  A 
clear majority agreed that either parent can sign to give consent for a child 
to participate in a research biobank. We concluded that in varying degrees 
all four groups believe such elements of ethical consideration are critical. 
However, the group with the least understanding of research and 
research ethics had the smaller portion of respondents on the importance 
of having children involved in research. Even considering differences in 
religion, culture, and other factors, the study’s results were consistent 
with results presented in the literature and research conducted in other 
countries. 
Key words: Survey; Ethics; Biobank; Genetic research; Consent 
INTRODUCTION 
Conducting research on stored tissue is becoming very important these 
days. The use of stored tissue samples from minors has gained some 
123 
 
interest recently.1,2 However children’s participation leads to different 
ethical challenges than that found in adult research biobanks.2,3 One of 
these distinctive challenges is related to a child’s ability to make decisions 
in regard to participation in medical research and information sharing. 
There are many discussions about validity and sufficiency of parent 
consent and/or child assent in research biobanks,4-6 the suitable age for 
accepting child consent,7 child withdrawal2,6,8,9 and re-consenting of a 
child when reaching adulthood.2,10,11 Moreover questions are asked about 
the right to expose or share a child’s information and whether there is any 
difference between medical and genetic information in relation to 
confidentiality.2,3  
A literature review showed many surveys querying the ethical challenges 
for participation in research biobanks,3 but most of them concentrate on 
adult biobanks,12 and investigated professionals,13 patients,14,15 biobank 
participants16 or general public.17 Surveys regarding biobanking samples 
from children have been done with pregnant women,18 child patients 
after they had grown up19 and professionals.2,20 
Recently some countries in the Middle East have shown interest in 
establishing research biobanks, such as Saudi Arabia and Qatar, which 
include both adults and children. The Saudi biobank context is very 
different from other biobanks, particularly those in Europe and North 
America, because of the region’s distinct social issues and its ethics 
system built on Islamic values. Saudi society is characterized by large 
family size (eight members on average),21 the presence of genetic isolates 
and semi-isolates, high rate of consanguinity, and the youthfulness of its 
population, with 32.5% being younger than 15 years old and only 2% 
above the age of 65 years.21 Considering these social parameters, 
variations in ethical challenges may appear in regard to research 
biobanks. 
Very few surveys about research on stored samples have been conducted 
in the Middle East.  Abou-Zeid A, et al. 2010 surveyed patients who are 
proxy participants of research in Egypt, obtaining the viewpoints of 
patients regarding stored sample research, including genetic samples.22 
Also, Alahmad G, et al. 2014 conducted a qualitative study about the 
ethics of research on stored samples in the Middle East, including samples 
taken from children.23 
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Given the importance of research on stored samples from children, the 
distinctive context of Saudi biobanks, and the lack of publications in this 
specific area, we found it necessary to query the opinions of Saudi 
professionals and biobank participants with regard to this clinical and 
genetic pediatric research. We asked about their opinion on the 
importance of research on stored tissue samples of children, the validity 
of parental consent and child assent, which parent has the right to 
consent, the child’s right to withdraw and to be re-consented, and who 
has investigated their opinions regarding medical and genetic 
confidentiality inside and outside the child’s family. This paper is a report 
of our findings. 
METHODS 
This is a cross sectional analytical study. A survey was conducted on a 
sample selected randomly from people working at or visiting King 
Abdulaziz Medical City “KAMC”, Riyadh City. The sample included 40 
medical doctors at King Fahad Hospital “KFH”, 40 researchers at King 
Abdullah International Medical Research Center “KAIMRC”, 40 medical 
students at King Saud bin Abdulaziz University for health Sciences “KSAU-
HS”, plus 40 visitors or patients’ companions at King Fahad Hospital. In 
order to explore lay perspectives, visitors and patients’ companions with 
medical backgrounds or those working in medical research teams were 
excluded.  We continued collecting surveys until we reached 160 
participants. 
We created a structured questionnaire based on our interviews with 
professionals from the Middle East.23  The questionnaire was drafted in 
English and pretested prior to data collection. Face validity was performed 
by revising the instrument’s appearance to be a good measure of the 
concept being measured, which at the same time can be considered as a 
subtype of content validity.  The content validity and feasibility of the 
questionnaire was ensured through consultation with various relevant 
experts: a medical doctor, a researcher in genetics, and a researcher in 
medical quality management at King Abdullah International Medical 
Research Centre. Several additions and amendments were made to 
ensure that the questions were relevant, clear, and valid in a Saudi 
context. The questionnaire was translated into Arabic, and the content 
was validated. The English copy was used with researchers, physicians, 
and students; while the Arabic copy was used with lay people. 
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All respondents completed the questionnaires by themselves, except for 
the lay people where interview-based questionnaires were used.  The 
questionnaires were collected during an eight-month period by two 
trained research coordinators with the assistance of one medical student 
who helped collect surveys from medical students. No monetary or other 
incentive was afforded. 
Reliability of the questionnaire was calculated using Cronbach’s alpha to 
test for internal consistency, with the 31-item questionnaire receiving a 
consistency coefficient of 0.863, indicating a high degree of internal 
consistency. Test–retest reliability was ensured in a pilot study of 5 
subjects before starting data collection. 
The interview schedule consisted of two parts:  
Part 1: The importance of research on children 
This 4-item attitude statement scale evaluates the respondents’ beliefs 
about the importance of research in general and biobanking research in 
particular, using a 5-point Likert scale ranging from strongly disagree, 
disagree, not sure, agree, or strongly agree. The respondents were asked 
to rate the importance of conducting such research in Saudi Arabia as well 
as in other countries. 
Part 2: Parents informed consent and child assent in biobanking research 
This part explored the attitude of subjects towards parent’s consent, 
child’s assent, re-consent, and withdrawal.  Three items with scale from 1 
to 18 years were used to determine the beliefs regarding age sufficiency 
of parent’s consent alone, child assent alone, or both of them. A special 
item was created to determine the gender of parent who is entitled to 
sign the informed consent for the child, father alone, mother alone, any 
of them, both, and none of them. Three statements were used to 
determine the agreement on the need to re-consent the child when 
he/she becomes adult, modify consent information to be understandable 
by children, and respect a child’s wish to withdraw; all measured on 5-
point Likert scales. 
Ethical Considerations 
An ethical approval was received from the institutional review board of 
the National Guard Health Affairs, Riyadh, Saudi Arabia. All respondents 
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who agreed to participate were assured confidentiality. All respondents 
had the right to withdraw any time during the interview. 
Statistical Analysis 
The data were coded and analyzed using SPSS software version 19 in 
windows 7. A 5-point Likert scale was transformed to three point Likert 
scale for the purpose of analysis and the 5-point Likert scale was used to 
calculate the mean and standard deviation for quantitative analysis. 
For inferential statistics chi square test (X2), student t-test, and paired 
sample t-test were used with a p-value of 0.05 as a level of significance.  
RESULTS 
Personal Characteristics 
The study sample comprising 160 respondents from four different groups 
consisted of nearly the same numbers of men and women (table 1).  Ages, 
having children, and educational levels were significantly different among 
these groups. Students were the least likely to have children.  
Table 1: Socio- demographic characteristics of study sample 
Professions 
Physicians Researchers Students 
Lay 
people 
Total 
Age group (years) 
18-40 77.5% 92.5% 100% 76.9% 86.8% 
>40 22.5% 7.5% 0.0% 23.1% 13.2% 
P-value a X2 = 14.545, P = 0.002 
Gender 
Male 62.5% 27.5% 75% 40% 51.25% 
Female 37.5% 22.5% 25% 60% 48.75% 
P-value a X2 = 22.114, P < 0.001 
Having children 
Yes 85% 82.5% 20% 82.5% 67.5% 
No 15% 17.5% 80% 17.5% 32.5% 
P-value a X2 = 54.929, P < 0.001 
Educational level 
Secondary 
School and less 
0% 0% 0% 20% 5% 
Diploma or 
Bachelor 
0% 70% 82.5% 62.5% 54.1% 
Master and 
above 
100% 30% 17.5% 17.5% 40.9% 
P-value a X2 = 98.459, P < 0.001 
Training in 
research ethics 
Yes 64.1% 65% 52.5% - 60.5% 
No 35.9% 35% 47.5% - 39.5% 
P-value a X2 = 1.622, P = 0.444 
Data missing in some categories; percentages are calculated for those respondents from whom data 
were available. aPearson chi-squared. 
Characteristics 
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All physicians had master’s degrees or above, while the majority of the 
other three groups have only diplomas or bachelor degrees. A substantial 
minority of lay people had secondary school or less as a final degree.   
Even though it is not significantly different, researchers had more training 
in research ethics compared with physicians and students.  
Experience with Biomedical and Genetic Research Conducted with 
Adults and Children 
Descriptive statistics of respondents shows a high tendency to agree with 
the importance of clinical and genetic research conducted on (samples of) 
children, both generally and specifically in Saudi Arabia. The relation 
between profession and the importance of conducting clinical research in 
general was mildly significant (p = 0.049). Physicians agree to a higher 
degree compared with other groups, followed by researchers, students, 
and finally the lay people. The same results are seen regarding clinical 
research in Saudi Arabia and genetic research in general and in Saudi 
Arabia but without significant differences. 
Table 2 Responses of participants toward the importance of research on children 
 
Conducting 
clinical 
research on 
children is 
important 
Conducting 
clinical research 
on children in 
Saudi is 
important 
Conducting 
research on 
samples of 
children is 
important 
Conducting 
research on 
samples of 
children in Saudi 
is important 
Physicians 
Agree 97.5% 85.0% 85.0% 85.0% 
Don't 
know 
0.0% 10.0% 10.0% 10.0% 
Disagree 2.5% 6.9% 5.0% 5.0% 
Researchers 
Agree 92.3% 87.2% 89.7% 87.5% 
Don't 
know 
2.6% 7.7% 5.1% 7.7% 
Disagree 5.1% 5.1% 5.1% 5.1% 
Students 
Agree 90.0% 85.0% 87.5% 85.0% 
Don't 
know 
10.0% 15.0% 12.5% 15.0% 
Disagree 0.0% 0.0% 0.0% 0.0% 
Lay people 
Agree 77.5% 67.5% 70.0% 67.5% 
Don't 
know 
12.5% 15.0% 17.5% 15.0% 
Disagree 10.0% 17.5% 12.5% 17.5% 
Total 
Agree 89.3% 81.1% 83.3% 81.1% 
Don't 
know 
6.3% 11.9% 11.3% 11.9% 
Disagree 4.4% 6.9% 5.7% 6.9% 
P value - 0.049 0.060 0.145 0.057 
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There is no significant difference between the importance of conducting 
clinical research in general and specifically in Saudi Arabia, as well in 
genetic research generally and specifically in Saudi Arabia.  Most 
respondents agree on the importance of clinical research on a higher 
degree compared with research on samples either generally or in Saudi 
Arabia; none of these differences were significant.  No significant 
difference could be found as well among the respondents who have or do 
not have children about the importance of clinical and genetic research 
inside or outside Saudi. 
Attitudes towards Consenting for Research on Children 
 
Fig. 1: Parents’ consent alone is enough for Child participation
 
For research on children younger than 12 years, 60% of our respondents 
believe that parents’ consent alone is enough and that children should 
only participate in making decision after the age of 12 years (table 3). 
Moreover around 30% of respondents agree that assent is required 
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between age 10-12 years (figure 1). Around 40% of our participants 
believe that till the age of 18 years there is no need to discuss 
participation with children and that parents’ consent is enough alone. 
Except for some students, all participants agree that for people above 18 
years the consent of parents is not sufficient.   We observe that the 
number of people who agree that the children above 12 years should 
assent is significantly different in lay people (82.5%) than in physicians 
(38.5%) and students (47.5%).  
Fig: 2 Age at which Children Can Understand and Assent for Participation in Genetic 
Research 
 
 
For genetic research 3.2% of all respondents believe that children under 
the age of 12 could understand and give their assent for genetic research 
while 58.2% believe that children can understand and give their assent 
when they are between 12 and 18 year old; however, 38.6% still believed 
that participants have to be over 18 years of age to be able to understand 
the research and provide consent. Regarding those who believe that 
children under 18 years can understand genetic research and give assent, 
the difference between lay people (66.7%) and physicians (55%) is 
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significant. For more than 50% of participants, minors between 16-18 
years can understand and assent for genetic research (figure 2). 
Almost 90% of all four groups agree without significant difference among 
groups on the importance of the following statements: child assent is 
important when he is able to do (91.9%), the Information must be 
adapted for minors (82.9%), re-consent when children become adults 
(90.5%) and respect the wish of the child of withdrawal (86.2%). 
Table 3: Agreement on signing consent in association with different age groups of for consent and Child 
assent  
 Profession 
Child’s age People above 
18 Less than 12 12-18 
Till which age parents’ consent is 
sufficient for child participation in 
research without child assent? 
Physicians 38.5% 61.5% 0.0% 
Researchers 72.5% 27.5% 0.0% 
Students 47.5% 47.5% 5.0% 
Lay people 82.5% 17.5% 0.0% 
Total 60.4% 38.4% 1.3% 
At which age child can 
understand genetic research and 
can give assent? 
Physicians 0.0% 55.0% 45.0% 
Researchers 2.6% 61.5% 35.9% 
Students 7.5% 50.0% 42.5% 
Lay people 2.6% 66.7% 30.8% 
Total 3.2% 58.2% 38.6% 
The number of respondents that agree that any parents can sign the 
consent on behalf of participating child (74.5%) is significantly higher 
(p<0.001) than the other alternative options (both parents, father only, 
mother only and none of them). Fathers alone were preferred more than 
were mothers alone. No significant difference could be found among the 
professional groups (p = 0.216), or between the two genders (p = 0.276). 
Table 4: percentages of who can sign informed consent for child participation in clinical and genetic 
research 
Profession 
Who do you think should sign informed consent for child participation in clinical 
and genetic research 
Father only 
(%) 
Mother only 
(%) 
Both parents 
(%) 
None of them 
(%) 
Any parent 
(%) 
Physicians 2.7 0.0 27.0 0.0 70.0 
Researchers 10.3 0.0 25.6 0.0 64.1 
Students 6.1 0.0 15.2 0.0 78.8 
Lay people 5.0 2.5 5.0 2.5 85.0 
Total 6.0 0.7 18.1 0.7 74.5 
 
 
DISCUSSION  
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While this study comes from only one country,  the results of this study 
may provide a reasonably complete guide for research biobanks in the 
Gulf region and in the Middle East in general. The majorities of 
communities in these countries are Muslim and share the same social and 
economic factors. They are characterized by a high percentage of children 
compared to communities of the Western world. Saudi Biobank includes 
respondents from varying ages, including children from the age of ten 
years. Other banks in the region are expected to include children within 
the other respondents; especially those biobanks in Gulf countries that 
have relatively small populations and that include the entire population, 
including children.  
Knowing that Saudi is an Islamic country, respondents’ views will be 
discussed in light of Islamic opinions expressed by fatwas released by 
official juristic councils. 
Common Trends in Pediatric Research Attitudes 
Results show a clear positive attitude in regard to pediatric clinical and 
genetic research, both inside and outside Saudi Arabia. This can be 
supported by knowing that the physicians and researchers working 
directly or indirectly at KAIMRC as one of biggest research centers in the 
region, where many educational activities related to medical research are 
organized for all kinds of professions, such as many courses about 
research methodologies, clinical trials, biobanking research plus many 
professional programs like “clinical research coordinators.” The 
environment of the research was also implemented as a part of medical 
students’ study components in both undergraduate and postgraduate 
standards, such as a two-week research summer school organized yearly 
for medical students. Opinions in Saudi are not affected negatively by 
historical medical research violations. We do not notice any major 
apparent medical scandals in Saudi as seen in Europe such as Nazi trials in 
the Second World War,24 in the USA such as the Tuskegee experiment,25 
or even in other places such as the Trovan trial in Nigeria.26  
There is no significant difference of the positive attitude in regard to 
pediatric clinical and genetic research, both inside and outside Saudi 
Arabia among professional groups; however lay people give lower results, 
which could be explained both by their lower education and limited 
insight of clinical and genetic research, as seen in other studies. 27 
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Moreover, lay people usually concentrate on immediate benefits of 
research rather than final results as doctors do.2 
Even so, the attitudes of lay people are positive, which is in line with a 
previous study conducted at the same place that showed that (68.8%) are 
willing to participate in clinical research,28 and also with studies in other 
places, such as Sweden and USA.17,29 This might be explained by the fact 
that many lay people have educational degrees and they may understand 
the importance of research because of their degrees; moreover many of 
those interviewed had previously engaged with the health care system. 
They know that KAMC provides an advanced level of care and is a tertiary 
hospital where research leads to better care.  
One could argue at this time that the lay participants who have children 
might believe that clinical and genetic research on children is an 
important issue.30 Even participants without children agree on the 
importance of research on stored samples taken from children, since in 
the future they want to have children or if they have friends or family with 
a child with a medical concern.30 However, in the sampling of 160 
participants, it is unclear how many, if any, had children involved in 
research, sample collection, or biobanks. One could reasonably question 
whether parental status influenced responses to the issues of research 
and biobanks.27 Would a person without children understand the ages 
and developmental abilities of the child well enough to make a reasonable 
decision about consent, denying consent, or the meaning of the research 
in the long-term? Another question that follows in logic is whether the 
parent views their child accurately or if they still see their child as a 
younger and less emotionally or developmentally mature than they are.2 
The parent’s inaccurate view of the child could alter their willingness to 
allow a child to make the decision or take part in the decision. 
Our participants do not feel that clinical research or research on stored 
human materials is more important in Saudi Arabia than in other places. 
A possible explanation is that Saudi people do not feel themselves to be 
different from other populations; besides, the Saudi facilities and patients 
usually get benefits from research conducted abroad. 
This positive attitude regarding research on children and their samples is 
in line with International guidelines such as Declaration of Helsinki and 
the Council for International Organizations of Medical Sciences (CIOMS) 
guidelines,32,33 even though there are few regulations on research on 
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children and their samples in the Middle East.33 Even though this study 
was conducted in a Muslim country, the highly positive attitudes of the 
respondents contrast with fatwa 67 (1992) of the International Islamic 
Fiqh International Islamic Fiqh Academy about prohibiting research on 
children.34 However, the respondents’ attitudes are in line with more 
recent fatwas that permit research on children, like fatwa 3/17 (2002) by 
Islamic Fiqh Council,35 and fatwa No. 598 (2008) by Dar-Alifta Al-Misrriyah 
that allows research on children;36 and also with fatwa No. 161 (2006) by 
IIFA,37 and the opinion of International Islamic Organization of Medical 
Sciences that allows research on children in case of an exclusive or 
preponderant interest or an urgent need of the child or if it is absolutely 
necessary to conduct research on childhood diseases.38  
Consenting for Children’s Participation in Biobanks 
Parental Consent  
Our respondents show highly positive attitudes regarding parental 
consent, with 60% saying parental consent is sufficient for children up to 
12 years old and 40% between 12-18 years old.  Lay people gave the 
highest agreement on that. 
A parent consenting to the study on behalf of minor child is a common 
situation when children are involved in research.5,11,32  The intent of the 
consent is to provide the information in a manner that is easy to read and 
to understand the details of the research so the participant will be able to 
autonomously participate in research. The high percentages of agreement 
by lay people compared with other groups might be explained by 
considering the belief that children between 12 and 18 years of age can 
properly understand the information in informed consent.   
The necessity of parent consent is also explicitly mentioned in some 
Islamic resources such as IOMS38 and fatwas, such as fatwa No. 3/17 by 
the Islamic Fiqh Council,35 fatwa No. 161 by the International Islamic Fiqh 
Academy34 and fatwa No. 598 by the  Dar-Alifta Al-Misrriyah.37 
Even for people older than 18 years, 1.3% of respondents said that 
parents’ consent alone is enough, while 38.6% still believe that a child is 
unable to understand and to make decisions about participation without 
their parents’ consent. This selection by respondents is related to 
common social factors in Saudi, where most of people will not become 
134 
 
independent just by becoming older than 18 years, they remain living with 
their families and depending on their parents in living matters. Thirty-
eight percent   of the respondents said the parents’ consent is enough 
when the child is between 12-18 years. This is supported by other studies 
that show that children may face some difficulties in understanding and 
making decisions, as concluded by some authors.39 Islamic resources do 
not specify the age at which consent of parents alone is enough.40 
Assent and Age of Understanding and Assenting 
In relation to child assent for research participation, more than 90% of 
respondents prefer to have assent from the child who has decision-
making capacity. And for the age of understanding and assent, 58.2% of 
respondents believed that children between 12 and 18 years can 
understand and give their assent for genetic research, while 38.6% still 
believe that people have to be older than 18 years to do that. The lay 
people were the most likely group to agree that children can understand 
and assent under 18 years.   
Requiring assent by children supports the moral idea that these children 
have to play a role in decisions related to their health matters and is 
consistent with other studies.2,6,41 Getting assent from children is a 
reflection of respecting their autonomy. 
Children can develop the ability to make such decisions about their health 
and give assent to participate in medical research at earlier ages.28 Often 
a child who has a life threatening illness that could cause death can 
mature more quickly in his or her understanding of the significance of 
medical research. A child such as this may understand that if their tissue, 
blood, or other information is used long after their health struggle ends, 
the benefits for others is greater than their own.42 Even more, some other 
studies recommended involving children in participation decisions at very 
young ages.43 
The results fall in line with the normal development of children for 
understanding more complex ideas, following logic, and communicating 
at a higher level. Many individuals default to the age of majority when 
considering when a child has the right to consent. In some locations the 
age of majority may be as young as 16 but commonly is seen as 18 or 
above.2,24 Each country has their determining factors and as such, the 
cultural and legal aspects can vary. Involving children in decision making 
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is compatible with international documents such as CIOMS and the 
Helsinki Declaration, which mention the importance of considering child 
opinion.20,19 Also, CIOMS has stated that a child of 12-13 years old should 
be allowed to decide, which seems compatible with our results that only 
3.2% of our respondents believe that people under 12 can understand and 
give assent.32 This can explain why the Saudi biobank set a minimum age 
of 10 years for allowing participation of children and getting assent from 
them. 
Respondents’ views match Islamic opinion as expressed by the Islamic 
Organization for Medical Sciences (IOMS) about the importance of having 
a child’s assent.37 No certain age is specified by Islamic authorities for a 
child to give assent for medical research;40 rather, other factors, such as 
maturity and social development, play an important part in judging a 
child’s decision making abilities. Islamic views consider the child’s capacity 
for judgment as a main factor in allowing decisions made by children, and 
return defining the exact age of majority to the regulation of each 
country, which is different from country to country, although it is 18 years 
in Saudi, as an example.44 
Re-Consent 
In regard to re-consenting children when they become adults, for the 
genetic research they are part of, a clear majority agreed that their 
previous participation was according their guardians’ consent only. 
Therefore, upon reaching adulthood, the participants have the right to 
override the decisions their parents made for them when they were 
children.45 Children must have the ability to state when and if they are 
willing to continue in the research, have the ability to withdraw, have the 
ability to consent if they are at an age and level to understand the 
consent, and must be able to as adults take over the consent abilities. 
However, re-consenting may face some technical difficulties related to 
success of contacting participants and their responses rate. Some 
biobanks consider the participants to have agreed to continue 
participating in the biobank when they become adults unless they come 
forward and declare their withdrawal, which is also the practice of the 
Saudi biobank.46 There are no Islamic resources that address the issue of 
re-consenting for clinical research purposes when children become 
adults.  
Withdrawal 
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When questioning the right to withdraw consent, the Majority of our 
respondents agreed with allowing the child to withdraw any time without 
any consequences not only after 18 years old but even before that.  
A child should always have the opportunity to withdraw from a study no 
matter who signs the consent form.47 If the child is uncomfortable with 
the study’s intent, procedures, or other components, the child should 
have the right to withdraw from the study. The right to withdraw is not 
contingent on the person who consents to the study but to the person 
and in this case, the child actively involved in the study. Some even say 
that the withdrawal right is much more important for children than for 
adults considering that children participated in biobank according to 
parents' consent and not their own consent.2   
Which Parent? 
A clear majority of respondents agreed that any parent can sign the 
consent for a child to participate in a research biobank, followed by both 
parents together, fathers alone, and lastly mothers alone. No significant 
difference could be found among the professional groups.  
In a previous study with genetic researchers from the Middle East consent 
of both parents together is preferred for child participation in research 
biobank, but with giving fathers priority over mothers in case of 
disagreement.24 There are no other similar studies on this issue, except 
what had been written by Diekema about preferring not to perform any 
procedure in case of a disagreement between both parents.48 
For many individuals in any number of countries, the question of which 
parent should sign the consent form can bring confusion as to why it 
would matter which one signed. Any parent should have equal rights to 
sign off on a consent form. However, in reality there are different cultural 
and legal considerations involved in this question. In some societies, such 
as Saudi society where fathers have traditionally held the power of 
decisions in the family structure, the question is more justified; it is 
expected that fathers will be given priority; however, both parents were 
preferred by the majority.  
In Islam, there is a certain orderliness of child guardians who have the 
right to make decisions on a child’s behalf; they are only the males in the 
family: father, then grandfather, then brother.49 However it is interesting 
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to see the majority of respondents prefer to get consent from both 
parents rather than fathers only, which also explains why a number of 
participants felt the father only should be the person consenting. 
However, this male preference from an Islamic point of view can be 
challenged, because limiting guardians to males only has not been stated 
in Islamic resources except in reference to guardianship in marriage and 
the inheritance of orphans.40 Joint consent by both parents may be a good 
solution. 
CONCLUSION 
The conclusion of this study is overwhelmingly in favor of parents 
providing consent for children in research studies until a child is of age to 
provide their own consent. Any parent can give the consent, however 
small minority preferred fathers alone. The study demonstrated that the 
physicians had a greater response to the use of children in research 
studies. Respondents believed it was important to encourage children to 
take an active role in their involvement by deciding to continue if parents 
consented, withdraw if that is what they felt was right, and to ensure 
children could re-consent upon reaching adulthood, with adequate 
information of what that means. All the components of adults consenting 
to participate in research were critical for children in research but with an 
added element of allowing the children to withdraw, re-consent, and 
adapting all the consent materials to a level a child could understand. The 
study showed to varying degrees that all four groups believed these 
elements of ethical consideration are critical. However, the group with 
the least understanding of research and ethics involving research had a 
smaller portion of respondents seeing the importance of children 
involved in research. This demonstrates the importance of education 
regarding research, and specifically children in research, on the whole of 
society. 
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ABSTRACT  
This article outlines and discusses confidentiality, informed consent and 
children participating in the governance of the Saudi Biobank (SB), which 
is expected to be launched in 2014. We examined strengths and 
weaknesses of SB`s governance as well as the similarities and differences 
with other biobanks, regarding three different ethical issues: 
confidentiality, informed consent and children’s participation in research. 
We evaluated these issues in relation to international guidelines and 
Islamic law. The insights gained may be useful in developing national 
biobanking regulations in other Islamic countries, particularly in the 
Middle East. 
INTRODUCTION 
Today, research biobanks play a significant role in advancing medical 
science by offering the necessary elements for conducting research 
involving large numbers of samples and data. However, these research 
biobanks have created many new ethical challenges, such as giving broad 
consent rather than specific consent for each research study, risks from 
breaches in confidentiality from the use and handling of genetic samples 
and data, misusing genetic information, children’s participation, and the 
lack of a direct benefit for biobank participants.1 Consequently, scholars 
have studied these challenges to identify proper solutions and prevent 
negative effects. Many guidelines, laws and regulations concerning 
biobanks have appeared, with different standards, such as the UK 
biobanks governance (national guidelines),2 the "Guidelines for Human 
Biobanks and Genetic Research Databases" by the Organization for 
Economic Co-operation and Development ([OECD], regional guidelines),3 
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and the "International Declaration on Human Genetic Data" by UNESCO 
(i.e., the declaration of UNESCO, international guidelines).4 
The Saudi Biobank (SB) is a newly established national biobank. Other new 
national biobanks in Middle Eastern countries are either launched (Qatar 
biobank) or expected to launch in the near future, particularly in the Gulf 
region.5 The ethical standards and governance of any biobank are also 
affected by the societal ethos. The SB was built in a manner to respect 
Islamic values,* Saudi law and international guidelines, as outlined by the 
SB governance.6 It is stated in the SB governance that a consideration will 
be given to Islamic resources to assure that SB is compliant with Islamic 
law, especially Quran, Sunnah and other resources like the decisions of 
juristic councils, such as the Council of Senior Scholars in Saudi Arabia and 
International Islamic Fiqh Academy. The International Ethical Guidelines 
for Biomedical Research Involving Human Subjects-Islamic view by the 
Islamic Organization for Medical Sciences7 is one of the references of SB 
governance. Furthermore SB governance considers as well the Saudi law 
of ethics of research on living creatures made by the National Committee 
of Medical & Bioethics. However there is no clear mechanism stated how 
to apply Islamic opinions driven from these resources on the SB 
governance.  
No previous studies have discussed SB governance. Moreover, there is a 
lack of genetic or general research ethics concerning guidelines in the 
region.  
This paper aims to perform a comparative analysis of SB governance with 
different types of western national or regional biobanks, particularly 
regarding the key topics of confidentiality, informed consent and 
children’s participation and how they are translated in the Islamic context. 
This paper will help future biobanks in the Middle Eastern region, and 
areas with similar values and circumstances, to build their governance and 
benefit from the SB’s strengths and weaknesses. 
Saudi Biobank 
The SB was established and co-financed by two governmental 
organizations: the King Abdul Aziz City for Science and Technology and the 
                                                             
* Islamic values are driven by Quran teaching and prophetic tradition. The primary human basic values 
in Islam which are considered fundamental for good individual and social life include: life, reason, 
descent, property, and religion. Islam protects these human values and prevents any violation of them. 
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King Abdullah International Medical Research which is a part of the 
National Guard Health Affairs (NGHA). The SB project aims to conduct an 
extensive study on the influence of genes, environment and lifestyle in 
causing common diseases.8[8]  
The SB plans to obtain samples and collect data from approximately 
200,000 NGHA workers and their families. NGHA has four large hospitals 
and 60 health centers (primary or secondary) with a total capacity of 
2,000 beds; it serves a community population of 2.5 million and 
approximately 60,000 patients a year.8 Muslims are 97.1% of the Saudi 
population.9  
The NGHA offers the following advantages: a high quality health care 
system, new program development, IT resources and strategic 
development. These factors were important in selecting the NGHA as the 
SB headquarters. 
Saudi Arabia has a high proportion of young people compared to Western 
nations as well as a different demographic. The under 40 years population 
in Saudi Arabia is approximately 78%, and 32% are under 15 years. 10 
Therefore, it was decided to include participants aged between 10 to 70 
years.6  
METHODOLOGY 
This article concentrates on SB governance and how it addresses three 
basic ethical issues: informed consent, confidentiality, and children’s 
participation. The components of each of these ethical issues were 
analyzed. 
To make a proper evaluation of the SB governance, it was compared with 
governances of four different biobanks selected from biobanks that 
fulfilled the following criteria: national or regional biobanks established 
for research purposes; the ethical guidelines were accessible online to 
third parties from different countries; they varied in size; and participants 
ranged in age. The selected biobanks' governances are the governances 
of UK biobank,2 Estonian Genome Project,11 DeCODE genetics in Iceland,12 
and CARTaGENE in Quebec.13   
Some international guidelines that address research biobank ethical 
issues are more general than explicit;14 therefore, we noted these 
guidelines but did not include them in our comparative result section, 
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however we refer to them in the discussion. These international 
guidelines included HUGO statement,15 the declaration of UNESCO,4 WHO 
report16 and the guidelines of the OECD.3  
RESULTS 
The reviewed biobanks represent a varied portrayal of biobanks. They 
differ in many aspects, including the establishment date and the number 
of participants and their ages. Each biobank has its own ethical system, 
which is guided by the general law in the country in which it is based. Our 
review concentrated on three issues: confidentiality, informed consent 
and children’s participation. 
Table 1: Confidentiality, informed consent and children participation in five different biobanks 
  
SB 
UK 
Bioban
k 
Estonian 
Genome 
Project 
DeCODE 
genetics 
in 
Iceland 
CARTaGE
NE 
General 
information 
Date of establishment 2011 2004 2001 1998 1999 
Number of 
participants 
200,000 
500,00
0 
1,000,000 112,500 60,000 
Ages of participants 
10-70 
years 
40-69 
years 
18 years 
and older 
All 
25-74 
years 
Confidentiali
ty 
Obligation of respect 
of Confidentiality 
Yes Yes Yes Yes Yes 
Confidentiali
ty Methods  
Coding Yes Yes Yes Yes Yes 
Access 
policy 
Yes Yes Yes Yes Yes 
Securit
y 
syste
m 
Yes Yes Yes Yes Yes 
Prohibition of 
discrimination 
Yes - Yes Yes - 
Prohibition of 
stigmatization 
Yes - - - - 
Informed 
Consent 
Obligation of 
informed consent 
Yes Yes Yes 
Consent 
is 
presume
d 
Yes 
Limited or general 
consent 
General 
consent 
Gener
al 
consen
t 
General 
consent 
Limited 
or a 
broad 
informe
d 
consent. 
General 
consent 
Possibility of re-
consent or re-contact 
Yes Yes - - Yes 
Right to withdraw Yes Yes Yes Yes Yes 
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Applications of 
withdrawal 
Three 
options: 
(1) No 
further 
contact. 
(2) No 
further 
contact 
and no 
more 
Samples. 
(3) 
Biobank 
can only 
use fully 
irreversibl
e 
anonymiz
ed 
samples 
and data. 
Three 
option
s: 
(1) No 
further 
contac
t. 
(2)No 
further 
access. 
(3) No 
further 
use. 
Two 
stages: (1) 
before 
coding: 
withdraw
al, (2) 
after 
coding: 
data 
destructio
n 
  In 
unlawfull
y disclose: 
sample 
destructio
n 
Tow 
conditio
ns for 
samples: 
(1) to be 
destroye
d or (2) 
not to be 
destroye
d 
Data will 
remain 
No more 
use of 
data, 
sample 
and 
destructio
n of codes 
Children 
Children  participation Yes NA NA Yes NA 
Guardian consent Yes NA NA Yes NA 
Guardian 
Any 
parent, 
but father 
has 
superiorit
y in 
conflict of 
interest 
NA NA 
Any 
parent 
NA 
Child assent Yes NA NA Yes NA 
When start getting 
assent 
10 NA NA  NA 
Consent when donor 
child becomes an 
adult 
Continuou
s consent 
is 
assumed 
and child 
has the 
right to 
withdraw 
NA NA - NA 
Confidentiality is a major concern in all the reviewed biobanks.2,6,11-13 
Different protection mechanisms are employed to guarantee the 
confidentiality of personal information (see Table 1). The stored samples 
and data are coded and/or anonymized and kept under strict control, and 
they are protected by a good security system. 2,6,11-13 Preventing 
discrimination (taking an action against or negative attitudes toward a 
person based on variations in his or her genome)17 is mentioned in the 
Icelandic, Estonian and Saudi biobanks but not to the same degree.6,11,13 
In their informed consent, the Estonian biobank states, "No one may 
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discriminate against me on the basis of being or not being a gene 
donor."11 The Icelandic biobank affirms avoiding discrimination: "It is 
prohibited to discriminate against a donor of a biological sample on the 
grounds of data derived from a biological sample."12 In a special 
paragraph, the SB governance discusses preventing discrimination and 
outlines three levels, "Protection against any discrimination will be 
applied in the three levels: Individuals, families and tribes."6 The SB also 
mentions preventing any type of stigmatization (socially or economically 
categorizing people according to their attitudes, stereotypes, beliefs,18 or 
medical conditions).19 
All biobanks are obligated to collect an informed consent from all 
participants prior to participation (see Table 1).2,6,11-13 The Icelandic 
biobank distinguishes between healthy volunteers who donate for 
research purposes and patients from whom samples are collected 
primarily for clinical reasons and will be used later for research. Written 
signed informed consent is needed in the former case, while it is assumed 
without the need of a donor’s signature in the latter provided that the 
samples are not personally identified.*12 SB requires written informed 
consent in both cases.6 Informed consent must contain all the information 
that is required to enable the participants to make a voluntary decision. 
General consent covering all research in the biobank is used by all 
biobanks, except the Icelandic biobank, which provides two choices: 
either a limited consent for a specific research proposal or a one-time 
broad consent that cover future researches.2,6,11-13 
The SB, UK biobank and CARTaGENE allow re-contacting participants for 
the following reasons: to collect new information, to collect new consents 
for new uses, or to provide some results.2,6,13  
Withdrawal is a guaranteed right for all participants in all biobanks at any 
time without penalty (see Table 1). Both the SB and UK biobank use three 
degrees of withdrawals. The first degree in both biobanks is the same: not 
to have further contact; however 2nd and 3rd degrees are different. In the 
2nd degree the UK Biobank will stop accessing samples and data, but the 
SB will continue accessing them without collecting new samples or 
contacting donors. The 3rd withdrawal degree in the SB and the 
                                                             
* Assumed consent according to Icelandic biobank is: "Consent that consists in the donor of a biological 
sample not expressing any unwillingness for a biological sample taken from him/her for a clinical test to 
be permanently preserved in a biobank for use under Article 9, information in writing on this possibility 
having been available to him/her"(12. Welfare Mo. Biobanks Act, No. 110/2000 as amended by 
Act No. 27/2008 and Act No. 48/2009. In: Welfare Mo, ed. Iceland2009.) 
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withdrawal of assumed consent in the Icelandic biobank do not refer to 
destroying samples, as is the case in the 3rd withdrawal degree in the UK 
biobank and other biobanks, including the withdrawal from expressed 
consent in the Icelandinc biobank. Instead, the SB mandates making 
anonymization irreversible, and will continue using previously collected 
samples only after making them irreversible anonymized. The Estonian 
Biobank gives donors the right to withdrawal until coding is completed, 
but after that donors can apply, at any time, for the destruction of data 
which enables decoding. But in unlawfully disclosing, the gene donor in 
the Estonian Biobank has the right to apply for the destruction of the 
tissue sample, description of DNA and description of the state of health. 
For DeCODE genetics in Iceland upon withdrawal, the biological sample 
shall be destroyed. On withdrawal of assumed consent, the biological 
sample shall not be destroyed, but preserved for use in the interests of 
the donor. On withdrawal, any data existing in the database will remain, 
but no new data will be entered. In the CARTaGENE, no more use of data 
or samples besides of destruction of codes, except for previous statistical 
analyses and publications.2,6,11-13 
The Saudi and Icelandic biobanks are familial biobanks that recruit 
children (see Table 1). Participants in the SB are aged between 10 and 70 
years. The UK, CARTaGENE and Estonian biobanks recruit participants 
aged 40-69 years, 15-74 years and 18 and above, respectively. 
The Icelandic biobank and SB mandate parental consent for children aged 
16 years and younger and 18 years and younger, respectively. For the SB, 
any parent can give the consent, however father has superiority in case of 
conflict of opinions. The children’s assents are also sought when possible. 
None of them define the age of child when he can start giving his assent. 
SB does not ask consent or contact donor when they reach 18, but they 
can withdraw. The children will know about their participation either 
when they give assent or when their guardians notify them of 
participation. 
DISCUSSION 
Before discussing the current situation of Saudi Biobank, two important 
factors that might affect the ethics of Saudi Biobank need to be 
considered: Firstly, Islam, which is the religion of the majority, colors 
various aspects of life, including medical issues. Secondly, social 
characteristics and the tribal structure of the Saudi community still have 
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deep influences on people’s social behavior. Extended families and 
consanguineous marriages are still common in Saudi. Although the effects 
of these two factors cannot be separated, they are interrelated and lead 
to certain types of customs in Saudi society. The precedence of male 
guardians in taking decisions related to children is an example where we 
can find both Islamic and social effects. 
Considering this dual effect, Islamic and social effects, we will discuss 
three issues: confidentiality, informed consent, and research on children 
in Saudi Biobank, considering the international guidelines and 
governances of other national biobanks. Saudi Biobank aims to conform 
to international guidelines, as noted in SB governance; however, different 
variances can be seen also in other national biobanks, giving each biobank 
its own unique flavor. 
Confidentiality 
We observed that all biobanks, including the SB, insisted on respecting 
confidentiality, followed certain kinds of practical data protection 
procedures, and maintained information confidentiality by making the 
data inaccessible to biobank staff, insurers, and other parties. The interest 
shown in confidentiality by the SB and other biobanks reflects the 
importance of this issue. The collected samples and data contain a great 
deal of vital and sensitive information. Respecting information 
confidentiality is one of the ethical principles that are a primary concern 
of bioethicists who are interested in performing research in these fields.20-
22  
The SB uses International and national guidelines as references and grants 
confidentiality the level of importance matching what is stated in the "Law 
of ethics of research on human creations” by the Saudi “National 
Committee of Medical & Bioethics”,23 and international guidelines, such 
as HUGO, UNESCO, WHO databases, and OECD, which clarify that 
maintaining confidentiality is mandatory for all biobanks.  
Another study shows that the Saudi law of research ethics indicates the 
need to respect confidentiality in medical research in general. 24 
Moreover, this system particularly specifies respecting confidentiality of 
genetic materials biobanks.19 The SB governance is fully compatible with 
these materials and well matches the respect for confidentiality 
mentioned in Islamic fatwas.24  
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It is expected that the tribal structure and the religion of Saudi society 
may have impact differently in regard to confidentiality. We observe that 
the SB focuses more on the issues resulting from breaches of 
confidentiality, such as discrimination and stigma. The Icelandic and 
Estonian biobanks also address preventing discrimination, but the SB is 
the only biobank that specifically addresses this issue in a particular 
paragraph. Moreover, the SB discusses preventing stigma. These 
preventions reflect the sensitivity of the SB against any type of 
discrimination or stigmatization caused by social values and the tribal 
structure of a community. Breaches of individual confidentially may lead 
not only to individual stigma but also to familial and tribal stigmas.25 In a 
society with such strong and extended families and a high percentage of 
inter-family marriages, any stigma would affect all family members and 
might adversely impact their daily lives and issues such as marriage. The 
concern regarding extended stigmas is supported by other studies about 
the high rate of consanguinity and genetically inherited diseases in Middle 
Eastern countries, such as in Saudi Arabia and among some other Muslim 
populations.26,27 On the other hand, there is also increased concern by 
Western authorities about protecting groups from disclosure of genetic 
information, especially after the harm that occurred to the Havasupai 
American Indian Tribe.28,29 
Preventing discrimination in the SB governance is supported by the law of 
ethics of research on living creatures (Article 36). There are no specific 
laws in Iceland and Estonia to prevent genetic discrimination;30 however, 
both the Icelandic and Estonian biobanks mention preventing 
discrimination in their governance. Even though preventing 
discrimination has not been stated clearly in the governance of UK and 
CARTaGENE, many legal documents in the UK and Canada offer protection 
against any kind of discrimination, including genetic discrimination. In the 
UK, there is no specific law or legislation related to genetic discrimination 
rather, the legislators have merged the “Disability Discrimination Act 
1995” into the “Equality Act of 2010,” and both of these include an anti-
discrimination schema.31 Likewise, Canada has enacted laws such as, 
“Article 15 of the Canadian Charter of Rights and Freedoms,” “The 
Canadian Human Rights Act,” “The Tri-Council Policy Statement,” and 
PIPEDA ("About Genetic Discrimination"). Similarly, in Iceland, the 
parliament passed a bill in December of 1998, that permitted the creation 
of a consolidated record of all the Icelandic peoples concerning 
genealogy, genetics, and personal medical information.32 
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Informed consent 
Informed consent is considered to be a cornerstone of ethical practices in 
conducting medical research, including research biobanks. Informed 
consent is a reflection of an individual’s autonomy, which is a basic 
principle of bioethics. Obtaining valid consent, free and voluntary 
participation and clear and adequate disclosure and understanding 
information are ethical prerequisites. The SB and other biobanks require 
informed consent from all participants. This policy matches the 
requirements of the Saudi law of research ethics, international guidelines 
such as the UNESCO Universal Declaration on Bioethics and Human Rights 
(2005) and others guidelines about research on stored materials.  
One-time consent for all research conducted on donor samples and data 
has been selected by the SB. However it receives criticisms because the 
donors might not well be informed about future research, and the 
principle of autonomy might be undermined.33 Although these critiques 
are recognized in literature, we see that one time consent matches the 
requirements written in international documents, and is in alignment with 
the findings of other authors of biobank studies.34-37 Moreover one time 
consent is the standard selected by many biobanks worldwide.12 This 
might be due to the benefit of this one time approach. First, because 
getting informed consent for every research is impractical and may hinder 
progress.38 Second, using some strategies such as adequate counseling of 
the donors and keep the door open for questioning and answering will 
help in making donors more acknowledged.39 Moreover, even if the donor 
will sign for just once, research ethics committees should review and 
approve each research separately, and the donor should enjoy 
withdrawal right any time. Both ethics approval from an IRB and 
withdrawal right can offer protection to the donor.40,41 
The obligation to obtain informed consent before performing research in 
the SB is supported by Islamic perspectives. Although nothing is written 
in Islamic texts concerning biobanks, the research ethics guidelines issued 
by the Islamic Organization of Medical Sciences IOMS mandate requires 
informed consent before any medical research.7 In addition, Islamic 
fatwas issued by juristic councils support the obligation of informed 
consent, such as fatwa No. 161 (17:10) by the International Islamic Fiqh 
Academy (IIFA) about Islamic perspectives of medical research,42 the 
fatwa about stem cells (17:3) 2002 by the Islamic Fiqh Council (IFC),43 etc. 
Moreover, a survey of guidelines showed that regulations in the Middle 
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East mandate informed consent.44 Nothing is written about "one-time" 
consent in Islamic fatwas, as shown in a previous study. "One-time" 
consent does not contradict any Islamic laws. 
Most international guidelines consider withdrawal without any adverse 
consequences to be the right of any participant in a research study. The 
SB offers three degrees of withdrawal, but none of them leads to a 
complete destruction of the samples and data. In the third degree of 
withdrawal which is a complete withdrawal the SB will completely 
anonymize the samples and data after receiving a withdrawal request, but 
it does not allow their destruction.6 The Declaration of UNESCO, WHO 
databases, and the HUGO statement provide two alternatives of 
complete withdrawal: either to destroy any unused samples and data or 
keep them but with full anonymization.4,15,16 The OECD mentions 
destroying the samples and data with respect to the cultural heritage 
and/or religious beliefs of the participant.3 The Singapore Tissue Network 
and CARTaGENE will destroy the samples, as will the UK biobank in its 
third degree of withdrawal except for previous analysis, while the SB will 
keep samples after they are completely anonymized. Estonian biobank 
will not destroy samples, but destruction may be applied if identity of 
gene donor is unlawfully disclosed. Clearly, sample destruction provides 
the best guarantee of a participant’s protection, but it may result in the 
loss of effort and money. Although full anonymization cannot assure 
absolute protection, especially in case of abuse by key holders,45 it can 
offer both protection and respect to a certain degree, especially in that 
donors will be informed before participating about impossibility of 
complete destruction of their samples when a withdrawal is requested. 
Whichever method is chosen, biobanks must make all possible policy and 
management efforts to guarantee sufficient protection. The multiple 
degrees of withdrawal in the SB are similar but not completely the same 
as those of the UK biobank.  
Children’s participation 
The inclusion of children in research biobanks is widely accepted and 
necessary, especially to study pediatric childhood diseases and cases 
associated with childhood health.[46] Besides these conditions there is 
another reason behind selecting children to participate in SB, namely the 
high percentage of children in relation to the total population of Saudi 
Arabia, in which 77.5% of the population is under the age of 40, as 
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opposed to a ratio of 49.6% in the UK. Because of this demographic, it is 
important to study childhood diseases and respond to children’s needs. 
However, children are not simply small adults, and we cannot simply 
apply the results of research on adults to children. Children’s participation 
in research raises different ethical challenges than for adults’ 
participation. For example, research on children can be performed only if 
it addresses a medical problem related to a child’s health. Other 
conditions for children’s participation in research include:  minimizing 
risks to children, considering the best interest of the child, obtaining 
guardian consent and—when appropriate based upon the age of the 
child—the child’s assent as well.46-48 Many researchers distinguish 
between research on children and research on samples taken from 
children, especially regarding the minimum risks of both.49,50 The SB 
recruits participants aged between 10 and 70 years differently from many 
other biobanks, such as the UK and CARTaGENE. The process is similar to 
some other biobanks that recruit children among their participants, such 
as the Icelandic biobank.  According to the declaration of UNESCO, WHO 
databases, and the OECD guidelines, research on children is allowed 
provided they are offered enough safeguards, and the guardian’s consent 
is obtained. The SB guidelines also align with the OECD guidelines. 
Although the child’s opinion is not obligatory, it must be respected, and 
his or her assent must be collected if it is possible. 
Concerning research on children, the SB governance matches the 
predominate opinion stated in some Islamic resources regarding pediatric 
research, such as the fatwas of IIFA (161, 2006),42 ICF (3/17, 2002),43 and 
the IOMS guidelines (2005).7 According to Islamic resources, pediatric 
research has to be in the best interest of the child and cannot cause more 
than minimal risks. According to IOMS the best interest of the child can 
be a direct individual benefit to the child himself, or indirect general 
benefit to the childhood community.7 
 The same conditions are stated in the Saudi “Law of Ethics of Research 
on Living creations”. Islam as a reference can explain why SB gives 
superiority to fathers over mothers in case of conflict of interest. 
According to Islamic references fathers are guardian to their children. 51 
This is dissimilar to the case Iceland where the Biobank does not refer to 
which parent has the superiority, due to culture differences. 
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However, the question arises, why does the SB start recruiting 
participants at age 10? The Icelandic biobank and Marshfield Clinic 
Personalized Medicine Research Project have no minimum age limit to 
accept participants. There is no clear justification provided by the SB why 
the exact age of 10 years was chosen, particularly because children 
younger than 10-years-old form a significant portion of the population. It 
is interesting to see that SB defines 10 years as a minimum age for 
allowing research; the Saudi law of research ethics does not mention a 
minimum age.  
Collecting assent from children for research biobanking is important and 
consistent with the ethical principle of respecting children’s autonomy 
and including them in decision making. The necessity of obtaining a child’s 
assent is supported by other studies, and it is mentioned in international 
guidelines about research ethics, such as the “Declaration of Helsinki,” 52 
the “International ethical guidelines for biomedical research involving 
human subjects” by the Council for International Organizations of Medical 
Sciences,53 and the “Convention on the rights of the child” by the UN.54 
Saudi Biobank encourages but does not require child assent to allow 
children’s participation in biobanks, and it seems that SB governance 
chooses the age of ten to ensure that participating children understand 
the biobank’s principles and procedures, and they want the children to 
participate in the decision making process. The idea of understanding is 
also mentioned in the guidelines of other biobanks (e.g., West Australia). 
Guidelines by CIOMS state that from ages 12-13 the child’s opinion should 
be taken into account.53  However other studies define a higher age for 
the understanding of genetic research, and suggest an age of 16-18 years, 
while yet others give much lower ages, even as low as four years old for 
understanding their own medical issues.55 
None of the Islamic resources defines at which age medical research can 
be performed on children. According to a previous study, the authors 
could not find any Islamic fatwa about the age at which children can 
ethically be considered to be able to give an assent to medical research. 
That paper suggested collecting assent from children aged seven years 
and older. 
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CONCLUSION 
The SB, which is based on international and national guidelines and 
Islamic religion shares same ethical values with other biobanks, and does 
not show major differences from other biobanks, although some 
dissimilarity could be found in some issues. Confidentiality is a sensitive 
concern, particularly when it relates to discrimination and stigmatization. 
Informed consent is another important issue in all biobanks. Differently 
from some other biobanks SB does not allow samples and data 
destruction in all withdrawal degrees. Participating of children in 
biobanking is important in Saudi, and can be offered the required 
protection. We suggest more discussion with scholars from other 
biobanks worldwide to reach better harmonization and collaboration. 
Governance of SB is one of the newly established health policies in the 
Middle East that regulates biobanking research and can be adapted 
partially or completely by other biobanks in the Arabic and Islamic worlds.  
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In recent times, an increasing number of research biobanks have been 
established in many parts of the world, and medical research has 
increased as well.1 Getting access to large numbers of samples and data 
is a key factor in the development of successful research, which requires 
collaboration between researchers and biobanks and among biobanks 
themselves and pharmaceutical companies.2 However, this is 
accompanied by logistical difficulties and ethical challenges, especially 
those related to medical confidentiality. A good balance between allowing 
access to samples and data and conducting medical research on one hand, 
and preserving the rights of the participants—especially protecting the 
confidentiality and privacy of donors and not harming them—are key 
factors in the success of biobanks.3 
In this section we'll explain the provisions under which researchers are 
allowed access to samples and data in a biobank in Saudi Arabia . 
In 2011 King Abdul Aziz Medical City in the National Guard, in cooperation 
with the King Abdul Aziz City for Science and Technology, decided to 
establish a biobank, which currently contains 200,000 participants, as a 
base to conduct basic medical research in Saudi Arabia. Half of the 
participants were patients with certain common diseases, and the other 
half were healthy participants.4  
The samples are collected on the basis that ownership is given to the 
biobank, with the possibility of allowing researchers to have access to the 
samples and the data they need to do their research. Samples and data 
will be managed by the biobank as a part of the King Abdullah 
International Medical Research. Access policy has been approved by the 
Steering Committee for the Saudi Biobank.5 
Saudi biobank regulates access to samples and data, using a system of 
clear administration and procedures, including the use of double coding 
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to ensure the anonymity and limiting access to anonymized samples and 
data only. According to Saudi biobank, individual researchers and 
institutions can get access after obtaining an approval from the 
Institutional Review Board (IRB). Access is limited to samples and data 
needed by the researcher, and with previous approval by the IRB. Saudi 
biobank intends to encourage medical research while preserving 
confidentiality and protecting participants.5 
Full implementation of the Saudi biobank is still underway, with an 
expected start in 2014. The program will give access to both local and 
foreign researchers, similarly to other biobanks such as UK, Icelandic, 
Estonian, and other biobanks.6-8 Previous study discovered widespread 
agreement to giving access to researchers inside and outside the country. 
Saudi biobanks as well as other biobanks require that information be 
anonymized to allow access.1,6-8  
Giving access to samples and data to local and foreign researchers is vital 
to the conduct and development of research in Saudi, especially because 
it offers the use of a large number of samples and data in research, which 
will increase the credibility of research results. On other side and from an 
economic point of view, giving access to researchers will save financial 
costs of establishing other biobanks requiring expensive buildings and 
equipment. Usually, research institutes and researchers are interested in 
investing in conducting research directly rather than spending money on 
building and costly tools. Giving access to researchers is important and 
acceptable, especially if done according to correct conditions and with 
appropriate safeguards for confidentiality and privacy through using 
anonymized samples and data.  
 
 
 
 
 
162 
 
REFERENCES 
1. Bowton E, Field JR, Wang S, et al. Biobanks and electronic medical records: 
enabling cost-effective research. Science translational medicine. Apr 30 
2014;6:234. 
2. Hewitt RE. Biobanking: the foundation of personalized medicine. Current 
opinion in oncology. Jan 2011;23(1):112-119. 
3. Hallmans G, Vaught JB. Best practices for establishing a biobank. Methods Mol 
Biol. 2011;675:241-260. 
4. King Abdulla International Research Center KAIMRC. Saudi Biobank. 
http://www.kaimrc.med.sa/index.php?option=com_content&view=article&i
d=31;%202013/. 
5. King Abdulla International Research Center KAIMRC. The Governance of Saudi 
Biobank. Riyadh; 2011. 
6. UK Biobank. Ethics & Governance Framework. 2007. 
http://www.ukbiobank.ac.uk/wp-content/uploads/2011/05/EGF20082.pdf 
7. Estonia. Parliament. Human Genes Research Act Passed 13 December 2000 (RT 
I 2000, 104, 685), Enforced  8 January 2001. Changed with the next law 
14.02.2007 (RT I 2007, 22, 111). Riigikogu; 2007. 
8. Iceland. Ministry of Welfare. Biobanks Act, No. 110/2000 as amended by Act 
No. 27/2008 and Act No. 48/2009. Iceland; 2009. 
 
 
 
 
 
 
 
 
 
 
 
 
163 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
164 
 
PART IV: ISLAM AND BIOBANKS 
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Abstract: 
Research biobanks can offer great benefits for science and health care. 
However, there arise many ethical challenges. These challenges may have 
different perspectives in Muslim countries, where some research 
biobanks start to appear. 
We propose principles for good practice related to the research biobanks 
in Islamic countries, focusing on issues related to confidentiality, informed 
consent and children participation.  These issues are explored according 
to Islamic fatwas and Usul Al Fiqh, we conclude by providing principles for 
good practice for policy makers of biobanks, researchers and anyone 
involved in dealing with stored tissue samples from Muslims. Actual 
implementation of the principles will vary according to different 
jurisdictions. 
Introduction 
Research biobanks are considered basic to clinical research these days 
and are expected to play an important role in the future.1 They support 
studies of the relations between genes, environment and other factors to 
know the mechanisms and pathology of diseases and ways to have 
appropriate treatments.1 However biobanks come with many ethical 
challenges, especially related to respect of the participants' autonomy, 
protection, and financial issues.2,3 
Research biobanks are beginning to appear in many countries in the 
Middle East, such as Saudi Arabia and Qatar, where Muslims form the 
majority of the population. However, the Islamic aspects of the related 
ethical issues have not yet been studied. A literature search in PubMed 
shows no results from the combination of “biobank” and “Islam” as 
keywords. Studying Islamic perspectives on research biobanks is also vital 
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in other countries, including Western countries where Muslim minorities 
form a significant part of society and Islamic perspectives are not well 
known by the staff of biobanks and by the Muslims themselves. There is 
a lack of literature that explains the ethical issues of biobanks from an 
Islamic point of view, and we hope that this paper will make a new 
contribution to the subject. Our paper will help both Muslim and Western 
scholars to understand the Islamic perspectives regarding research 
biobanks and the similarities and differences between them and other 
(especially Western) perspectives. We also aim to develop an Islamic 
opinion on research biobanks to be used as a reference by biobanks in 
Islamic countries, especially in the areas of informed consent, children’s 
participation, and confidentiality. 
Research Question and Methods 
The ethical principles of medical research and research biobanks are a 
reflection of many ethical and moral principles, including society's ethos 
and morals. The ethics of research on a Muslim population are also 
influenced by Islamic perspectives. 
A problem that may be noticed here is how the age of Islamic resources 
like the Quran (the holy book) and the Sunnah (the sayings, actions, 
approvals or descriptions of the features of the Prophet Muhammad), 
both of which date to more than 14 centuries ago, may say something 
about recent matters still being under discussion and negotiation. Such 
problematic issues can be solved from an Islamic point of view through 
knowing the mechanisms of rules stated in Islam. This can be seen as 
similar to other religions when they state an opinion about new matters 
such as cloning, disconnecting the ventilator, and other new similar issues  
Even though the Quran and the Sunnah, the main resources of Islamic 
jurisprudence, do not mention medical research, biobanks, or other new 
developments, Muslim jurists use many mechanisms to derive rules about 
new matters and issues as Islamic resources. This process is called al-
Ijtihad, which means “to make every effort to reach the correct decision”. 
Al-Ijtihad is one of the principal characteristics of Islamic Jurisprudence. 
Although al-Ijtihad considers both the Qur'an and the Sunnah, it uses 
many tools, such as analogy, consensus, equitable preference, customs, 
and the public interest; all of these are called "Usul Al-Fiqh" (Source 
methodology in Islamic jurisprudence).4 There are many juristic rules. 
"Qawa’id al-Fiqhiyyah" concluded from "Usul Al-Fiqh" that are also used 
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in matters of daily life, such as: "Hardship begets facility," "Harm must be 
eliminated," "Necessity makes the unlawful lawful," "A greater harm is 
eliminated by means of a lesser harm," and others.4 
Another problem comes from the differences among many Muslims 
groups, and when we say "Islamic perspectives," we must acknowledge a 
diversity of perspectives.  However, in this paper we choose to talk about 
the Sunni School, although similarities exist among the different Muslim 
doctrines with regard to new juristic issues. The Sunni school represents 
a large majority (87 %–90 %) of Muslim populations.5 Although, many 
differences are found among the Sunni groups, especially in issues related 
to praying, fasting and others; it is different for new issues, such as organ 
donation, IVF and medical research, especially when that juristic councils 
are formed from (and have representatives of) all Sunni groups. Juristic 
councils' decisions, which we rely on in our studies, are cumulative 
opinions among majority of scholars in each juristic council.    
In order to explain and evaluate Islamic opinions about research 
biobanking, we first surveyed the most prevalent ethical challenges in 
research biobanking through a review of the literature.  Among the most 
relevant sources were: Hens et al., about children’s research biobanks;6 
Trommelmans et al. and White et al., about informed consent;7,8 and 
Alahmad and Dierickx, about the governance of research biobanks. 9 
Second, we reviewed Islamic institutional and individual fatwas* that may 
be connected directly or indirectly to research biobanks and their ethical 
challenges, including the International Islamic Fiqh Academy (IIFA), the 
Islamic Fiqh Council (IFC), and the Islamic Organization of Medical 
Sciences (IOMS). Three previous empirical studies in the Middle East 
about biobanking ethics were used to highlight Muslims’ perspectives. 
Also, two theoretical studies—one about research ethics guidelines in 
Muslim countries and the second an analysis of Saudi biobank 
governance— are used to explore the real factual situation. Third, we 
used "Usul Al-Fiqh," including the Quran, the Sunnah, and other resources 
to analyze their Islamic opinions regarding research biobanking. We 
differentiated between two things: issues that Islam has a position on, and 
issues that Islam does not have any position on.We developed a model of 
                                                             
* Fatwa is an Arabic word used in Islamic jurisprudence, and means a religious opinion concerning 
Islamic law about a specific new matter issued by an Islamic scholar according to general Islamic 
perspectives and depending on the primary Islamic resources like the Qur'an, the Sunnah, consensus, 
and analogy, besides some secondary resources. The mufti (the person who issues fatwa) must be well 
informed about both Islamic jurisprudence and about the matter of the fatwa to be issued.  
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Islamic ethical standards that can be considered by biobanks in Islamic 
countries. 
Before highlighting the ethical perspectives of research biobanking in 
Islam, a few simple questions are relevant, that is: what is the position of 
Islam toward medical research itself? And does Islam allow establishing 
research biobanks? 
Islam and Medical Research 
Islamic teachings do not limit scientific progress or development; on the 
contrary, they encourage progress. Many Quranic verses and prophetic 
Hadiths insist on both learning and teaching. Some Muslim interpreters of 
the holy Qur'an discuss the importance of learning new sciences when 
they interpret the verses of the story of Moses and how he learned from 
the good man.10 The International Islamic Fiqh Academy stated in the 
introduction of its decision 94 (10/2) on human cloning and in decision 
142 (15/8) that Islam does not put any obstacle in the way of research, 
and requires respect for human dignity and privacy, as long as it is a 
beneficial research.11,12 Also, in its decision about human resource 
development 164 (18/2), it encourages doing research.13 This comes in 
line with a saying of Prophet Muhammad: "Seeking knowledge is the duty 
of every Muslim."14 Therefore, learning and finding new knowledge is a 
religious duty, not just a matter of necessity.   
According to Muslim scholars, Muslims must fulfill two kinds of 
obligations. The first kind is a full obligation for every individual (e.g., to 
know how to pray or fast). If a person does not meet these obligations, he 
or she is sinful, regardless of other actions. This kind of obligation is called 
"fard al-'ayn" (individually required duty). The second kind of obligation is 
a partial obligation that is a partial imposition, where only part of a 
community and not all community members has to meet this kind of 
obligation. If this obligation is not met, the entire community is 
considered sinful. This type of obligation is called "fard al-kifaya" 
(collective duty), if fulfilled by a certain number it relieves others from 
performing it.  The presence of doctors in a society is an example of this 
second type of obligation; having some doctors is in the public interest, 
but not all individuals have to be doctors.4 
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Medical research is in the public interest because it contributes to a better 
quality of life and decreases human suffering. Therefore, medical research 
represents the second type of obligation. 
The understanding of the relationship between humans and diseases and 
the search for new means of treatment led Islamic civilization to a great 
scientific and medical renaissance during the Middle Ages. Integrated 
hospitals were created in Damascus, Baghdad, and Egypt. These 
understandings also fostered the emergence of a large number of Muslim 
doctors and scientists, including al-Razi, Ibn Sina, and Ibn al-Nafis.15  
Although the teachings of Islam support medical research in general, we 
can identify some limits that regulate and define the boundaries of 
research for certain cases in which violations may occur. For any new 
matter, including medical research, to be permitted in Islam, five things 
must be protected: religious principles, life, money, intelligence, and 
offspring. Islam aims to preserve these five items.16  
Islamic resources show that Islam relies on a sense of responsibility, with 
a special dimension of concern for social transactions (mu'amalat) with 
other parties. The Prophet Mohammad said, "Every one of you is a 
guardian, and responsible for what is in his custody."17 The meaning of 
this statement is that everyone in a profession has full responsibility for 
their profession; they must be good leaders and work for the benefit of 
their followers.  We may apply this statement to medical research and 
biobanks: researchers and biobank staff are responsible for their research 
and their subjects, and they are responsible to society. 
Research Biobanks Ethics 
The literature presents many challenges facing research biobanks, such as 
informed consent, respect for confidentiality, informed consent and 
children participation in biobanks. The following sections of this paper will 
discuss these challenges from an Islamic point of view. 
Confidentiality 
Confidentiality is crucial in all human relationships and medical matters 
including medical research, and all medical workers and researchers have 
confidentiality as a major ethical concern and duty.18-20 International 
ethics guidelines, such as the Declaration of Helsinki and the Belmont 
Report state the importance and obligation of medical confidentiality.21,22 
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Research biobanks contain huge numbers of samples and personal and 
genetic data and offer easy and safe access to computerized medical 
information needed for research.1,23 The disclosure of individual 
information to the research participant has received a lot of discussion 
and debate since 1990s. Medical confidentiality is built on the concept of 
trust, which is considered necessary to conduct research.18,24 Genetic 
information holds a special importance because it is related to sensitive 
issues that may not only be attached to one person himself but also to the 
person’s relatives. It is very essential to have a balance between the 
necessities of giving access to information for research purposes on one 
side and the obligation of respecting medical confidentiality on the other 
side. Any disclosure of medical information in clinical research or practice 
must be according to informed consent by participants to allow 
researchers to access or disclose any information related to 
participants.25,26 However, in some situations disclosing medical 
information without consent by research participants in research may be 
necessary to avoid greater harm, as in cases of clear individual or societal 
benefits like notification of infectious diseases, like AIDS.27 Confidentiality 
is not limited to information provided by research participants, or taken 
from their samples or data, but also extends to the research results.28,29  
Even though sample and data information are supposed to be collected 
on an individual basis, in practice, it is not. All family members share 
similar genetic profiles; moreover, in some societies where the tribal 
system is still strong, like in many Muslim societies, the tribes have, to 
some degree, cognate genes. Potential stigmatization and harm will not 
be individual, but familial, and maybe tribal.30 Furthermore, people who 
may wish not to be involved in research biobanking will be indirectly 
involved to some extent, through samples collected from their close 
relatives. 
Many fatwas released by juristic councils have shown that respecting 
medical confidentiality is an important issue, both such general fatwas as 
the fatwa No. 79 by the IIFA,31 the fatwa (8/1) 33, and the fatwa (8/1) 35 
by the Islamic Fiqh Academy in India,32,33 as well as fatwas specific to 
clinical research such as the fatwa No. 1 (15) by the IFC,34  and the fatwa 
No. 161 (17/10) by the IIFA.35 Besides these juristic fatwas, confidentiality 
is clearly stated in the document issued by the IOMS.36 Besides these 
institutional fatwas and opinions about the importance of medical 
confidentiality, there are many individual fatwas by some scholars such as 
In Baz (the former grand Mufti in Saudi),37 and writings by doctors such as 
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Albar and Chamsi Pasha.38 On the other side, in spite of the importance 
given to confidentiality by institutional and individual fatwas, justification 
for breaching of confidentiality can be accepted in some situations, 
especially when the harm of maintaining confidentiality overrides its 
benefits, such report HIV-positive individuals to competent authorities in 
order to protect their relatives or community.31-33,39-41 
Informed consent 
Confidentiality in research is essential because participants disclose 
personal information by the participants to the research team. This 
disclosure must be voluntary for the participants and obtained by using a 
complete informed consent form, preapproved by an Institutional Review 
Board. However, obtaining informed consent from the participants is a 
very complicated and controversial topic.42-44 A vast body of literature has 
been published discussing the significance, limitations, and inadequacy of 
informed consent in promoting voluntary participation in research.45-47  
Some fatwas related to informed consent in clinical research, released by 
the International Islamic Fiqh Academy have included decision No. 67 
(5/7) about medical treatment,48 and decision No. 161 (17/10) about 
juridical regulation of biomedical research on humans.35 According to 
these two decisions, informed consent is an obligation for all research. It 
must contain enough and understandable information. Decision making 
must be voluntary and the decision maker must be able to make the 
decision. Implied consent has the same value as expressed consent. 
According to IIFA decision No. 142 (15/8) a doctor is responsible in case 
harm occurs in the absence of informed consent.12 The Islamic 
Organization for Medical Sciences (IOMS) agreed to these juridical 
decisions and provided more details about the obligation of informed 
consent and its required elements, such as benefits, risks, confidentiality, 
and other issues.36 Many authors have talked about informed consent as 
an obligation in research, such as Albar, Chamsi Pasha, and others. 38,49,50  
Research on children 
Obtaining samples from children for the bio-repository is both crucial and 
problematic. Considering children’s vulnerability and their need for 
greater protection, the inability to provide consent raises many ethical 
questions regarding their participation in research, considering very little 
or no direct benefits, and some inherent risk to be associated with it. 
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There are a lot of concerns about the proper age for a child to be able to 
give consent, and about who should give consent for minors and about 
the significance of children' assents.51 
Few Islamic fatwas by juristic councils talked about medical research and 
children, besides an opinion by the IOMS.36 Few number of individual 
writing are found about, but they only copied parts of IOMS 
opinion.38,49,50.  
Three positions could be found about conducting medical research on 
minors. Two have opposite extremes: a complete prohibition by fatwa 
IIFA 67 in 1992,48 because it is not in the best interest on child, a complete 
permission by the Islamic Fiqh Council Fatwa in 200252 regarding stem 
cells and the fatwa by Dar-Alifta Al-Misrriyah, in 598 in 2008.60 However 
the most famous opinion which has been selected by the IOMS and 
accepted by IIFA in the fatwa 161 in 2006  is that research on children is 
not allowed unless it is in the best interest of child or there is a public need 
to such research, without causing any harm to children, and after getting 
guardian consent and after the approval of ethics committee 
approval.35,36  
Discussion 
Confidentiality, biobank & Islam 
Respecting medical confidentiality is a basic issue in Islam. Many related 
institutional and individual fatwas are issued in this regard. By using one 
of the principles of "Usul Al-Fiqh" (source methodology in Islamic 
jurisprudence), called "Qiyas" (analogy), confidentiality is important in 
clinical practice and research and can be applied on biobanks as well, 
considering that the research in biobanks includes research on stored 
tissues, which is a kind of medical research. Moreover, confidentiality in 
biobanks is possibly more important than in clinical research because 
longitudinal studies last for decades, and because it deals with genetic 
information which is not individual information only but also familial and 
tribal, and any leak of information may lead to bigger harm. Disclosing of 
information may be justified for some reasons, especially to avoid larger 
harms, such as harms to at risk- relatives who share same genes. Many 
juristic rules in Islam can be used to allow such information disclosing like: 
"Necessity makes the unlawful lawful", which allows disclosing of 
information which is unlawful, but when it is necessary it becomes lawful 
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as the case of prevent public harm as stated by the fatwa of IIFA.35 
Disclosing of information in necessities is used by the governance of the 
Saudi biobank, which allows this disclosure in risky cases where there is a 
clear clinical proof, after making necessary consultation.53 Interviews with 
professionals from the Middle East support this Islamic opinion about the 
importance of confidentiality in research on stored tissues and disclosing 
can only be accepted according to justified reasons,54 which also is 
supported by the guidelines of research ethics in some Muslim countries 
in the Middle East.55 
 Even there is no fatwas about preventing genetic discrimination and 
stigma in genetic research on stored tissues; there are many juristic rules 
"Qawa’id al-Fiqhiyyah" which can be applied here, such as: "Harm must 
be eliminated", "Harm may neither be inflicted nor reciprocated" and 
"The greater harm is repelled by the lesser harm".56 These juristic rules 
clearly prevent harms. It is not a surprise to see that professionals in the 
Middle East agree that discrimination and stigma neither be accepted in 
genetic research.54 The Saudi biobank also prevents any act that may lead 
to discrimination or stigma, this is also agreed by the research ethics 
regulations in the many Muslim countries, such as Saudi and Qatar.57,58 
Fatwas or juristic rules about confidentiality are stated in general terms; 
they do not show any interest in the mechanisms. We do not find anything 
about which security system or which kind of coding has to be selected. 
(Table 1) 
Table 3: Islamic position about confidentiality in biobanking research 
 
Islamic position 
Available Supported 
Fatwa 
Compatible with Usul Al-Fiqh 
methods 
Respect of confidentiality Yes Yes 
Justified disclosure of 
information 
Yes Yes 
Prevent discrimination No Yes 
Prevent stigmatization No Yes 
Type of security system No Neutral 
Type of coding No Neutral 
Informed consent, biobank & Islam 
Many juristic fatwas, the statements of IOMS, and many authors mandate 
getting informed consent to allow participation in clinical 
research,35,36,38,48-50  which is also applicable to biobanks. Informed 
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consent must be voluntary without any coercion. This opinion matches 
many juristic rules such as, “A person’s right is not to be revoked without 
his permission,” and “Man’s right is not to be used without his  
permission.” Voluntary participation requires using understandable 
informed consent and the ability to understand.35,36,48. Using written 
consent rather than verbal consent is preferred because it helps research 
participants to understand informed consent more clearly.38 
There is no preference in Islamic fatwas with regard to using one-time 
consent for all research conducted on the same samples, rather than a 
separate consent for each research. This issue is left to the system of each 
biobank. The Saudi biobank, as an example, chooses to use a one-time 
consent. The same is applicable to the degrees of withdrawal used by 
many biobanks like UK and Saudi biobanks; it also is left to the governance 
of the biobank. 
Table 2: Islamic position about informed consent in research biobank 
 
Islamic position 
Available Supportive 
Fatwa 
Compatible with Usul Al-Fiqh 
methods 
Obligation of informed 
consent 
Yes Yes 
Voluntary Yes Yes 
Ability to decide Yes Yes 
Enough information Yes Yes 
Understandable information No Yes 
Withdrawal No Yes 
Degrees of withdrawal No Neutral 
One time consent No Neutral 
Children’s participation, biobank and Islam 
The position taken by the IOMS,36 IIFA in its fatwa 161,35 and many 
authors, seems to be applicable as well to children’s participation in 
research biobanks, considering that research on children' biobanks are 
necessary to prevent and treat childhood diseases. All conditions 
mentioned by IOMS are presented: best interest of child or a public need 
for such research, no harm, guardian consent, and required approval of 
ethics committee.35,36  
Children’s participation in biobanks is crucial, and even though there may 
be no direct benefit to the participating child there are benefits to future 
generations and to the community of children. This public benefit justifies 
their participation, as stated by IOMS and IIFA 161.35,36  Moreover, the risk 
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in biobank participation is considered minimal, since the physical risk is 
limited to just a needle puncture or even less, as when collecting 
remaining samples taken from participants during their hospital visits. The 
risk of confidentiality breaches can be avoided by using good coding and 
effective security systems. Allowing children,’ participation in biobanks 
not only matches fatwas of IIFA35 and positions of IOMS36 but also is 
compatible with juristic rules of Usul Al-Fiqh, such as "do no harm" and 
"necessity makes the unlawful lawful," considering that children 
participation in research biobanks is necessary compared with minimum 
risks.6,59 Islamic resources do not define an age for children’s participation 
in research, which is instead left to the governance of each biobank. The 
Saudi biobank, for example, accepts children from age 10 years. 
A guardian’s consent is needed to allow a child to participate in a biobank, 
and this is well supported by Islamic fatwas, like fatwas IFC 3/17, IIFA 161 
and Dar-Alifta Al-Misrriyah (598), besides the opinion of IOMS and the 
authors cited in this study.35,36,38,52,60 However these fatwas do not define 
who can fulfill the role of guardian, which can be estimated from other 
resources that talk about guardianship in regard to issues such as orphans 
or marriage, namely: father, then grandfather, then brother.61 This 
guardianship is selected in some medical issues such as surgeries.62 
Although some people, argue that mothers know and are concerned more 
about their children, women according Islamic law cannot be a guardian 
except if they are authorized by child legal guardian.63 
Table 2: Islamic position about children to participate in a research biobank 
 
Islamic position 
Available Supported 
Fatwa 
Compatible with Usul Al-Fiqh 
methods 
Allowing research on children Yes Yes 
At which age child can 
participate 
No Neutral 
Guardian consent Yes Yes 
Child assent No Yes 
Best interest of child Yes Yes 
Re-consent at adulthood No Yes 
Who is the guardian No Yes 
Juristic fatwas do not mention child assent: however, IOMS refers to the 
importance of a child’s assent when he is able to give it.36 According to Al-
Mausoha Al-Feqhia (Juridical Encyclopedia) a child above 7 years may be 
able to understand and his assent can be accepted if it is according to his 
best interest.61 With respect to best interest of the child, no major harm, 
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child assent and guardian consent make participation in biobanks 
acceptable. 
No fatwas refer to the necessities of research ethics approval, but this is 
mentioned by IOMS,36 and matches the spirit of Islamic law by following 
the means that guarantee child protection, through requiring a review by 
experts. 
Conclusion 
Confidentiality, informed consent, and child participation are considered 
important challenges in research biobanks. In spite of differences in 
religion, culture, and other factors, ethical solutions show a lot of 
similarities. 
Islam shows a clear interest in respecting confidentiality and preventing 
any kind of discrimination or stigmatization. Islam does not express any 
opinion regarding the coding method and security system, since these are 
practical issues that must be decided by each biobank. 
Informed consent is considered an obligation for participation in a 
research biobank. This participation must be voluntary, and the informed 
consent must contain enough information and a suitable environment to 
allow the participant to make an informed participation decision. 
Withdrawal of consent is a right for every participant. Islam does not 
express any opinion on the degrees of withdrawal or whether collecting a 
one-time consent is sufficient or whether consent must be obtained for 
every research study. 
Islam allows child participation in biobanks, but requires that no harm be 
tolerated, that a guardian gives consent, and that the child gives assent if 
he is able to do. No certain age is set for participation. Fathers are 
preferred to give consent. 
 
Recommended Principles for good practice of biobanks: Islamic 
perspectives 
1. Islam allows the establishment of research biobanks, as long as 
autonomy is respected, and harm is prevented. 
2. Confidentiality must be respected. 
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3. No discrimination is allowed. 
4. No stigmatization is allowed. 
5. Informed consent is an obligation before participation.   
6. Informed consent must contain all information needed to allow 
a participant to make a well-informed decision. 
7. Participation must be voluntary. 
8. One-time consent is not mandatory. 
9. Withdrawal of consent is a right of every participant. 
10. Degrees of withdrawal are up to every biobank. 
11. Children can participate.  
12. No harm is allowed for participating children.  
13. A guardian’s consent is essential, with fathers preferred. 
14. The assent of the child is preferred when the child is able to do 
so. 
15. A child must give consent upon becoming an adult to continue 
participating. 
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PART V: SUMMARY & RECOMMENDATIONS  
Summary and recommendations 
ABSTRACT 
Research biobanks can offer great benefits for science and health care. 
However, they give rise to many ethical challenges. These challenges may 
have different perspectives in Muslim countries, where research biobanks 
have begun to appear. In this PhD project we have investigated ethical 
implications of research biobanks from an Islamic point of view. In this 
concluding chapter we first provide a summary of our findings. Next we 
formulate a set of recommendations that can be used or further 
elaborated by professional organizations in Islamic and Arabic countries. 
To conclude we point out the limitations of our research and indicate 
directions for further research.  
SUMMARY OF FINDINGS 
In the introduction we discussed how research biobanks raise many 
ethical issues, such as those related to confidentiality and privacy, 
informed consent, ownership, and child participation. Many Arabic and 
Islamic countries like Saudi Arabia have begun to establish research 
biobanks. These countries show many differences with other countries 
that may affect the way they deal with the ethical challenges of research 
biobanks. These differences are related to Islam, which is the religion of 
the majority, along with other factors such as societal and family 
structure. In the first part of this PhD project we reviewed and explored 
current research ethics and practices in the context of Islam and the 
Middle East. In the second part we conducted empirical inquiries into the 
current ethos of the Islamic community regarding confidentiality, 
informed consent, and research on children, using both qualitative and 
quantitative research. In the third part we analyzed the existing 
governance of the Saudi biobank, compared with the governance of other 
biobanks. In the fourth part we developed an Islamic opinion regarding 
research biobanks and formulated recommendations for research 
biobanks in the Middle East and in Islamic countries. 
In chapter 1 we explored medical and research confidentiality and 
potential ethical conflicts involving fatwas released by international, 
regional, and national Islamic Sunni juristic councils. We discuss how 
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these fatwas affect research and publication by Muslim doctors, 
researchers, and Islamic medical organizations. We documented fatwas 
in three categories: medical confidentiality, research confidentiality and 
justified breach of confidentiality. For fatwas that have already been 
issued, confidentiality seems to be a very important issue; however, these 
fatwas do not go far beyond general studies and do not fully investigate 
the issue of patient confidentiality. Additionally, there is a lack of accurate 
and detailed research about medical confidentiality, especially in sensitive 
areas, and in determining which cases may require an infringement of 
confidentiality. We argue that more specialized fatwas are needed to 
clarify Islamic juristic views about medical and research confidentiality, 
especially the circumstances in which infringements on this 
confidentiality are justified. 
In chapter 2 we discussed the Islamic position regarding research on 
children. We analyzed medical research on children from three Islamic 
resources: plural fatwas by juristic institutions, the opinions of Islamic 
medical organizations, and individual writings. Seven plural fatwas from 
three juristic councils could be found. Only four of them raise ethical 
concerns about research on children. Two documents from medical 
organizations were identified. Three different positions could be 
concluded from these fatwas: a total prohibition, prohibition unless, and 
permission. Preventing any harm is a major concern in all fatwas. A 
guardian's consent is necessary, but more details are needed. The 
guidelines of Islamic Organization of Medical Sciences (IOMS) reflect the 
best available Islamic perspective about research on children. 
In chapter 3 we reviewed the national research ethics regulations and 
guidelines in the Middle Eastern Arabic countries. Thirteen Arab countries 
in the Middle East were explored for available national codes, regulations, 
and guidelines concerning research ethics, and 10 documents from eight 
countries were found. We studied these documents, considering the 
ethical principles stated in the Declaration of Helsinki, the Council for 
International Organizations of Medical Sciences (CIOMS) guidelines, and 
the International Conference of Harmonization-Guidelines for Good 
Clinical Practice (ICH-GCP). Our paper comprises a complete list of 
protections, such as confidentiality, informed consent, ethics committees, 
and others. Results: This study found different levels and kinds of research 
ethics regulations and guidelines in the countries examined. Two groups 
can be distinguished: the countries in the first group have one or more 
research ethics regulations or guidelines, while the countries in the 
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second group have not yet established any. Most of the documents 
showed various degrees of deficiencies in regard to ethical protection. 
The majority of the documents that were examined refer to one or more 
international documents on biomedical research ethics. We concluded 
that recently a lot of efforts have been made in many countries in the 
Middle East. However, compared with international documents, most of 
the research ethics documents in use in this region demonstrate 
numerous deficiencies. These documents show extensive differences in 
regard to their development, structure, content, and reference to 
international guidelines. 
In chapter 4 we described our findings based on 12 in-depth interviews 
with professionals from the Middle East involved in or with ties to genetic 
research. Four themes were introduced during the discussion: research 
ethics regulations, confidentiality, informed consent, and child 
participation in research. We found few differences between those 
interviewed; their primary concerns were mainly similar to what is stated 
internationally; they generally believed that confidentiality protection is 
socially very important and that informed consent must be obtained from 
both adult and child participants. In addition, because most populations 
have a high percentage of children, and because children are not just 
small adults, but show important differences, the interviewed 
professionals strongly believed that it is imperative to include children in 
biobank research. 
In chapter 5 we described the findings of a survey conducted with 200 
respondents at King Abdulaziz Medical City in Riyadh, Saudi Arabia, 
among five groups of equal size, which included researchers, physicians, 
medical students, donors, and laypersons. The majority of participants 
agreed that confidentiality is an important issue and that it is well 
protected in the Saudi biobank. All five groups showed different attitudes 
toward disclosing information to various third parties. They were in favor 
of allowing treating physicians, and to a certain extent family members, 
to have access to medical and genetic results from research. No significant 
difference was found between views on medical and genetic 
confidentiality. The majority of the respondents agreed that 
confidentiality may be breached in case of justified reasons. Even 
considering differences in religion, culture, and other factors, the study’s 
results were consistent with results presented in the literature and 
research conducted in other countries. 
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In chapter 6 we described the findings of a survey of attitudes toward 
ethical issues conducted on 160 respondents from four groups of equal 
size comprised of researchers, physicians, medical students, and 
laypersons, at King Abdulaziz Medical City in Riyadh, Saudi Arabia. The 
results show a clear and positive attitude toward pediatric clinical and 
genetic research inside and outside of Saudi Arabia. Parental consent is 
viewed as essential with 60% saying parental consent is sufficient for 
children up to 12 and 40% for children 12-18 years. More than 90% of the 
respondents preferred to gain approval from any child with decision-
making capacity; 58.2% and 38.6% believe that children between 12 and 
18 and people above 18 years, respectively, can understand and thus give 
their approval for genetic research. Clear majorities in the study agreed 
with re-consenting children when they become adults, and with allowing 
the child to withdraw at any time.  A clear majority agreed that either 
parent can sign to give consent for a child to participate in a research 
biobank. We concluded that in varying degrees all four groups believe 
such elements of ethical consideration are critical. However, the group 
with the least understanding of research and its ethics had the smaller 
percentage of respondents that agreed on the importance of having 
children involved in research. Even considering differences in religion, 
culture, and other factors, the study’s results were consistent with results 
presented in the literature and research conducted in other countries.  
In chapter 7 we described our findings of a comparison of the governance 
of the Saudi biobank (SB) compared with four different western biobanks: 
UK biobank, Estonian Genome Project, DeCODE genetics in Iceland, and 
CARTaGENE in Quebec. We examined strengths and weaknesses of SB`s 
governance as well as the similarities and differences with other biobanks, 
regarding three different ethical issues: confidentiality, informed consent, 
and children’s participation in research. We concluded that SB, which is 
based on international and national guidelines and Islamic religion, shares 
the same ethical values with other biobanks and does not show major 
differences from other biobanks, although some dissimilarity could be 
found in some issues. Confidentiality is a sensitive concern, particularly 
when it relates to discrimination and stigmatization. Informed consent is 
another important issue in all biobanks. Unlike some other biobanks, SB 
does not allow samples and data destruction in all withdrawal degrees. 
Participation of children in biobanking is important in Saudi, and can be 
offered the required protection. We proposed meeting with other 
biobanks worldwide for future collaborations, greater discussion, and 
harmonization. Governance of SB is one of the newly established health 
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policies in the Middle East that regulate biobanking research and can be 
adapted partially or completely by other biobanks in the Arabic and 
Islamic world. 
In chapter 8 we developed an Islamic opinion on research biobanks and 
formulated recommendations for research banks in Middle Eastern and 
Islamic countries. We applied our findings from all previous chapters to 
generate a normative reflection and develop an opinion about ethics of 
research biobanks that we think reflects an Islamic position on research 
biobanks. We concluded that Islam shows a great interest in respecting 
confidentiality and preventing any kind of discrimination or 
stigmatization. Islam does not express any opinion regarding the coding 
method and security system, since these are practical issues that must be 
decided by each biobank. Informed consent is considered an obligation 
for participation in a research biobank. This participation must be 
voluntary, and the informed consent must contain enough information 
and a suitable environment to allow the participant to make an informed 
participation decision. Withdrawal of consent is a right for every 
participant. Islam does not express any opinion on the degrees of 
withdrawal or whether collecting a one-time consent is sufficient or 
whether consent must be obtained for every research study. Islam allows 
child participation in biobanks, but requires that no harm be tolerated, 
that a guardian give consent, and that the child give assent if he is able to 
do. No certain age is set for participation. Fathers are preferred for giving 
consent for child participation. 
RECOMMENDATIONS & CONCLUSION  
Biobanks raise many ethical challenges for which researchers, policy 
makers, and philosophers have a duty to find solutions, and establish best 
practices that biobanks and their employees can follow. We show below 
the most important recommendations derived from our research. 
Preamble 
1. It is noticed that many Arabic and Islamic countries, especially the Gulf 
countries show a significant interest in medical research and in the 
establishment of research centers and biobanks as is the case in Qatar, 
Saudi Arabia, and others. 
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2.  The dominant religion in these countries Islam, which affects the lives 
of people and their behavior and builds their positions. Laws in Arabic 
and Islamic countries must have no conflict with Islamic law. 
3. Communities in these countries enjoy a set of customs, traditions and 
social norms, and have social and familial structure that must be 
considered and taken into account. 
4. The increasing presence of Muslims in most countries around the 
world, including Western countries, makes it important for decision-
makers in these countries to be aware of the concerns of this part of 
the population, especially about any modern issues that have an 
impact on the people’s lives, as is the case with biobanks. 
 
Research biobanks 
There is a positive trend towards medical research done within an 
acceptable ethical frame. This positive position is supported by fatwas 
issued by Islamic juridical councils, and the opinions of the Islamic 
Organization for Medical Sciences (IOMS). Medical doctors and 
researchers agree also on the importance of conducting medical research, 
which also is acceptable by the research participants and lay people. The 
existence of solid ethical controls, will ensure against any deviation of 
medical research from its noble objectives, and guard against falling into 
ethical violations.  Some Arab and Islamic countries already have 
established good research ethics guidelines, and many others are going in 
the same direction. The positive trend towards medical research is fully 
applied on in establishing research biobanks that must be controlled by a 
good ethical system. 
  
 
 
Confidentiality 
Respect of confidentiality is an important ethical principle in the work of 
research biobanks generally, as well as those established in the Islamic 
world. Respecting confidentiality is consistent with Islamic fatwas of 
juristic councils and the regulation of medical research ethics. It is also 
supported by the opinions of researchers and medical doctors, besides 
1. Establishment of research biobanks is important and allowed, as long as autonomy 
is respected, and harm is prevented. 
2. More, specific fatwas about research biobanks and their ethical standards are 
needed 
3. Updated and improved research ethics guidelines are needed in most of Arabic 
countries. 
 
 
Establis ment of research biobanks is important and allowed, as long as autonomy is 
respected, and harm is prevent d.  
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the opinions of research participants, who consider confidentiality an 
obligation. Because of tribal and extended family structure of many 
Muslim societies and the social customs, preventing any kind of 
discrimination or stigma has a great importance because the effect 
extends beyond individuals to families and societies. 
 
 
Informed consent 
Participation in research biobanks is not allowed without a complete and 
correct informed consent from donors, which must be voluntary and with 
no coercion. Participants must also enjoy the right of withdrawal any time. 
Both informed consent and right of withdrawal match the perspectives of 
Islamic fatwas and research ethics guidelines besides the opinions of 
researchers, and research participants.  
Using one-time consent in research biobanks rather that informed 
consent for each research proposal is preferred for both scientific and 
practical reasons, and it is accepted ethically and in Islamic thinking. The 
same is correct when it comes to multi-degrees of withdrawal. 
 
 
 
 
 
Child participation in research biobanks 
Participation of children in research biobanks is important and necessary, 
especially in societies with high percentages of childhood. However, risks 
must be not more than minimum, a standard that biobanks readily 
endorse.  There is no Islamic or ethical objection to child participation in 
research biobanks, and it is accepted according to the views of both 
researchers and lay people. Getting consent from parents in essential and 
7. Informed consent is an obligation before participation.   
8. Informed consent must contain all information needed to allow a participant to 
make a well-informed decision. 
9. Participation must be voluntary. 
10. One-time consent is not mandatory but preferred. 
11. Withdrawal of consent is a right of every participant. 
12. Degrees of withdrawal are up to every biobank. 
 
4. Confidentiality must be respected. 
5. No discrimination is allowed. 
6. No stigmatization is allowed. 
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obligatory and having child assent is preferred when the child is able to 
give it.  
  
 
 
 
LIMITATIONS AND SUGGESTIONS FOR FURTHER RESEARCH 
We have several limitations in our research, and further research is 
needed in this field.  
In studying Islamic opinion we relied mainly on Juristic fatwas, especially 
the International Islamic Fiqh Academy and the Islamic Fiqh Council, 
besides the document of the Islamic Organization of Medical Sciences. 
Although we tried to review individual efforts of Muslim scholars in this 
field we were not able to do an exhaustive search because no such search 
engines are available in the Arabic language like PubMed Google Scholars 
and others. 
When studying the guidelines in Middle Eastern countries, restrictions on 
the data should be noted even though we used the most recent data 
available. Analysis of and comparison between the contents of the 
guidelines among national documents and international documents—
such as defining minors, incompetent persons, benefits, risks, and so 
forth—cannot be performed in a precise manner because these 
guidelines are designed to provide concise and general ethical 
protections. Numerous ongoing efforts in establishing research ethics 
guidelines in Arabic and Islamic countries are not included in our study. 
For our empirical studies, the qualitative research includes only 12 
scholars from a few countries in the Middle East. Such results cannot be 
generalized to express the opinion of all Muslim Scholars. This is also true 
regarding the two quantitative studies conducted in Saudi. Thus, it would 
be important to increase the sample size and have samples from different 
regions in future research. 
13. Children can participate in research biobanks.  
14. No harm is allowed for participating children.  
15. A guardian’s consent is essential, with fathers preferred. 
16. The assent of the child is preferred when the child is able to do so. 
17. More specific fatwas about child research is needed, especially about the 
minimum age to allow participation, who can sign consent, and others.    
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The governance of Saudi biobank, as analyzed in this study, cannot be 
assumed to represent the governance of other biobanks in the region or 
to express the factual situations of biobanks in Islamic and Arabic 
countries in general. More study across these countries is needed to 
provide a comprehensive understanding of the governance of their 
biobanks. 
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Scientific Summary 
ETHICS OF RESEARCH BIOBANKS 
ISLAMIC PERSPECTIVES IN AN INTERNATIONAL CONTEXT 
INTRODUCTION 
Research biobanks can offer great benefits for science and health care. 
However, they give rise to many ethical challenges. These challenges may 
have different perspectives in Muslim countries, where research biobanks 
have begun to appear. Although much has been written about ethics 
challenges of research biobanks, no literature discussing these challenges 
from Islamic perspectives could be found. 
In this project we investigated the ethical issues related to 
medical/biobanking research in the context of Islamic and Middle Eastern 
countries. We especially focused on three issues: confidentiality, 
informed consent, and child participation in research biobanks, which are 
very important and under-researched issues in the Islamic and Middle 
Eastern world. Based on this investigation, we attempted to provide 
insight into the above-mentioned issues and recommend guidelines that 
can be used by fellow researchers, policy makers, and ethics committees 
in Islamic and Middle Eastern countries as well as other countries where 
Muslims are a component of society.   
STUDY DESIGN AND RESULTS 
Our inquiry and subsequent recommendations are based on four steps. In 
the first part we reviewed and explored the current research ethics and 
practices in the context of Islam and in the Middle East. In the second part 
we conducted empirical inquiries, using qualitative and quantitative 
research, into current ethos of the Islamic community regarding 
confidentiality, informed consent, and research on children. In the third 
part we analyzed the existing governance of the Saudi biobank compared 
with governance of other biobanks outside Middle Eastern and Islamic 
countries. In the fourth part we developed an Islamic opinion on research 
biobanks and formulated recommendations for the research banks in 
Middle Eastern and Islamic countries. 
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Part I: The state-of-the-art of current research ethics and practices are 
reviewed in the context of Islam and in the Middle East.  
Our reviews were performed in two phases. In phase one, we investigated 
the influence of Islamic values on the issues of confidentiality and 
participation of children in clinical research. We explored patient 
confidentiality and potential conflicts with research practice in light of 
institutional fatwas released by international, regional, and national 
Islamic Sunni juristic councils. We discussed how these fatwas affect 
research and publication by Muslim doctors, researchers, and Islamic 
medical organizations. Next we investigated the guidelines from thirteen 
Arabic countries in the Middle East, considering the ethical principles 
stated in the international guidelines.    
Part II: Empirical inquiries into current ethos of the Islamic community 
regarding confidentiality, informed consent, and research on children. 
To review the opinion of medical professionals in the Middle East, we first 
performed semi-structured interviews with professionals who are actively 
involved in using stored tissue samples to perform genetic research. This 
qualitative study was followed by a survey among different professionals 
(medical doctors, students, and researchers), as well lay people who were 
participants in the Saudi biobank.  
Part III: A theoretical analysis of the existing governance of the Saudi 
biobank.   
Saudi Biobank governance was investigated and checked against the 
concepts and themes derived from the first and the second phase of this 
study. We examined the similarities, differences, strengths and 
weaknesses of the current governance of SB regarding three major ethical 
issues: confidentiality, informed consent, and children’s participation in 
research, compared to some selected western national biobanks. We 
evaluated these issues in relation to international guidelines as well as 
Islamic law.   
Part IV: Developing an Islamic opinion on research biobanks in Middle 
Eastern and Islamic countries.  
Based on our research findings, we developed an opinion that reflects 
Islamic methods in reasoning and taking into account the fatwas 
reviewed. 
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Part V: Summary and recommendations  
We presented a summary of our findings, and then we formulated 
recommendations regarding the use of stored tissue samples in the 
Middle East. These recommendations can be used by researchers, ethics 
committees, and policy makers. 
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Wetenschappelijke samenvatting 
DE ETHIEK VAN BIOBANKEN  
VOOR WETENSCHAPPELIJK ONDERZOEK 
ISLAMITISCH PERSPECTIEF IN EEN INTERNATIONALE CONTEXT 
INTRODUCTIE 
Biobanken voor wetenschappelijk onderzoek kunnen grote voordelen 
bieden aan de wetenschap en de gezondheidszorg. Zij veroorzaken echter 
ook vele ethische problemen. Deze problemen kunnen een ander 
perspectief hebben in islamitische landen waar biobanken voor 
wetenschappelijk onderzoek beginnen te verschijnen. Hoewel er al veel is 
geschreven over de ethische problemen van biobanken voor 
wetenschappelijk onderzoek, zijn er geen publicaties te vinden waarin 
deze problemen vanuit islamitisch perspectief worden behandeld. 
In dit project hebben we de ethische problemen in verband met medisch 
wetenschappelijk onderzoek met biobanken onder de loep genomen in 
de context van islamitische landen en het Midden-Oosten. We hebben 
ons vooral gefocust op drie problemen: vertrouwelijkheid, geïnformeerde 
toestemming, en de deelname van kinderen aan biobanken voor 
wetenschappelijk onderzoek. Dit zijn zeer belangrijke problemen in de 
islamitische wereld en het Midden-Oosten en ze zijn te weinig 
onderzocht. Op basis van dit onderzoek hebben we geprobeerd inzicht te 
geven in de eerder genoemde problemen en hebben we richtlijnen 
aanbevolen die kunnen worden gebruikt door mede-onderzoekers, 
beleidsmakers en ethische commissies in islamitische landen en het 
Midden-Oosten evenals andere landen waar moslims deel uitmaken van 
de maatschappij.  
OPZET EN RESULTATEN VAN HET ONDERZOEK 
Onze vraagstelling en de daaropvolgende aanbevelingen zijn gebaseerd 
op vier stappen. In het eerste onderdeel hebben we de onderzoeksethiek 
en –praktijk geëvalueerd en onderzocht in de context van de islam en het 
Midden-Oosten. In het tweede onderdeel hebben we empirische vragen 
gesteld met behulp van kwalitatief en kwantitatief onderzoek over het 
huidige ethos van de islamitische gemeenschap in het Midden-Oosten in 
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verband met vertrouwelijkheid, geïnformeerde toestemming en 
wetenschappelijk onderzoek bij kinderen. In het derde onderdeel hebben 
we het bestaande management van de Saudische biobank vergeleken met 
het management van andere biobanken, buiten het Midden-Oosten en 
islamitische landen. In het vierde onderdeel hebben we een islamitische 
visie ontwikkeld op biobanken voor wetenschappelijk onderzoek en 
hebben we aanbevelingen geformuleerd voor de biobanken voor 
wetenschappelijk onderzoek in het Midden-Oosten en islamitische 
landen. 
Deel I: Het overzicht van de huidige ethiek van wetenschappelijk 
onderzoek, geëvalueerd in de context van de Islam en het Midden-
Oosten.  
Onze evaluaties werden in twee fasen uitgevoerd. In fase één hebben we 
de invloed van de islamitische waarden op de problemen van 
vertrouwelijkheid en deelname van kinderen aan klinische 
wetenschappelijke onderzoeken onderzocht. We hebben de 
geheimhouding van de patiënt en potentiële conflicten met de 
wetenschappelijke onderzoeksmethoden onderzocht tegen de 
achtergrond van institutionele fatwa's uitgesproken door internationale, 
regionale en nationale Sunni-islamitische juridische adviseurs. We 
hebben besproken welke invloed deze fatwa's hebben op het 
wetenschappelijke onderzoek en publicaties door moslim-artsen, -
onderzoekers en islamitische medische organisaties. Vervolgens hebben 
we de richtlijnen van dertien Arabische landen in het Midden Oosten 
onderzocht, rekening houdend met de ethische principes in de 
internationale richtlijnen.   
Deel II: Empirische vragen over het huidige ethos van de islamitische 
gemeenschap in verband met vertrouwelijkheid, geïnformeerde 
toestemming en wetenschappelijk onderzoek bij kinderen. 
Voor de evaluatie van de houding van artsen in het Midden-Oosten 
hebben we eerst semi-gestructureerde interviews gehouden met artsen 
die actief zijn betrokken bij het gebruik van opgeslagen weefselmonsters 
voor het uitvoeren van wetenschappelijk genetisch onderzoek. Dit 
kwalitatieve onderzoek werd gevolgd door een enquête onder 
verschillende medische beroepskrachten (artsen, studenten en 
onderzoekers), en ook onder leken die hebben deelgenomen aan de 
Saudische biobank.  
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Deel III: Een theoretische analyse van het bestaande management van 
de Saudische biobank.  
Het management van de Saudische biobank (SB) werd onderzocht en 
gecontroleerd aan de hand van de concepten en thema's afgeleid uit de 
eerste en de tweede fase van dit onderzoek. We hebben de 
overeenkomsten, verschillen, de sterke en zwakke punten van het huidige 
management van de SB bestudeerd in verband met drie belangrijke 
ethische problemen: vertrouwelijkheid, geïnformeerde toestemming en 
deelname van kinderen aan wetenschappelijke onderzoeken, in 
vergelijking met enkele geselecteerde westerse nationale biobanken. We 
hebben deze problemen beoordeeld aan de hand van internationale 
richtlijnen en van de islamitische wet.  
CONCLUSIE EN AANBEVELINGEN 
Deel IV: De ontwikkeling van een islamitische opinie over biobanken 
voor wetenschappelijk onderzoek en het formuleren van aanbevelingen 
inzake de banken voor wetenschappelijk onderzoek in het Midden-
Oosten en islamitische landen. 
Op basis van onze bevindingen over wetenschappelijk onderzoek hebben 
we een opinie ontwikkeld die de islamitische manier van denken en  de 
geëvalueerde fatwa's weergeeft. Vervolgens hebben we aanbevelingen 
geformuleerd in verband met het gebruik van opgeslagen 
weefselmonsters in het Midden-Oosten. Deze aanbevelingen kunnen 
worden gebruikt door wetenschappelijke onderzoekers, ethische 
commissies en beleidsmakers. 
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